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SYMPOSIUM 1: FUNCTIONAL GENOMICS, PROTEOMICS
AND BIOINFORMATICS
1.1. Epigenetics: DNA Methylation and Far Beyond
IL 1.1–1
The role of MeCP2 in the brain
A. Bird, P. Skene, R. Illingworth and J. Guy
Wellcome Trust Centre for Cell Biology, University of Edinburgh,
Edinburgh, UK
The DNA of every cell in the body carries a pattern of chemical
modifications due to the methylation of cytosine in the dinucleo-
tide sequence 5¢CG. It is thought that these chemical marks help
to define the pattern of gene expression that is appropriate for
each cell type. The nuclear protein MeCP2 was originally discov-
ered because of its ability to specifically bind to methylated CG
sites, but not to CGs lacking the methyl moiety. Because of its
DNA binding preference, it was hypothesised that MeCP2 inter-
prets the DNA methylation signal. A considerable body of
evidence indicates that DNA methylation causes gene silencing
and, in line with this view, early evidence established that MeCP2
can attract molecular machinery that contains enzymes capable
of altering chromatin structure, for example by removing acetyl
groups from histone tails. A plausible hypothesis is therefore that
MeCP2 binds to methylated DNA and recruits deacetylase activ-
ity so that the chromatin environment becomes incompatible with
efficient transcription. This scenario predicts that the absence of
MeCP2, as in neurons of patients with the autism spectrum dis-
order Rett Syndrome, will cause inappropriate gene expression
due to relaxed repression. Decisive evidence supporting this
prediction has proven elusive so far and other potential functions
for MeCP2 have been proposed – for example that it is an acti-
vator of transcription or a regulator of messenger RNA splicing.
The functional significance of MeCP2 will be assessed in the light
of studies of the structure and dynamics of the interaction
between MeCP2 and methylated DNA at the molecular level. At
the level of brain physiology, the unexpected reversibility of Rett
Syndrome-like symptoms in Mecp2-null mice has important
implications, as it demonstrates that MeCP2 can assume its nor-
mal functions in a brain that developed and acquired severe
neurological symptoms in the complete absence of MeCP2. These
results challenge the long-held view that Rett Syndrome is a
‘neurodevelopmental disorder’. Taken together, the molecular
and neurobiological information implicate MeCP2 as a protein
that is essential for the tight maintenance and stability of gene
expression programs in mature nerve cells.
IL 1.1–2
Asymmetric cell division through epigenetic
differentiation of sister chromatids and their
selective segregation in mitosis
A. Klar
National Cancer Institute, GRCBL, Frederick, USA
Our studies with the model system of fission yeast have discovered
two new principles of biology. First, developmental asymmetry of
sister cells simply results from the inheritance of older ‘Watson’
versus older ‘Crick’ chain-containing chromatids at the mat1 locus
where through epigenetic means nonequivalent sister chromatids
are generated by chromosome replication. Second, epigenetic
states controlling gene repression are inherited in mitosis and
meiosis as remarkably stable conventional Mendelian markers (1).
We propose that likewise asymmetric cell divisions in higher
eukaryotes might result by further postulating biased segregation
of differentiated sister chromatids of both copies of a specific
chromosome to daughter cells (2,3). Can we explain hitherto
unexplained developmental traits/disorders in humans and verte-
brates by invoking such principles? The causes of schizophrenia
and bipolar human psychiatric disorders are unknown. A novel
somatic cell genetics, SSIS (Somatic Strand-specific Imprinting
and Selective strand segregation) model, postulated biased segre-
gation of differentiated older ‘Watson’ versus ‘Crick’ DNA chains
of a chromosome to specific daughter cells. Such an oriented
asymmetric cell division in embryogenesis may constitute the
mechanism for development of healthy, functionally nonequiva-
lent brain hemispheres in humans. For evidence, genetic translo-
cations of the relevant chromosome might therefore cause disease
by disrupting the chromosome-specific biased chromatid segrega-
tion process. This way the epialleles of a hypothetical gene
controlling brain laterality development in the translocation-
containing chromosome will be randomly distributed to sister
cells. Accordingly, the model predicts that symmetrical brain
hemispheres might develop in 50% of translocation carriers.
Thus, the observation of only 50% of chromosome 1/6/9;11 trans-
location carriers that do develop disease is in accord with the
model (4). Likewise, the SSIS model is also advanced for visceral
laterality development in mice.
References:
1. Klar AJS. Lessons learned from studies of fission yeast
mating-type switching and silencing. Annual Review of
Genetics 2007; 41: 213–36.
2. Armakolas A and Klar AJS. Cell type regulates selective
segregation of mouse chromosome 7 DNA strands in mitosis.
Science 2006; 311: 1146–1149.
3. Armakolas A and Klar AJS. Left-right dynein motor impli-
cated in selective chromatid segregation in mouse cells. Science
2007; 315:100–1.
4. Klar AJS. A genetic mechanism implicates chromosome 11 in
schizophrenia and bipolar diseases. Genetics 2004; 167:
1833–1840.
IL 1.1–3
Epigenomic programs and reprogramming in
mammals
J. Walter
Genetics/Epigenetics, Universitat de Saarlandes, Saarbru¨cken,
GERMANY
Epigenetic programs play an essential role for the establishment
of pluri-and totipotency of cells in the early embryo. In mammals
histone modificatons and DNA-methylation patterns are rapidly
changed on the parental chromosomes merged from from the egg
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and the sperm. This reprogramming begins rapidly after fertiliza-
tion and predominantly affects the paternal (sperm) chromo-
somes in the first cell cycle. The reprogramming is apparently
crucial to reset the chromatin for developmentally regulated
genetic programs. Comparative immunofluorescence based analy-
sis of chromatin changes reveals a striking conservation of the
dynamic and specificty of such epigenetic reprogramming events
in early mammalian embryos. Of particular interest are enzymatic
mechanisms which trigger a rapid replication independent elimi-
nation of DNA-methylation from the paternal chromosomes in
the zygote. Such ‘active’ demethylation mechanisms occur in a
time window of about 4–7 hours postfertilization. We investi-
gated the potential involvement of DNA-repair mechanisms in
this DNA-demethylation process and identified a striking accu-
mulation of strand breaks and repair markers around the early
phases of zygotic development. We furthermore observe that
potential repair activities can be separated from DNA-replication
processes. We conclude that epigenetic reprogramming is indeed
partially linked to DNA repair processes. I will discus the poten-
tial mechanisms of such DNA-demethylation processes and some
of their general implications for genetic and epigenetic variation.
IL 1.1–4
Molecular coupling of X-inactivation regulation
and pluripotency
P. Navarro1, I. Chambers2, V. Karwacki-Neisius2, C. Chureau1,
C. Morey1, A. Dubois1, A. Oldfield3, C. Rougeulle3 and
P. Avner1
1Institut Pasteur, Developmental Biology, Paris, France, 2MRC
Centre Development in Stem Cell Biology, Institute for Stem Cell
Research, Edinburgh, UK, 3Universite´ Paris Diderot, UMR 7216
Epige´ne´tique et Destin Cellulaire, Paris, FRANCE
The integration of X-chromosome inactivation into the develop-
mental process is a crucial aspect of this paradigm of epigenetic
regulation. During early female mice development, X-inactivation
reprogramming occurs in pluripotent cells of the inner cell mass
of the blastocyst, when imprinted X-inactivation is replaced by
random inactivation, via a transient stage characterized by the
presence of two active X-chromosomes. Reactivation of the inac-
tive X also occurs in pluripotent primordial germ cells and is also
observed in-vitro, during the reprogramming of female somatic
cells mediated by nuclear cloning, by fusion with embryonic stem
(ES) cells, and during the generation of induced pluripotent stem
(iPS) cells. Reprogramming of X-inactivation is therefore associ-
ated with the acquisition of pluripotencyin-vivo and in-vitro.
Using ES cells, we have demonstrated that the coupling of
X-inactivation reprogramming with pluripotency depends on the
functional interaction of the master genes controlling pluripoten-
cy with key players in the X-inactivation process such as its
molecular trigger, the non-coding Xist RNA, and its antisens
cis-repressor Tsix. Nanog, Oct4 and Sox2 (the triumvirate of
factors underlying pluripotency) all cooperate to repress Xist in
undifferentiated ES cells. Additionally, Rex1 (a well-known mar-
ker of pluripotent cells), Klf4 and c-Myc (which in conjunction
with Oct4 and Sox2 are required to generate iPS cells) are
involved in conferring maximal transcriptional activity to Tsix in
undifferentiated ES cells. Our results provide a molecular frame-
work linking X-inactivation reprogramming to the control of plu-
ripotency, and shed light on how pluripotency and genome
reprogramming factors reset established epigenetic states.
OP 1.1-1
Recognition of monomethylated histone
peptides by the malignant brain tumor repeats
of human SCML2
C. M. Santiveri1, B. C. Lechtenberg2, M. D. Allen2, A. Sathya-
murthy2, A. M. Jaulent2, S. M. V. Freund2 and M. Bycroft2
1Instituto Quimica-Fisica Rocasolano, CSIC, Espectroscopia y
Estructura Molecular, Madrid, SPAIN, 2Medical Research
Council, Centre for Protein Engineering, Cambridge, UK
SCML2 (Sex Comb on Midleg-like 2) is a constituent of the
Polycomb repressive complex 1, a large multiprotein assembly
involved in the long term silencing of gene expression required to
maintain cell identity. SCML2 contains two N-terminal 100-resi-
due malignant brain tumor (MBT) repeats, a protein module
adopting a beta-barrel core similar to that of chromatin-binding
domains like chromo- and Tudor domains. All are members of
the Royal superfamily of effector modules able to ‘‘read’’ differ-
ent types of histone post-translational modifications. We have
used NMR spectroscopy to investigate the binding specificity of
the MBT repeats of human SCML2. Our data show that they
preferentially recognize histone peptides monomethylated at
lysine residues, with no apparent sequence specificity, and also
free monomethylated lysine. Patterns of chemical shift changes
are very similar for all the monomethylated lysine-containing
peptides and for the monomethylated lysine residue, mapping a
cluster of residues at one end of the beta-barrel of the second
repeat. The crystal structure of the complex between the protein
and monomethylated lysine shows that the modified amino acid
is buried deep into a conserved aromatic pocket formed by two
phenylalanine and one tryptophan residues. A salt bridge
between the monomethylammonium moiety and the carboxylate
group of a conserved aspartate residue further provides specificity
for the lowest lysine methylation state. This work is a good
example of synergy between NMR and X-ray crystallography.
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1.2. Evolution of Polyploid Genomes
IL 1.2-1
Epigenetic variation and inheritance
E. Richards1, H. R. Woo2, D. Travis2 and S. Rangwala2
1Boyce Thompson Institute, for Plant Research, Ithaca, NY, USA,
2Washington University, Biology, St. Louis, MI, USA
Our group has been studying the regulation and function of cyto-
sine methylation by combining different genetic approaches in
Arabidopsis. One arm of this analysis has been characterization
of variation in DNA methylation found in natural accessions.
This approach has the advantage of allowing us to assess and
dissect the contributions from both genetic and epigenetic varia-
tion. In some cases, we find that epigenetic variation and inheri-
tance plays a major role in shaping extant variation in DNA
methylation. For example, differences in DNA methylation of
the Sadhu class of transposable elements among different natural
accessions co-segregates in inter-strain crosses with the elements
themselves. This cis-regulation is consistent with epigenetic
inheritance of parental DNA methylation levels. However, this
epigenetic inheritance can also be modulated by trans-acting
genetic variation. In some cases, trans-acting genetic variation
plays a dominant role. For example, we have identified one nat-
ural accession that has reduced centromere DNA methylation
caused by deletion in a gene encoding an SRA domain methylcy-
tosine-binding protein, VIM1 (variant in methylation 1). VIM1
and a subset of its paralogs function together to maintain
CpG methylation and transcriptional silencing throughout the
Arabidopsis genome.
IL 1.2–2
Plant chromosomes at interphase - paired?
cohesed? dynamic?
I. Schubert
IPK, Cytogenetics & Genome analysis, Gatersleben, GERMANY
Eukaryotic chromosomes occupy distinct territories within inter-
phase nuclei. The arrangement of chromosome territories (and of
specific chromatin domains therein) is likely to be important in key
events that occur within cell nuclei such as replication, transcrip-
tion, repair and recombination processes. Our knowledge about
interphase chromatin arrangement, mainly based on results
obtained by means of various in situ labelling approaches, is still
meagre. Nevertheless, it is emerging that phylogenetic affiliation of
a species, cell cycle and differentiation status, as well as environ-
mental influences may have an impact on, and may cause altera-
tions of, interphase nuclear architecture. Most data regarding
interphase structural organization in plants have been obtained for
Brassicaceae (Arabidopsis thaliana and related species) and for
cereal species. I will survey the present knowledge about interphase
arrangement of Brassicaceae chromosomes concerning the relative
positioning of chromosome territories, somatic pairing of homo-
logues, and sister chromatid alignment in meristematic and differ-
entiated tissues. Furthermore I will discuss the morphological
constraints and epigenetic impacts on the nuclear architecture and
the evolutionary stability of chromosome arrangement patterns as
well as alterations of nuclear architecture during transcription and
repair, in mutants with increased recombination activity, and in
lines carrying transgenic tandem repeat arrays.
IL 1.2–3
Genetics and epigenetics in diploid and
tetraploid Arabidopsis
O. Mittelsten Scheid, T. Baubec, H. Q. Dinh, W. Fang,
A. M. Foerster, N. Lettner, A. Pecinka, M. Rehmsmeier,
M. Rosa, L. Sedman and B. Wohlrab
Gregor Mendel Institute of Molecular Plant Biology, GMI,
Vienna, AUSTRIA
Approximately three decades ago, a small genome and low
genetic redundancy were major arguments for the choice of the
small weed Arabidopsis thaliana as a model organism for molecu-
lar biology of higher plants. Nevertheless, genome analysis has
revealed remnants from probably three ancient polyploidization
events. Fertile polyploid Arabidopsis is easy to generate from
recent diploid accessions. Furthermore, a substantial portion of
cells undergo endoreplicationeven in diploid plants, reaching high
levels of ploidy. Therefore, the plentiful resources of genetic and
genomic Arabidopsis information have been helpful to study the
consequences of auto- and allopolyploidization. These changes
are suspected to be important driving forces for plant evolution,
since many higher plants and most crop plants are polyploid.
Like in many other species, polyploidization in Arabidopsis is
associated with changes in the sequence and/or the chromatin
configuration of nuclear DNA. Multiplications of chromosome
numbers can thereby contribute to heritable, genetic and
epigenetic diversity. We will report on the formation and stability
of epialleles at transgenic and endogenous sequences and the role
of chromatin-modifying factors, based on analysis with molecu-
lar, genetic and cytological approaches. The work in the lab is
supported by grants from the Austrian Science Fund (FWF), the
EU Network of Excellence ‘Epigenome’ and the GEN-AU
program of the Austrian Ministry for Science and Research.
IL 1.2–4
Mechanisms of gene expression rewiring in
hybrids and polyploids
A. Levy1, I. Tirosh2, S. Reikhav3, M. Kenan-Eichler1 and
N. Barkai2
1Weizmann Institute of Science, Plant Sciences, Rehovot,
ISRAEL, 2Weizmann Institute of Science, Molecular Genetics,
Rehovot, ISRAEL, 3Weizmann Institute of Science, Plant Science
and Molecular Genetics, Rehovot, ISRAEL
Genome merging, in interspecific hybrids and allopolyploids, is
associated with novel patterns of gene expression. We have ana-
lyzed the genetic and epigenetic basis for this rewiring in two
model systems, namely a yeast hybrid between Saccharomyces
cerevisiae and S. paradoxus, and a synthetic wheat hybrid and
allopolyploid analogous to bread wheat. In yeast, we have ana-
lyzed how hybrid-specific gene expression patterns are generated
from the divergence in regulatory components between the paren-
tal species. Between the species, we have distinguished changes in
regulatory sequences of the gene itself (cis) from changes in
upstream factors (trans). Expression divergence was mostly due to
changes in cis. Changes in trans were condition-specific and
reflected mostly differences in environmental sensing. In the
hybrid, over-dominance in gene expression occurred through
novel cis-trans interactions or, more often, through modified trans
regulation associated with environmental sensing. We will discuss
the phenotypic impact of hybrid-specific expression patterns. In
wheat we have previously shown rapid genetic and epigenetic
alterations in genes or transposons at the onset of hybridization
Symposium Abstracts
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and/or in nascent allopolyploids. As small RNAs are candidates
for affecting these events, we have analyzed the changes in small
RNAs (Micro and siRNAs) populations in hybrids and allopolyp-
loids and their connection with gene and transposon expression.
We show that small RNA populations are altered in hybrids and
polyploids with the strongest changes occurring upon polyploidi-
zation. Overall, in the first generation of the polyploid, there was
a massive suppression of siRNAs that corresponds to repeats and
transposons. This is consistent with the observed transcriptional
activation of transposons upon polyploidization and supports the
role of siRNAs in heterochromatinization and repression of trans-
posons. These works emphasize how different levels of regulation,
namely genetic, epigenetic and environmental, can bring about
hybrid-specific expression patterns in lower and higher eukaryotes.
OP 1.2–1
Transcription through transgene is the most
frequent cause of positive position effects in
Drosophila melanogaster
O. Maksimenko, M. Silicheva, P. Georgiev
Department of the Control of Genetic Processes, Institute of Gene
Biology, Moscow, RUSSIA
This work is dedicated to study position effects in Drosophila
using a mini-white gene as a model system. As a result of
insertion of P-element vectors containing a mini-white gene with-
out enhancers into random chromosomal sites, flies with different
eye color phenotypes appear. Such effects are usually explained
by the influence of enhancer/silencer elements located around the
insertion site of the mini-white transposon. As a consequence,
insulators/MAR elements were broadly used to protect a trans-
gene expression from position effects. Alternatively we supposed
and showed that in many cases transcription through the trans-
gene is responsible for high levels of its expression in most of
chromosomal sites and be the cause of positive position effects.
Moreover the white promoter was decayed by efficient transcrip-
tion initiated from an upstream promoter. These results suggest
that enhancer–promoter interactions are more specific and that
incorrect stimulation of a promoter by a wrong enhancer is a rel-
atively rare event. It seems likely that the initiation of white
translation is able to induce from internal regions of transcripts.
Thus, in the absence of this property, transcription through a
transgene might lead to reducing of its expression. Our results
also showed that transcriptional terminators but not a strongest
Drosophila gypsy insulator, are efficient in protecting gene
expression from transcription-mediated position effects. There-
fore, combining an insulator and a terminator is the best way to
make transgene expression independent from position effects.
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1.3.Bioinformatics: fromComparisonstoFunctionalPredictions
IL 1.3–1
The evolution of enzyme mechanisms and
functional diversity
J. Thornton1, G. Holliday1, S. A. Rahman1 and J. Mitchell2
1EMBL-EBI, Directorate, Hinxton, UK, 2Unilever Centre,
University of Cambridge, Cambridge, UK
Enzyme activity is essential for almost all aspects of life. With
completely sequenced genomes, the full complement of enzymes
in an organism can be defined, and 3D structures have been
determined for many enzyme families. Traditionally each enzyme
has been studied individually, but as more enzymes are character-
ised it is now timely to revisit the molecular basis of catalysis, by
comparing different enzymes and their mechanisms, and to con-
sider how complex pathways and networks may have evolved.
IL 1.3–2
UniProtKB/Swiss-Prot: from sequences to
functions
A. Bairoch
Swiss Institute of Bioinformatics, Swiss-Prot, Geneva,
SWITZERLAND
The UniProtKB/Swiss-Prot knowledgebase [1] strives to provide
its users a corpus of manually annotated protein entries. Swiss-
Prot is far from being a mere repository of sequence. Since its cre-
ation in 1986, its mission has always been to provide its users, an
up-to-date description of what is known about a particular pro-
tein. Today, genomic sequences are very easily obtained and from
them it is relatively trivial to predict the corresponding protein-
coding regions. But there is still no shortcut to allow the high-
throughput elucidation of the function of all of these predicted
proteins. It is therefore important to capture in a knowledgebase
such as Swiss-Prot experimentally-derived information that will
permit to infer the function of related proteins in an increasingly
widening variety of organisms. We therefore concentrate our
annotation efforts on a palette of model organisms that are the
target of characterization studies. For these organisms that range
from bacteria (E. coli), fungi (S. cerevisiae), plants (A. thaliana) to
mammals (human and mouse) we try to be as complete as possi-
ble and provide as much information as we can that helps travel-
ling the path that leads from sequence to function.
Reference:
1. Nucleic Acids Res. 37:D169-D174(2009); DOI=10.1093/nar/
gkn664.
IL 1.3–3
Computational approaches to unveiling
ancient genome duplications
Y. Van de Peer
UGent-VIB Research, PSB, Gent, BELGIUM
Recent analyses of eukaryotic genome sequences have revealed
that gene duplication, by which identical copies of genes are
created within a single genome by unequal crossing over, reverse
transcription, or the duplication of entire genomes, has been
rampant. The creation of extra genes by such duplication events
has now been generally accepted as crucial for evolution and of
major importance for adaptive radiations of species and the gen-
eral increase of genetic and biological complexity. We have devel-
oped software to identify remnants of large-scale gene
duplication events and more recently, we have also developed
mathematical models that simulate the birth and death of genes
based on observed age distributions of duplicated genes, consid-
ering both small and large scale duplication events. Applying our
model to the model plant Arabidopsis shows that much of the
genetic material in extant plants, i.e., about 60% has been
created by several genome duplication events. More importantly,
it seems that a major fraction of that material could have been
retained only because it was created through large-scale gene
duplication events. In particular transcription factors, signal
transducers, and regulatory genes in general seem to have been
retained subsequent to large-scale gene duplication events. Since
the divergence of (duplicated) regulatory genes is being consid-
ered necessary to bring about phenotypic variation and increase
in biological complexity, it is indeed tempting to conclude that
such large scale gene duplication events have indeed been of
major importance for evolution.
IL 1.3–4
The evolutionary design of proteins
R. Ranganathan
UT Southwestern Medical Center, Department of Pharmacology,
Dallas, TX, USA
Natural proteins display structural and functional features that
seem beautifully matched for their biological role. They fold
spontaneously into well-defined three-dimensional structures, and
can display complex biochemical properties such as signal trans-
mission, efficient catalysis of chemical reactions, specificity in
molecular recognition, and allosteric conformational change.
These properties are known to arise from the cooperative action
of amino acid residues, but the pattern of residue cooperativity
in the tertiary structure is generally unknown. To address this,
we have been developing an approach (the statistical coupling
analysis or SCA) for estimating the evolutionary constraints
between sites on proteins through statistical analysis of large and
diverse multiple sequence alignments1,2. This analysis indicates
a novel decomposition of proteins into sparse groups of
co-evolving amino acids that we term ‘protein sectors’9. The
sectors are statistically quasi-independent and comprise physically
connected networks in the tertiary structure. Experiments in
several protein systems demonstrate the functional importance of
the sectors1,3,4,7,8 and recently, the SCA information was shown
to the necessary and sufficient to design functional artificial
members of two protein families in the absence of any structural
or chemical information. These results support the hypothesis
that the SCA captures the basic architecture of functional inter-
actions in proteins. We are now working on understanding the
physical mechanisms underlying statistical coupling, and perhaps
more importantly, trying to understand any principles of why the
SCA pattern might represent the natural design of proteins that
emerge through the evolutionary process.
References:
1. Lockless, Ranganathan R. Science 1999; 286: 295–9.
2. Suel et al., Nature Struct. Biol. 2003; 10: 59–69.
3. Hatley, et al., PNAS 2003; 100: 14445–14450.
4. Shulman et al., Cell 2004; 116: 417–429.
5. Socolich et al., Nature 2005; 437: 512–518.
6. Russ et al., Nature 2005 437: 579–583.
7. Mishra et al., Cell 2007; 131: 80–92.
8. Lee et al., Science 2008; 322: 438–442.
9. Halabi et al., 2009. manuscript submitted.
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OP 1.3–1
Promoter mapping: in silico, in vitro and
in vivo
M. Tutukina, K. Shavkunov, A. Ashikhmina, I. Masulis and
O. Ozoline
Institute of Cell Biophysics RAS, Functional Genomics and
Cellular Stress, Pushchino, RUSSIA
Nowadays a large number of promoter-search protocols for both
eukaryotic and prokaryotic genomes have been designed. Being
based on different platforms, they take into account practically
all known features of promoter DNA and are attuned for accu-
rate and efficient recognition of known promoters. However,
highly sensitive promoter finders if used for genome scanning
tend to generate a large amount of false positives, resembling
promoters by formal criteria but functionally inactive. In this
study we evaluate conformity of in silico, in vitro and in vivo data
for the set of unexpected promoters predicted by pattern-recogni-
tion software PlatProm within coding sequences and intergenic
regions. RNA polymerase binding capacity in vitro was verified
for 32 out of 34 tested promoters, indicating high capacity of
PlatProm to recognize promoter region. The coefficient of corre-
lation between PlatProm scores and percentage of DNA-bound
enzyme appeared to be rather high (0.63) assuming ability of the
program to predict enzyme binding efficiency. However, only 23
tested promoter regions were captured by RNAPol in vivo show-
ing hybridization signals with microarray probes in ChIP-on-chip
assays. Correlation coefficient between PlatProm scores and effi-
ciency of RNAPol binding according to ChIP-on-chip data was
also low (0.23), reflecting yet unpredictable structural state of
promoters within nucleoide. Since the final goal of genome
analysis is to reconstruct regulatory events taking place on bacte-
rial chromosome novel approaches are required to account this
natural environment by promoter finders of new generation.
OP 1.3-2
Protein-protein interaction network analysis of
exosomal proteome
S. C. Jang1, J. Yang2, D. Kim1, S. Kim1 and Y. S. Gho1
1POSTECH, Department of Life Science, Pohang, SOUTH
KOREA,
2POSTECH, School of Interdisciplinary Bioscience and
Bioengineering, Pohang, SOUTH KOREA
Exosomes are membrane vesicles secreted from endosomal mem-
brane compartment by various cell types such as hematopoietic,
epithelial, and tumor cells. Actively growing tumor cells shed
exosomes, and the rate of shedding increases in malignant
tumors. Although recent progress in this area has revealed that
exosomes play multiple roles in intercellular communication
including immune modulation and signal transduction, the pre-
cise sorting mechanism into exosomes and their complex biologi-
cal roles are still unclear. Here, we organized a detailed
proteinprotein interaction map of this extracellular organelle
using comprehensive proteomic analysis and bioinformatics
approach. This network showed the overall architecture of the
exosomes and essential hub proteins such as 14-3-3 proteins,
CSNK2A1 and SRC. Also, we revealed that exosome proteins
are sorted together by protein-protein interactions and organized
by functional modules tightly associated with cell structure and
motility, intracellular protein traffic, protein targeting and locali-
zation. Our results highlights that the physically interacting pro-
teins are sorted together into exosomes and form modules with
functional relevance, which are associated with exosome biogen-
esis and functions. Taken together with previously reported
results, our observations suggest that exosomes may act as com-
municasomes, i.e. extracellular organelles that play diverse roles
in intercellular communication.
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SYMPOSIUM 2: PROTEIN STRUCTURE AND INTERACTIONS
2.1. Protein Folding
IL 2.1–1
Quantifying interactions and energy
landscapes of membrane proteins by
single-molecule force spectroscopy and
microscopy
D. J. Mu¨ller
Biotechnology Center, Technische Universitat Dresden, Dresden,
GERMANY
Molecular interactions drive all processes in life. They determine
the molecular crosstalk and build the basic language of biological
processes. By developing a combined approach of atomic force
microscopy and single-molecule force spectroscopy (SMFS) we
image individual membrane proteins and locate their molecular
interactions at submolecular resolution. The approach observes
how molecular interactions fold a polypeptide into the functional
protein, stabilize the structure, or lead to protein misfolding. It
also measures protein–protein interactions, interactions switching
on and off ion channels, ligand- or inhibitor-binding, the func-
tional states of receptors, and the supramolecular assembly of
molecular machines as functional units. Dynamic SMFS (DFS)
obtains insights into the mechanical rigidity, transition state, life-
time, and free energy stabilizing the structural regions of a mem-
brane protein. Using DFS we reveal mechanistic insights how
molecular interactions modulates these energetic parameters to
precisely tune the function of a membrane protein.
IL 2.1–2
Towards physico-chemical understanding of
fibril formation of the Alzheimer disease-
associated amyloid beta-peptide
S. Linse1, E. Thulin1, E. Hellstrand1, E. Sparr2 and D. Walsh3
1Biophysical Chemistry, Lund University, Lund, SWEDEN, 2Phys-
ical Chemistry, Lund University, Lund, SWEDEN, 3Biochemistry,
University College Dublin, Dublin, UK
Protein aggregation can result in a major disturbance of cellular
processes, and is associated with several human diseases. The
amyloid b peptide (Ab) seems to play an important role in the path-
ogenesis of Alzheimer’s disease (AD). Ab is produced from a pre-
cursor protein, APP, by specific proteases and is kept at a constant
concentration in healthy individuals. The main proteolytic products
have 40 and 42 residues, respectively, and the 42 residue peptide is
most aggregation prone and of higher significance for disease devel-
opment. Onset of AD correlates with an imbalance in the ratio of
the 42 versus 40 products or increased total concentration. The
fibrillar form of Ab has a characteristic stacking of b strands per-
pendicular to the long axis of the fiber. The molecular events behind
the process leading from native to fibrillar states remain elusive, but
accumulated data frommany studies suggest that it involves a num-
ber of intermediate oligomeric states of different association num-
bers and structures. Pre-fibrillar oligomers seem to be critical
components for development of disease symptoms. Important
questions regard molecular properties of Ab peptide and its envi-
ronment which prevent or promote aggregation and amyloid fibril
formation. To address these questions we have developed a recom-
binant expression system with a facile and scalable purification pro-
tocol for Ab(M1-40) and Ab(M1-42), which relies on inexpensive
tools [Walsh et al., 2009]. This allows us to produce large quantities
of highly pure monomeric peptide to enable large scale systematic
studies. We have also made an effort to eliminate as many sources
of experimental error as possible and can now acquire highly repro-
ducible kinetic data on Ab fibrillation. We will report here the
results of large scale systematic studies of the fibrillation kinetics of
Ab and its dependence of physic-chemical factors such as peptide
concentration, pH, temperature, ionic strength, salt type and con-
centration, as well as the results from studies of the effects of vari-
ous kinds of biological macromolecules and surfaces including
phospholipid membranes of different compositions.
Reference:
Walsh DM, Thulin E, Minuogue A, Gustafsson T, Pang E,
Teplow DB, Linse S. FEBS J. 2009; 276, 1266–1281.
IL 2.1–3
Molecular interactions/electron transfer
protein complexes using Docking algorithms,
spectroscopy (NMR) and site direct
mutagenesis
J. Moura, L. Krippahl, S. Pauleta, R. Almeida and S. Del Acqua
Department of Chemistry - FCT - UNL, REQUIMTE, Caparica,
PORTUGAL
Chemera 3.0 is a molecular modeling software package that
includes BiGGER (Bimolecular complex Generation with Global
Evaluation and Ranking), a protein docking algorithm. We will
focus on new features of Chemera 3.0, specially constrained dock-
ing, to the search for protein–protein complex consistent with the
ambiguity of some experimental data. We take advantage of sets
of experimental data obtained by NMR, site-directed mutagenesis,
or other techniques. Other features of Chemera 3.0 include filter-
ing the docking models according to different interaction scores,
importing and creating new scores. Chemera 3.0 also interfaces
directly with web services for domain identification, secondary
structure assignment or sequence conservation, simplifying the
analysis of the partners and complexes, and includes tools for the
computation and display of electrostatic fields, protonation, acces-
sible and contact surface, and other molecular properties. Protein–
protein complexes formed by short live electron transfer proteins
will be presented covering a wide range of examples: di-heme
peroxidase, N2O and nitrite reductases, hydrogenase and aldehyde
oxido reductase in interaction with specific redox partners.
Acknowledgements: Nuno Palma and Isabel Moura for several
inputs and the financial support of the Fundac¸a˜o Cieˆncia e Tecn-
ologia - MCTES.
References to algorithm:
Palma PN, Krippahl L, Wampler JE, Moura JJG. BiGGER:
A new (soft) docking algorithm for predicting protein interac-
tions. Proteins: Structure, Function, and Genetics 2000; 39,
372–84.
Krippahl L, Moura JJG, Palma PN. Modeling protein complexes
with BiGGER. Proteins: Structure, Function, and Genetics
2003; 52, 19–23.
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IL 2.1–4
Towards quantitative predictions in cell
biology using chemical properties of proteins
M. Vendruscolo
Department of Chemistry, University of Cambridge, Cambridge,
UK
It has recently been suggested that proteins in the cell are close
to their solubility limits, and that the even minor alteration in
their levels might results in misfolding diseases. This concept is
intriguing because the abundance of proteins is closely regulated
by complex cellular processes, while their solubility is primarily
determined by the chemical characters of their amino acid
sequences. I will discuss how the presence of a link between
abundance and solubility of proteins offers the opportunity to
make quantitative predictions in cell biology based on the chemi-
cal properties of proteins.
IL 2.1–5
Equilibrium H/D-exchange patterns are
insensitive to reversal of the protein-folding
pathway
M. Oliveberg
Department of Biochemistry and Biophysics, Stockholm University,
Stockholm, SWEDEN
An increasing number of proteins are found to contain multiple
folding nuclei, which allow their structures to be formed by
several competing pathways. One example is the ribosomal pro-
tein S6 that comprises two folding nuclei, s1 and s2, defining two
competing pathways in the folding energy landscape: s1–s2 and
s2–s1. The balance between the two pathways, and thus the fold-
ing order, is easily controlled by circular permutation. In this
study we demonstrate that the equilibrium H/D-exchange pattern
of S6 remains the same regardless of how the folding sequence is
routed: the dynamic character of the different parts of a protein
is independent of their folding order.
OP 2.1–1
Cracking the lectin code : in silico modeling
and structure-functional study of principles
driving sugar preference in PA-IIL family
J. Adam1, Z. Kriz1, M. Prokop1, T. Chatzipavlou2, P. Zotos2,
J. Koca1 and M. Wimmerova3
1National Centre for Biomolecular Research, Masaryk University
Fac Sci, Brno, CZECH REPUBLIC, 2Division of Pharmaceutical
Chemistry - School of Pharmacy, National and Capodistrian
University of Athens, Athens, GREECE, 3National Centre for
Biomolecular Research and Department of Biochemistry, Masaryk
University Fac Sci, Brno, CZECH REPUBLIC
Introduction: Pseudomonas aeruginosa is an opportunistic
human pathogen, a bacterium capable of attacking individuals
with lowered immunity barriers. It is e.g. responsible for lethal
complications in patients with cystic fibrosis. The PA-IIL lectin
(a C-type fucose-preferring lectin with sugar binding mediated by
two calcium ions), produced by the bacterium plays a crucial role
in the host-pathogen interaction. Similar lectin sequences were
found in other bacteria, displaying distinct differences in prefer-
ence despite only small differences in structure of binding site.
In vitro and in silico mutants were constructed in order to ana-
lyze the principles driving the sugar preference.
Methods: Molecular docking was performed using the AUTO-
DOCK and DOCK software. The AMBER package was used
for molecular dynamics simulations. Isothermal titration calorim-
etry was used to determine the thermodynamics of binding
behavior of the mutants, verifying the method for extrapolative
application on protein design.
Results: The experiments showed the importance of the specific-
ity-binding loop in the binding site. The strongly-directing effect
of the aminoacid 22 is further reinforced by presence of longer
charged residue in position 24. Docking experiments combined
with subsequent molecular dynamics were performed to help with
the structural reasoning and exploring induced-fit changes.
Conclusions: Molecular modeling greatly helps in elucidating
the structural principles driving the sugar preference. The binding
preferences of the PA-IIL family lectins and their mutants can be
customized by mutations, and the knowledge obtained from this
study can be applied in designing potential inhibitors of the host-
pathogen interaction.
Supported by LC06030, MSM0021622413, GA303/09/1168
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2.2. Bioactive Peptides
IL 2.2–1
Identification and characterization of novel
anti-infectious peptides from the male genital
tract
F. Bourgeon1, J. Nicolas2, N. Melaine1 and C. Pineau3
1Innova Proteomics SA., Rennes, FRANCE, 2Irisa Inria Symbiose,
Campus de Beaulieu, Rennes, FRANCE, 3Inserm U625, Campus
de Beaulieu, Rennes, FRANCE
Antimicrobial resistance has become aggravated over the last
20 years. During this period pharmaceutical industries have
focused on making incremental improvements on long-estab-
lished antibiotics and, to an extent, sidelined the search for new
drugs to overcome pharmaco-resistance strategies currently
employed by pathogens. As a consequence bacterial infections
are, to date, the most morbid and resistant among infectious dis-
eases. This is, in particular, true for: diarrheic or respiratory
infections, meningitis, sexually transmitted diseases and nosoco-
mial infections. The time has come to discover innovative mole-
cules for anti-infection therapies. Among new molecules with
potential interest are antimicrobial peptides, an important com-
ponent of the natural defenses of most living organisms. These
are welcomed as serious candidates considering: their rapid mi-
crobicidal action, their broad spectrum of activity (bacteria,
fungi, parasites, enveloped virus) and their original mechanism of
action; the latter being difficult to evade by the resistance strate-
gies employed by bacteria. Over the past decade, more than 700
microbicidal peptides have been inferred from various species
including vertebrates. In the latter it is known that organs of the
male genital tract express a potent and sophisticated anti-infec-
tious defense system based partly on antimicrobial peptides. It
follows that major reproductive organs such as the testis and epi-
didymis are an ideal source for novel, highly specific microbicidal
peptides. Using state-of-the-art proteomics and innovative syntac-
tical biocomputing approaches, we identified numerous peptides
with antimicrobial properties. This establishes the male genital
tract as a veritable gold-mine for new anti-infectious agents to be
exploited for future medicine.
IL 2.2–2
Comparative neuropeptidomics: the singular
contribution of amphibians to the discovery of
mammalian neuropeptides
H. Vaudry1, J. Leprince1, O. Le Marec1, C. Neveu1 and
J.M. Conlon2
1Molecular and Cellular Neuroendocrinology, European Institute
for Peptide Research, Mont-Saint-Aignan, FRANCE, 2Faculty of
Medicine and Health Sciences, UAE University, Al Ain, UNITED
ARAB EMIRATES
The concentration of many neuropeptides in the brain of ecto-
thermic vertebrates is several orders of magnitude higher than in
the brains of mammals. This singular situation has allowed us to
isolate a number of regulatory peptides from the brain of the
European green frog, Rana esculenta. A peptidomic approach
has led to the characterization of many biologically active
peptides that are orthologous to mammalian neuroendocrine pep-
tides including two GnRH variants, CRH, PACAP, NPY, two
tachykinins, alpha-MSH, gamma-MSH, CGRP, CNP, GRP and
ODN. More importantly, this project has led to the discovery of
several novel neuroendocrine peptides that were first isolated
from frog brain tissue and have subsequently been identified in
mammals. Notably, we have characterized (i) the somatostatin-14
(S14) isoform [Pro2, Met13]S14 together with authentic S14,
thereby providing the first evidence for the occurrence of two
somatostatin variants in the brain of a single species; (ii) the first
tetrapod urotensin II, thus demonstrating that this peptide was
not only the appendage of the fish caudal neurosecretory organ;
(iii) secretoneurin, a peptide derived from the post-translational
processing of secretogranin II; and (iv) 26RFa, a novel member
of the Arg-Phe-NH2 family of regulatory peptides. Orthologs of
all these frog neuropeptides have now been identified in man and
have been shown to exert important regulatory effects in mam-
mals.
Acknowledgements: Supported by INSERM (U413), IFRMP
23, the Platform for Cell Imaging (PRIMACEN) and the Conseil
Re´gional de Haute-Normandie.
IL 2.2–3
Novel toxins from snake venoms
M. Kini
Biological Sciences, National University of Singapore, Singapore,
SINGAPORE
Snake venoms are complex cocktails of pharmacologically active
proteins and polypeptides. Studies on these proteins have led to
(i) our understanding of mechanisms of toxicity of snake venom
poisoning; (ii) development of research tools which help in deci-
phering various physiological processes; (iii) sharpening of skills
in protein chemistry and molecular biology; (iv) understanding of
mechanisms of the origin and evolution of this unique set of pro-
teins expressed in a highly specialized venom gland; and (v) iden-
tification of pharmacological prototypes that could be developed
as therapeutic agents. We have been interested in the structure-
function relationships and the mechanism of action of snake
venom proteins. In the recent years, we have purified and charac-
terized a number of proteins with interesting pharmacological
properties. Some of them are new members of the well-character-
ized toxin families, whereas others belong to new families of pro-
teins, hitherto not described in snake venoms. Here I will present
our findings on some of these new snake venom proteins. These
studies may provide new impetus to search for novel proteins in
snake venoms.
IL 2.2–4
Evolution and development of peptides with
special activities such as on ion-channels and
receptors
D. Mebs1 and R. Sto¨cklin2
1Zentrum der Rechtsmedizin, Klinikum der Universita¨t, Frankfurt
am Main, GERMANY, 2Atheris Laboratories, C.P. 314,
Bernex-Geneva, SWITZERLAND
Venoms from animals such as from cone snails, spiders, scorpi-
ons or snakes are a unique cocktail of often more than 100 dif-
ferent peptides acting specifically on a variety of exogenous
targets, e.g., ion-channels and receptors. A large proportion of
venom peptides adopt specific folds which are characterized by
conserved cysteine patterns. Hypervariability in amino acid
sequences occurs between the cysteins leading to numerous
peptide isoforms. In effect, peptides with the same structural
signature, the cysteine patterns, exhibit different functional prop-
erties. The genes encoding venom peptides have been found to
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undergo an abnormally high rate of mutations which may allow
a rapid adaptation to changes in availability of prey, in predatory
pressure or to other environmental challenges. The mechanisms
and the evolutionary impacts underlying these high mutation
rates are unknown. Whether special selection pressures or simply
random expression of genes induced by exogenous stress factors
are involved, is still a matter of speculation. The high specificity
of most peptides for a particular ion-channel or receptor type
may indicate a strong coevolutionary adaptation to these targets,
eventually also triggering changes in the target¢s structure to
avoid envenoming. Exploring the ‘venome’, the sum of all natural
venomous peptides and proteins of an animal, provides a unique
opportunity to study peptide evolution in general as well as the
genetic mechanisms that lead to the development of the huge
variety of these compounds.
OP 2.2–1
Selecting peptides for breast cancer treatment
E. R. Suarez, E. J. Paredes-Gamero, H. B. Nader and
M. A.d. S. Pinhal
Biochemistry, Federal University of Sao Paulo, Sao Paulo,
BRAZIL
The monoclonal antibody trastuzumab has a tyrosine kinase
receptor HER2 as a target and it is currently in use as a gold
standard treatment in breast cancer patients who presents over-
expression of this receptor. However, there are some reports of
resistance to this treatment and it can develop a high rate of
cardiac failure, despite the high cost. As an alternative to trast-
uzumab we have selected specific peptides to HER2 using a
phage display technology. A cyclic 7 aminoacids random peptide
library had been panned using an external domain of recombi-
nant HER2. Specific peptides were dislodged and selected using
trastuzumab. After each round of binding assays, peptides were
selected, sequenced and analyzed by ClustalW program. These
peptides were assayed using different breast cancer cell lines in
comparison with trastuzumab. It was observed that one of the
selected peptides (CXBBXXXXC), where C represents cysteine,
X non charged and B positive charged aminoacids, had shown
inhibitory effect in MTT proliferation assay. Cell cycle analysis
demonstrated a cell death rate (sub-G0/G1 region) of 79% with
positive 1 phage treatment, compared with 64% in the trast-
uzumab treated group. Annexin V and Propidium iodide assay
confirmed cell death and suggest late apoptosis/necrosis as the
main mechanism of death mediated by this peptide. Confocal
microscopy confirmed co-localization of HER2 and selected
peptides. The data suggest a potential use of this peptide as an
alternative anti-tumor therapy for breast cancer. Supported by
CNPq, FAPESP, CAPES, and NEPAS.
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2.3. Protein Engineering and Directed Evolution
IL 2.3–1
Protein evolution - a reconstructive approach
D. Tawfik
Department of Biological Chemistry, Weizmann Institute of Sci-
ence, Rehovot, ISRAEL
In spite the robustness and perfection of their mechanism of
action, proteins possess a remarkable ability to rapidly change
and adopt new functions. I will describe experimental work
aimed at reproducing the evolution of new proteins in the labora-
tory, and unraveling the evolvability traits of proteins. Specifi-
cally, I will describe how the functional promiscuity of proteins,
their conformational plasticity, and their modularity of fold,
accelerate their rate of evolution. I will address the issue of
neutral (or actually, seemingly neutral) mutations, and neutral
networks, as facilitators of protein evolution. Finally, I will
address mechanisms for buffering and compensating the deleteri-
ous effects of mutations – these relate primarily to loss of protein
stability, and include compensatory stabilizing mutations and
chaperones.
IL 2.3–2
From random mutagenesis to focused directed
evolution: examples for altered
enantioselectivity and broadened substrate
range
U. Bornscheuer
Dept. of Biotechnology & Enzyme Catalysis, Institute of Biochem-
istry, Greifswald, GERMANY
An impressive number of applications has been developed in the
past decades for the use of enzymes in organic synthesis [1].
Whereas initially, commercial enzyme preparations have been
used ‘straight from the bottle’, the current trend is to tailor-
design the biocatalyst using methods of protein engineering such
as rational design and directed (molecular) evolution [2]. One of
the most important, but at the same time most challenging, prop-
erties of biocatalysts is their stereoselectivity. Examples will be
shown, in which high-throughput screening (HTS) systems for
hydrolases [3] were successfully developed and applied to sub-
stantially improve the enantioselectivity of esterases for the syn-
thesis of an important secondary alcohol serving as building
block [4] as well as for tertiary alcohols [5]. Here, the combina-
tion of rational protein design [6] and focused directed evolution
[7] allowed to increase or invert selectivity. In addition, the use
of Baeyer–Villiger monooxygenases (BMVO) will be presented,
which allow the highly selective kinetic resolution of aliphatic
ketones [8]. Finally, catalytic promiscuity [9] will be introduced
and first results will be given.
References:
1. Bornscheuer UT, Kazlauskas RJ. Hydrolases in Organic Syn-
thesis. 2nd edn. Wiley-VCH, Weinheim. Buchholz K; Kasche
V, Bornscheuer UT. Biocatalysts and Enzyme Technology,
2005, 2006; Wiley-VCH, Weinheim.
2. Lutz S, Bornscheuer UT. (eds) Protein Engineering Hand-
book. 2008; Wiley-VCH, Weinheim.
3. Angew. Chem. Int. Ed. 2001, 40, 4201–4204; Nature Prot.
2006, 1, 2340–2343; Angew. Chem. Int. Ed. 2003, 42, 1418–
1420.
4. ChemBioChem. 2006, 7, 805–809.
5. Angew. Chem. Int. Ed. 2002; 41, 3211–3213; ChemBioChem.
2003, 4, 485–493; Tetrah.: Asymmetry 2002; 13, 2693–2696;
J. Org. Chem. 2005; 70, 3737–3040; J. Org. Chem. 2005; 70,
8730–8733; Org. Biomol. Chem. 2007, 5, 3310–3313.
6. Prot. Eng. Des. Sel. 2007; 20, 125–131; Adv. Synth. Cat. 2007,
349, 1393–1398.
7. Angew. Chem. Int. Ed. 2008; 47, 1508–1511.
8. Appl. Microb. Biotechnol. 2007; 73, 1065–1072; Appl. Microb.
Biotechnol. 2007; 75, 1095–1101; Angew. Chem. Int. Ed. 2006;
42, 7004–7006; Appl. Microb. Biotechnol. 2007, 77, 1251–
1260; Appl. Microb. Biotechnol. 2008; 81, 465–472.
9. Angew. Chem. Int. Ed. 2004; 43, 6032–6040.
IL 2.3–3
Teaching enzymes to catalyze new reactions
R. Kazlauskas
Biochemistry Molecular Biology & Biophysics, University of
Minnesota, Saint Paul, MN, USA
Changing the catalytic activity of enzymes provides insight into
how nature evolves new enzymes and also creates unnatural
catalysts to solve synthetic problems. We have explored three
ways to change the catalytic activity of enzymes: replace the
active site metal, replace amino acids residue to enhance an
existing minor catalytic activity, or replace amino acids residue
to create a completely new catalytic activity. An example of
metal replacement is replacing the active site zinc in carbonic
anhydrase with manganese to create a stereoselective oxidation
catalyst. An example of mutagenesis to enhance catalytic activ-
ity is a Leu29Pro mutation in Pseudomonas esterase to enhance
perhydrolysis over hydrolysis. The resulting variant is an effi-
cient catalyst for synthesis of peracetic acid. An example of a
completely new catalytic activity are multiple mutations in an
esterase to create an oxyntrilase.
IL 2.3–4
Novel enzymes and designer microorganisms
for industrial application: tapping functional
sequence space from nature and beyond
J. Eck
B.R.A.I.N AG, Zwingenberg, GERMANY
Industrial ‘white’ biotechnology is regarded as a central feature
of the sustainable economic future of modern industrialized soci-
eties. Highly effective enzymes and ‘designer bugs’ promise
improvement for existing process or could enable novel product
ideas. For any industrial application, enzymes need to function
sufficiently well according to several application-specific perfor-
mance parameters. Instead of designing a process to fit a medio-
cre enzyme, it is conceivable that a comprehensive access to the
microbial diversity might be used to find a suitable natural
enzyme(s) that optimally fits process requirements [1,2,3]. In view
of multi-parameter process requirements current technologies and
screening strategies for the development of optimised biocatalysts
from microbial biodiversity as well as from ‘metagenome’
libraries will be presented. To tap into the next generation bioca-
talysis using engineered ‘designer’ microorganisms for multi-step
bioconversions, it is necessary to move into the construction of
artificial operons and the heterologous expression of modified
biosynthetic pathways.
References:
1. Eck J, Gabor E, Liebeton K, Meurer G, Niehaus F (2009)
From Prospecting to Product – Industrial Metagenomics is
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coming of age. In: Protein Engineering Handbook (Lutz S &
Bornscheuer U, eds.) Wiley-VCH Weinheim, pp. 295–323.
2. Gabor E, Liebeton K, Niehaus F, Eck J and Lorenz P.
Updating the metagenomics toolbox. Biotechnol. J. 2007; 2:
201–206.
3. Lorenz P and Eck J. Metagenomics and industrial applica-
tions. Nat. Rev. Microbiol. 2005; 3: 510–516
OP 2.3–1
Cold-adaptation of a hyperthermophilic group
II chaperonin
T. Kanzaki1, A. Nakagawa1, S. Ushioku1, T. Oka2, K. Takahash-
i3, T. Nakamura3, K. Kuwajima3, A. Yamagishi4 and M. Yohda1
1Biotechnology and Life Science, Tokyo University of Agriculture
and Technology, Tokyo, JAPAN, 2Physics, Shizuoka University,
Shizuoka, JAPAN, 3Okazaki Institute for Integrative Bioscience,
National Institutes of Natural Sciences, Aichi, JAPAN, 4Molecular
Biology, Tokyo University of Pharmacy and Life Science, Tokyo,
JAPAN
Group II chaperonins exist in the archaeal and eukaryotic cyto-
sol, and mediate protein folding in an ATP-dependent manner.
We have been studying the reaction mechanism of group II
chaperonin using hyperthermophilic archaum, Thermococcus sp.
strain KS-1 chaperonin (T. KS-1) [Iizuka et al., JBC (2003, 2004,
and 2005), and Kanzaki et al., JBC (2008)]. However, high ther-
mophilicity of T. KS-1 chaperonin caused difficulty in utilization
of various analytical methods. To resolve this difficulty, we tried
to make T. KS-1 group II chaperonin mutants which function at
relatively moderate temperatures. Comparison of amino acid
sequences among 26 thermophilic and 17 mesophilic chaperonins
has shown that three amino acid replacements are likely to be
responsible for the difference of their optimal temperatures.
Then, we compared three single mutant and three double mutant
chaperonins as candidates for cold-adapted mutants. Conse-
quently, K323R single mutant improved folding activity at lower
temperature, 50 C and 40 C. Small angle X-ray scattering
(SAXS) demonstrated that this improvement of folding activity
at lower temperatures is ascribable to the conformational change
ability at lower temperature. In group II chaperonins, an ATP
dependent signal for the conformational change transmits from
the ATP binding site, which is located at the bottom of a
chaperonin subunit, to the helical protrusion, which is located at
the tip of a chaperonin subunit. Our study suggests that the
amino acid residues, such as K323R, located in the conforma-
tional change pathway from ATP binding site to helical protru-
sion are important for the functions such as the ATP dependent
conformational change ability and folding activity.
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2.4. Proteolysis on and within the Biological Membrane
IL 2.4–1
Rhomboid proteases and growth factor
signaling
M. Freeman
MRC Laboratory of Molecular Biology, Cambridge, UK
The intramembrane proteases are an unexpected class of prote-
ases that have been discovered over the last 10 years. They have
the property of cleaving proteins within their transmembrane
domains. This is a surprising reaction since proteolysis is a
hydrolytic reaction that requires water; the hydrophobic lipid
bilayer of biological membranes is therefore an unexpected envi-
ronment for protease active sites. The rhomboids are a recently
discovered and widely conserved family of intramembrane serine
proteases. They were first identified as the primary activators of
EGF receptor signalling in Drosophila but recent work has impli-
cated them in a wide variety of other functions from bacteria to
humans. Despite this, little is known about most of their func-
tions. A major focus for us has been determining the biological
function of this diverse family of proteases in organisms beyond
Drosophila. Significantly, many of the rhomboid functions
discovered to date have potential medical relevance, including in
areas as diverse as cancer, mitochondrial diseases and parasitic
infection. Bacterial rhomboids may also be suitable therapeutic
targets. I will discuss our recent work investigating the function
of rhomboids in growth factor signalling. I will also discuss our
approaches to substrate identification – the bottleneck of much
protease research.
IL 2.4–2
Proteinase dysbalance in disease: the ACE and
NEP gene families
A. Turner and N.N. Nalivaeva
Institute of Molecular & Cellular Biology, Faculty of Biological
Sciences, Leeds, UK
Therapeutic targets in many diseases. Homologous proteinases
can often serve counter-regulatory roles in metabolism. Examples
will be taken from several disease paradigms: prostate cancer,
neurodegeneration and cardiovascular regulation. The closely
related proteinases neprilysin (NEP) and endothelin converting
enzyme-1 (ECE-1) play a counter-balancing role in the metabo-
lism of the mitogenic peptide, endothelin-1, which contributes to
the development of androgen-insensitive prostate cancer. In con-
trast, both NEP and ECE play a role in the clearance of the
amyloid beta-peptide in brain and are hence potential therapeutic
targets in Alzheimer’s disease. Therapeutic strategies based on
modulating these proteinases through epigenetic and other
approaches will be described. The third exemplar involves the
newly appreciated complexity of the renin-angiotensin system as
a regulator of the cardiovascular system. The application of func-
tional genomics approaches to the discovery of angiotensin-
converting enzyme-2 (ACE2) as a counterbalance to the well
known hypertensive target ACE will be highlighted and their dif-
ferential cellular targeting and enzymology addressed. Finally,
the serendipitous discovery of ACE2 as the SARS virus receptor
illustrates the surprises always in store from nature.
Acknowledgements: Supported by the U.K. Medical Research
Council, M.R.C., Yorkshire cancer Research and British Heart
Foundation.
IL 2.4–3
Intramembrane Proteolysis by GxGD Proteases
C. Haass, R. Fluhrer and H. Steiner
Adolf Butenandt Institute, Stoffwechselbiochemie, Munich,
GERMANY
Alzheimer’s disease is the most frequent neurodegenerative disor-
der and is pathologically characterized by the invariant deposi-
tion of amlyloid plaques. The amyloid cascade hypothesis
describes a series of cumulative events, which are initiated by
Amyloid ß-peptide and finally lead to synapse and neuronal loss.
Obviously, the proteases involved in Amyloid ß-peptide genera-
tion are targets for therapeutic treatment strategies. For the
development of a safe therapeutic intervention, it is however,
absolutely required to understand the precise physiological func-
tions and the cellular mechanisms involved in substrate recogni-
tion, selection and cleavage. Moreover, homologous proteases,
whose physiological function could be affected by inhibitors need
to be discovered and assays must be developed allowing to deter-
mine the cross-reactive potential of such inhibitors. I will focus
on the intramembrane cleavage of the ß-amyloid precursor pro-
tein, which is performed by the c-secretase complex. In parallel
the cellular and biochemical properties of similar proteases of the
same family of GxGD-type aspartyl proteases (the signal peptide
peptidases and their homologues) will be described. A common
multiple intramembrane cleavage mechanisms performed by these
proteases will be shown and evidence will be presented that
Alzheimer’s disease associated mutations lead to a partial loss of
intramembrane proteolysis.
IL 2.4–4
Beyond proteolysis: glutamate
carboxypeptidase II as a neuropeptidase and
prostate specific membrane antigen
P. Sacha1, C. Barinka2, J. Lubkowski2, K. Hlouchova´1,
J. Tykvart1, J. Starkova1, P. Mlcochova1, V. Klusak1,
V. Rulisek1 and J. Konvalinka1
1Biochemistry, Institute of Organic Chemistry and Biochemistry
AS CR v.v.i., Prague, CZECH REPUBLIC, 2Macromolecular
Crystallography Laboratory, National Cancer Institute, Frederick,
USA
Glutamate carboxypeptidase II (GCPII) is a membrane-bound
metallopeptidase expressed in a number of tissues such as
jejunum, kidney, prostate and brain. The brain form of GCPII is
expressed in astrocytes and cleaves N-acetyl-aspartyl glutamate,
an abundant neurotransmitter, to yield free glutamate. GCPII
thus represents an important target for the treatment of neuronal
damage caused by excess glutamate. The enzyme is also expressed
in the prostate where it is known as prostate-specific membrane
antigen (PSMA) since it is upregulated in prostate cancer. Using
specific monoclonal antibodies, we show that GCPII is also
expressed in other normal and malignant tissues and in the neo-
vasculature of number of different human tumors. Several GCPII
homologs have been described and partially characterized that
might compensate for the activity of GCPII in knock-out ani-
mals. We cloned, expressed and characterized two of them –
GCPIII and NaaladaseL. We determined the 3-D structure of
free GCPII, GCPIII and their complexes with inhibitors and sub-
strate analogs by protein X-ray crystallography. Based on an
extensive site-directed mutagenesis studies, we are able to identify
the key amino acid residues critical for the activity and substrate
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recognition. The series of 3-D structures explains the substrate
preferences of the enzymes, led to the hypothesis of an induced-
fit mechanism of substrate recognition and suggest a plausible
mechanism of action of GCPII. Taken together, these structure-
activity data and might lead to the design of novel, potent GCPII
inhibitors.
IL 2.4–5
Regulation of extracellular proteolysis by CUB-
domain containing proteins
J. Duke-Cohan
Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
The CUB domain, a discrete protein module originally defined
by expression in complement C1r/s, Uegf and Bone morpho-
genetic protein-1, has been shown recently to to underlie the
enhancer function of procollagen proteinase enhancer for procol-
lagen proteinase/BMP-1-mediated proteolytic degradation. This
module is also expressed in systemically-represented serum
attractin, a protein initially characterised as having a dipeptidyl
peptidase IV (DPPIV) activity. Despite recent reports demon-
strating that there is no DPPIV activity intrinsic to attractin, it is
clear that attractin enhances the activity of minimal amounts of
serum DPPIV leading to an activity out of proportion to its
apparent representation. We can localise a significant component
of this functionality to the attractin CUB domain. Data suggests
that this could result from modulation of substrate presentation,
increasing catalytic activity and specificity. We suggest that this
enhancer function may be a unique means of downregulating the
systemic activity of DPPIV substrates relatively restricting their
activity to locally-active sites, a property critical for proper func-
tionality of chemokine and neuropeptide substrates of DPPIV.
OP 2.4–1
Rhomboid intramembrane proteases: from
substrate specificity and mechanism to
biological function
K. Strisovsky and M. Freeman
MRC Laboratory of Molecular Biology, Cell Biology Division,
Cambridge, UK
Intramembrane proteolysis is a novel regulatory mechanism in
many biological processes. Intramembrane proteases comprise
four evolutionarily unrelated enzyme families of different cata-
lytic types. Despite their wide conservation, in most cases their
natural substrates and biological functions are not known and
their mechanism of action is unclear. Rhomboid proteases,
currently the best understood family, are conserved across the
tree of life and are key players in several biological processes,
including EGF receptor signaling in flies, mitochondrial fission in
yeast, apicomplexan parasite invasion, and protein secretion in
some bacteria. We nevertheless lack knowledge of their biological
functions beyond these few examples. A bottleneck in revealing
their function is our lack of methods for substrate identification.
One such method could be prediction of relevant candidate sub-
strates based on sufficiently well understood specificity of the
enzyme and bioinformatic analysis of the given proteome. Like
other intramembrane proteases, rhomboids were thought to
recognize a region of helical instability in the transmembrane
domain of their substrates, which is not strictly dependent on
amino acid sequence. However, substrate predictions based on
that model have been poor. Here we demonstrate, contrary to
expectation, that rhomboids do recognize a specific sequence in
their substrates. We define a recognition motif that is present in
several model substrates and required by evolutionarily distant
rhomboids and show that our model has predictive power. Our
work demonstrates that intramembrane proteases can be
sequence-specific. We will discuss the significance of our findings
in relation to rhomboid mechanism, the discovery of rhomboid
substrates and inhibitors.
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SYMPOSIUM 3: METABOLITES IN INTERACTIONS
3.1. Biotransformation of Carcinogens
IL 3.1–1
Effect of benzo[a]pyrene metabolism on cells
and vice versa
D. Phillips
Section of Molecular Carcinogenesis, Institute of Cancer Research,
Sutton, UK
Although discovered and identified more than 75 years ago, the
environmental carcinogen benzo[a]pyrene (BaP) is still widely
studied and has become a standard test agent for exploring the
metabolic capacity of biological systems and the responses of
cells or tissues in vitro or vivo to external genotoxic insult. We
have investigated the carcinogenic/genotoxic properties of
benzo[a]pyrene in cell culture and in whole animals, using DNA
adduct formation, gene expression and cell cycle distribution as
biomarkers of its effects. In all these studies, the principal path-
way of activation demonstrated is via formation of the 7,8-diol
10,11-epoxide of BaP (BPDE) to form an adduct with the N2
position of guanine in DNA. In cells in culture this pathway is
mediated by cytochrome P450, but it now appears that in vivo
P450 metabolism acts primarily to detoxify BaP. Gene expression
changes in vitro can be categorised as either resulting from induc-
tion of the Ah receptor, or from causation of DNA damage. In
cells that are p53 competent BP causes accumulation of p53,
evident at the protein level but not at the mRNA level. DNA
adduct formation by BaP, but not by BPDE, appears to be p53
dependent, suggesting that loss of p53 affects metabolic activa-
tion. Meanwhile in vivo studies show that BaP forms DNA
adducts with equal measure in both target and non-target tissues,
while gene expression changes are organ specific. Further insight
into the complexities of interactions of BaP with mammalian cells
may shed further light on mechanisms of carcinogenicity.
IL 3.1–2
The Hepatic Cytochrome P450 reductase null
(HRN) mouse model as a tool to study
xenobiotic metabolism
V. M. Arlt
Section of Molecular Carcinogenesis, Institute of Cancer Research,
Sutton, UK
Hepatic cytochrome P450 (CYP) enzymes play a pivotal role in the
metabolism of many drugs and carcinogens. Much of the work
carried out on the role of hepatic CYPs in xenobiotic metabolism
has been done in vitro. However, additional factors such as route
of administration, absorption, renal clearance and extra-hepatic
CYP expression, make it difficult to extrapolate from in-vitro data
to in-vivo pharmacokinetics. Moreover, functional redundancy
inevitably found in the large CYP family of isoenzymes make it
difficult to determine the role of CYPs in metabolism as a whole.
To overcome these limitations a mouse line, HRN (Hepatic Cyto-
chrome P450 Reductase Null), has been developed in which cyto-
chrome P450 oxidoreductase (POR), the unique electron donor to
CYPs is deleted specifically in the liver, resulting in the loss of
essentially all hepatic P450 function. We used the HRN model to
evaluate the role of hepatic versus extrahepatic metabolism and
disposition of different drugs (e.g. ellipticine) and environmental
carcinogens (e.g. benzo[a]pyrene [BaP], aristolochic acid, 3-nitro-
benzanthrone [3-NBA]). In one set of experiments, HRN and wild-
type (WT) mice were treated i.p. with 2 mg/kg body weight (bw) 3-
aminobenzanthrone (3-ABA), the metabolite of the air pollutant
3-NBA, for 24 hours. DNA binding by 3-ABA measured by 32P-
postlabelling was reduced by 80% in the livers of HRN relative to
WT mice, confirming previous results indicating that CYP1A1 and
-1A2 are mainly responsible for the metabolic activation of 3-
ABA. In contrast, no difference in DNA binding was observed
after treatment with 3-NBA indicating that 3-NBA is predomi-
nantly activated by cytosolic nitroreductases rather than micro-
somal POR. In another experiment HRN and WT mice were
treated i.p. with 125 mg/kg bw of BaP for 24 hours. DNA adduct
levels were around 10-fold higher in livers of HRN than in WT
mice. In contrast, when hepatic microsomal fractions from HRN
and WT mice were incubated with DNA and BaP, DNA adduct
formation was 7-fold higher in WT than in HRN fractions and
most of the hepatic microsomal activation of BaP in vitro was
attributable to CYP1A enzyme activity. These data reveal an
apparent paradox, whereby CYP enzyme activity appears to be
more important for detoxification of BaP in vivo, despite being
essential for its metabolic activation in vitro.
IL 3.1–3
Aristolochic acid, an old drug, is a human
carcinogen
H. Schmeiser
Deutsches Krebsforschungszentrum, C016, Department of Genetic
Alterations in Carcinogenesis, German Cancer Research Center,
Heidelberg, GERMANY
The use of traditional herbal medicines is increasing worldwide.
The old herbal drug aristolochic acid (AA), derived from Aristol-
ochia species has been associated with the development of a
novel nephropathy, designated as aristolochic acid nephropathy
(AAN), and human urothelial cancer. The major components of
the plant extract are nitrophenanthrene carboxylic acids, which
are genotoxic mutagens after metabolic activation. The major
activation pathway involves reduction of the nitro group primar-
ily catalysed by NAD(P)H:quinone oxidoreductase to an electro-
philic cyclic N-acylnitreniumion with delocalised charge that
reacts preferentially with purine bases to form covalent DNA
adducts. These aristolochic acid specific DNA adducts have been
identified and detected in experimental animals exposed to aris-
tolochic acid or botanical products containing aristolochic acid,
and in renal tissues from AAN patients. In rodent tumors the
major adduct formed by AA has been associated with the activa-
tion of ras oncogenes through a specific A:T to T:A transversion
mutation in codon 61. A:T to T:A transversions were also the
predominant mutation type found in human p53 knock-in mouse
fibroblasts treated with AA. In humans A:T to T:A transversions
in the p53 gene have been identified in several patients suffering
from Balkan endemic nephropathy and in an urothelial tumor
from an AAN patient along with AA-specific DNA adducts. This
concordance of specific mutations in patient tumours and
AA-exposed cells supports the argument that AA was responsible
for the high risk for cancer in individuals who ingested material
from Aristolochia plants – in the form of weight-loss pills in
Belgium, or from cereal fields in the Balkans where Aristolochia
plants grow as weeds. IARC has classified AA as carcinogenic to
humans (Group 1) and has urged a ban of all botanical products
known or suspected to contain AA from the market worldwide.
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IL 3.1–4
Biotransformation of the plant alkaloid
ellipticine dictates its genotoxic and
pharmacological effects
M. Stiborova
Department of Biochemistry, Charles University Faculty of
Science, Prague, CZECH REPUBLIC
Ellipticine is an antineoplastic agent, which should be considered
a drug, whose pharmacological efficiency and/or genotoxic side
effects are dictated by its cytochrome P450 (CYP) and/or peroxi-
dase-mediated activation in target tissues. Namely, among the
multiple modes of ellipticine antitumor action, formation of
covalent DNA adducts by ellipticine mediated by its oxidation
with CYPs and peroxidases was found to be the predominant
mechanism of cytotoxicity to human breast adenocarcinoma
MCF-7 cells and several leukemia and neuroblastoma cells. Such
DNA adducts were found also in vivo, in target and non-target
tissues of rats and mice exposed to ellipticine. We report the
molecular mechanism of ellipticine oxidation by CYPs and
peroxidases and identify CYPs responsible for ellipticine
metabolic activation and detoxication. Whereas 9-hydroxy- and
7-hydroxyellipticine formed by CYPs and the major product of
ellipticine oxidation by peroxidases, the ellipticine dimer, are the
detoxication metabolites, two carbenium ions, ellipticine-13-ylium
and ellipticine-12-ylium, derived from other two metabolites,
13-hydroxy- and 12-hydroxyellipticine, generate two major
deoxyguanosine adducts in DNA seen in vivo in rats and mice
treated with ellipticine. Ellipticine is also a strong inducer of
CYP1A enzymes, modulating levels of detoxication and activa-
tion metabolites and thus its own genotoxic and pharmacological
efficiencies. Furthermore, cytochrome b5 dictates the pattern of
ellipticine metabolites generated by CYP3A4 and mainly by
CYP1A1 and 1A2 enzymes, increasing formation of ellipticine
metabolites forming DNA adducts. The study forms the basis to
further predict the susceptibility of human cancers to ellipticine.
Acknowledgements: Supported by GACR (303/09/0472, 203/
09/0812) and Czech Ministry of Education (MSM0021620808,
1M0505).
IL 3.1–5
The fate of drugs conjugated to albumin:
Metabolism and effects on cellular targets
E. Frei, H. H. Schrenk, A. Breuer, D. Funk, G. Hu¨bner and
U. Zillmann
Molecular Toxicology, Deutsches Krebsforschungszentrum,
Heidelberg, GERMANY
We are developing drugs covalently linked to human serum albu-
min (HSA), because of the following properties of HSA: most
abundant protein in serum, transport of lipophilic molecules,
stability against organic solvents which allows chemical modifica-
tions, non-immunogenic to rats or mice, accumulation in tumours
and inflammation. Compounds were linked either as carbamides,
via triazinyl chloride, glucuronosides, or by peptide spacers and
their uptake into and effects upon cells, tumours or inflammation
were followed. From our early in vivo studies it was clear that a
molar loading ratio of 1.4 is not immunogenic and results in a con-
jugate with a half life of 12 days in humans, similar to that
reported for ‘native’ HSA. Aminofluoresceine-HSA (AFL-HSA) is
taken up by endocytosis into lysosomes of human epithelial
tumour cells, but also of fibroblasts. It accumulates in glioblastoma
and has been successfully used as intra-operative diagnostic agent
in the fluorescence guided surgery of glioma. Methotrexate linked
to HSA (MTX-HSA) was successfully tested in clinical Phase I and
II studies, with the result of a much reduced toxicity and a very
long half-life compared to MTX. Due to its cellular uptake by
endocytosis MTX-HSA was able to overcome transport resistance
to MTX. Intracellular liberation of the drug was reflected by S-
phase arrest of cells and inhibition of thymidylate synthase. To
improve efficacy of cleavage of the drug from HSA, MTX was
linked by a g-polyglutamylate (PG) linker to HSA. This physiolog-
ical compound is cleaved by lysosomal glutamylhydrolase to short
chain glutamates. The enzyme is secreted into media by human
melanoma cells and MTXPG4 was determined to be the substrate
most efficiently cleaved to MTX (MTXPG1). In a human lung ade-
nocarcinoma cell line MTXPG4-HSA was, however, much less
active than MTX-HSA, but was potent against fibroblasts. In vivo
MTXPG4-HSA was active against mouse Lewis lung carcinoma at
150 fold lower doses than MTX, but also much more toxic. This is
contrary to the lower toxicity seen by conjugating aminopterin or
MTX directly to HSA. The data show that the choice of linkers
between drug and protein may have a drastic effect on the drug’s
pharmacologic potency. This might also hold true for drugs linked
to therapeutic proteins like monoclonal antibodies.
OP 3.1–1
The mechanism of formation of
(deoxy)guanosine adducts derived from
peroxidase-catalyzed oxidation of the
carcinogenic non-aminoazo dye 1-phenylazo-2-
hydroxynaphthalene (Sudan I)
V. Martinek1, M. Dracinsky2, J. Cvacka2, M. Semanska1,
E. Frei3 and M. Stiborova1
1Department of Biochemistry, Faculty of Science Charles
University in Prague, Prague, CZECH REPUBLIC, 2Institute of
Organic Chemistry and Biochemistry v.v.i., Academy of Sciences
of the Czech Republic, Prague, CZECH REPUBLIC,
3Department of Molecular Toxicology, German Cancer Research
Center, Heidelberg, GERMANY
Sudan I is a liver and urinary bladder carcinogen for rodents and a
potent contact allergen and sensitizer for humans. Sudan I
metabolic activation in urinary bladder is attributed to its peroxi-
dase-mediated oxidation. We identified the structures of two perox-
idase-mediated Sudan I metabolites and those of adducts of
(deoxy)guanosine that are formed during Sudan I oxidation.
Peroxidase oxidizes Sudan I to radical species, reacting with
another Sudan I molecule to form a dimer, where the oxygen 2
radical of Sudan I reacted with carbon 1 in the second molecule. In
the presence of (deoxy)guanosine, the carbon 4 radical of Sudan I
can attack the exocyclic amino group of guanine, forming the
4-[(deoxy)guanosin-N2-yl]Sudan I adduct. The Sudan I dimer is
unstable and decomposes spontaneously to the second oxidation
product. This compound consists of 4-oxo-Sudan I skeleton con-
nected via oxygen of its 2-hydroxyl group and nitrogen of its azo
group with carbon 1 of 2-oxonaphthalene. If (deoxy)guanosine is
present during the formation of this metabolite, an adduct, in which
this metabolite is bound to the exocyclic amino group of guanine, is
generated. This adduct is again unstable and decomposes to the
same adduct that is formed by the direct reaction of radical,
4-[(deoxy)guanosin-N2-yl]Sudan I. The results presented here are
the first structural characterization of Sudan I-(deoxy)guanosine
adducts formed during oxidation of this carcinogen by peroxidase.
Acknowledgements: Supported by GACR (303/09/0472, 203/
09/0812), Czech Ministry of Education (MSM 0021620808) and
the Academy of Sciences of the Czech Republic (Z4 055 0506,
KJB 400 550 903).
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3.2. Heme Biosynthesis, Utilization and Degradation
IL 3.2–1
Metabolic basis of protoporphyrin
accumulation in Erythropoietic Protoporphyria:
Ferrochelatase deficiency versus Ala Synthase
2 gain of function
J. C. Deybach, S. Whatley, M. Badminton, G. Elder and H. Puy
Hoˆpital Louis Mourier APHP/INSERM U773, French Reference
Center for Porphyria, Colombes, FRANCE
Accumulation of protoporphyrin IX in human erythrocytes and
other tissues causes Erythropoietic Protoporphyria (EPP) (MIM
177000) an inherited disease which leads to life-long photo-
sensitivity and, in about 2% of patients, severe liver dysfunction.
EPP is usually caused by partial deficiency in mitochondrial
ferrochelatase (FECH) (EC 4.99.1.1), the terminal enzyme of
heme biosynthesis. Most patients have autosomal dominant EPP
(dEPP) in which clinical expression normally requires co-inheri-
tance of a FECH mutation that abolishes or markedly reduces
FECH activity trans to a hypomorphic FECH IVS3-48C allele
carried by about 11% of western Europeans. A limited number
of patient display recessive EPP (rEPP) with a marked ferroch-
elatase deficiency and FECH mutations on both alleles usually
with compound heterozygosity. However, mutational analysis
fails to detect FECH mutations in about 7% of EPP families of
which about 3% are homozygous for the wild type FECH
IVS3-48T allele, suggesting possible involvement of another
locus. Each of the seven inherited porphyrias results from a par-
tial deficiency of an enzyme of heme biosynthesis. Mutations that
cause porphyria have been identified in all the genes of the heme
biosynthetic pathway except ALAS1 and ALAS2 that encode the
ubiquitously expressed (ALAS1) and erythroid-specific (ALAS2)
isoforms of mitochondrial 5-aminolevulinate synthase (ALAS)
(EC 2.3.1.37). ALAS2 is essential for haemoglobin formation by
erythroid cells. All reported mutations in ALAS2, which encodes
the rate-regulating enzyme of erythroid heme biosynthesis, cause
X-linked sideroblastic anemia. We described eight families with
deletions in ALAS2, either c.1706-1709delAGTG (p.E569GfsX24)
or c.1699-1700delAT (p.M567EfsX2), resulting in frameshifts that
lead to replacement or deletion of the 19–20 C-terminal residues
of the enzyme. Prokaryotic expression studies show that both
mutations markedly increase ALAS2 activity. These gain of
function mutations cause a previously unrecognised form of
porphyria, X-linked dominant protoporphyria, characterised
biochemically by a high proportion of zinc-protoporphyrin in
erythrocytes, in which mismatching of protoporphyrin produc-
tion to the heme requirement of differentiating erythroid cells
leads to overproduction of protoporphyrin in amounts sufficient
to cause photosensitivity and liver disease.
IL 3.2–2
Lipid mediator signaling: structural and
evolutionary insights
C. S. Raman1, D. S. Lee1, P. Nioche2 and M. Hamberg3
1Biochemistry and Molecular Biology, University of Texas Medical
School, Houston, USA, 2INSERM University of Paris VI,
Signaling, Paris, FRANCE, 3Medical Biochemistry and Biophysics,
Karolinska Institutet, Stockholm, SWEDEN
Lipid mediators constitute a broad spectrum of molecules,
including vasoactive substances in mammals and volatile organic
compounds that confer characteristic flavors to fruits and vegeta-
bles. Plant oxylipins (such as jasmonates) and animal prostaglan-
dins are short-lived but potent peroxide-derived lipid mediators
that share strikingly similar biological activities, including meta-
bolic regulation, reproduction, and host defense. Their biosynthe-
sis involves extraordinary rearrangements of labile organic
peroxides by a novel group of heme thiolate enzymes belonging
to the cytochrome P450 superfamily. Despite three decades of
intense research, it has been difficult to gain molecular insights
into how some of these molecules are produced. Equally unclear
is the evolutionary origin of the enzymes that synthesize these
diverse group of signaling molecules. In this talk, I will offer an
atomic description of the enzymes involved in oxylipin biosynthe-
is. I will also elaborate on how our structural efforts led to the
discovery of new oxylipin signaling pathways in bacteria and
marine invertebrates (Lee, Nioche, Hamberg, Raman 2008
Nature 455: 363–368]. This work is funded by the Pew Charitable
Trusts, The Robert A. Welch Foundation, and the National
Institutes of Health.
IL 3.2–3
Structural insight of heme oxygenase catalysis
M. Ikeda-Saito, M. Unno and T. Matsui
Institute of Multidisciplinary Research for Advanced Materials,
Tohoku University, Sendai, JAPAN
Heme oxygenase (HO), a central enzyme in heme catabolism,
converts heme to biliverdin, CO, and a free Fe ion through three
monooxygenase reactions using seven electrons donated through
NADPH-cytochromeP450 reductase [1]. Electronic states, reactiv-
ities, and the crystal structures of eight key intermediates have
been determined with a help of cryo-reduction to trap unstable
intermediates. HO forms an enzyme-substrate complex with
heme, where heme serves both as the substrate and the active
center. After reduction to the ferrous form, O2 binds to the
ferrous heme iron with an acute FeOO angle of ~ 110, placing
its terminal oxygen atom close to the a-meso-carbon. An
extended distal pocket hydrogen bonding network functions as a
conduit for transferring protons required for the formation of
hydroperoxo, generated by one-electron reduction of the oxy
form, and also for the activation of hydroperoxo, leading to the
a-meso-hydroxylation. Hydroperoxo cannot be formed upon loss
of the nearby H2O, indicating a crucial role of this nearby H2O
molecule in HO catalysis. Ferrous verdoheme formation proceeds
by a reaction of the ferrous porphyrin neutral radical of ferric
a-meso-hydroxyheme with O2 and one electron. Conversion of
verdoheme to biliverdin [2] is realized through ferric hydroperoxo
in a manner very similar to that for the hydroxylation of the
heme a-meso-carbon, the first HO catalysis step.
References:
1. M. Unno, T. Matsui, M. Ikeda-Saito Nat. Prod. Rep. 2007;
12, 553–570.
2. T. Matsui, K. Omori, H. Jin, M. Ikeda-Saito, M. J. Am.
Chem. Soc. 2008; 130, 4220–4221.
IL 3.2–4
Macromolecular complexes involving
cytochrome P450 enzymes
I. Schlichting and M. J. Cryle
Department of Biomolecular Mechanisms, Max Planck Institute
for Medical Research, Heidelberg, GERMANY
Cytochrome P450s comprise a superfamily of oxidative hemo-
proteins, capable of catalyzing an extensive array of chemical
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transformations, with biological roles as varied as natural prod-
uct biosynthesis and xenobiotic metabolism. One important and
increasingly better characterized subsection of P450s include
those which, instead of binding free ligands, accept their
substrates bound to a carrier protein (CP). Such P450s have
mostly been identified in antibiotic biosynthesis pathways and
have been found to catalyze several different types of oxidative
reactions with substrates bound to peptidyl carrier proteins
(PCPs). These reactions include the hydroxylation of aliphatic or
aromatic amino acid C-H bonds, found in the biosynthesis of the
antibiotics novobiocin, coumermycin A, and nikkomycin, and
the oxidative phenolic coupling of heptapeptides, found in the
biosynthesis of vancomycin-type antibiotics. The latter reactions
are catalyzed by the Oxy-proteins. Their mode of action will be
reviewed, insights on P450 carrier protein systems will be exem-
plified using the model system P450BioI.
OP 3.2–1
Efficient utilization of iron for hemoglobin
synthesis requires endosomal transport of
transferrin to mitochondria
P. Ponka1, A.S. Zhang2, T. Kahawita1, O. Shirihai3 and
A.D. Sheftel4
1Lady Davis Institute, McGill University, Montre´al, CANADA,
2Department of Cell and Developmental Biology, OHSU, Portland,
USA, 3Section of Molecular Medicine, Boston University School
of Medicine, Boston, USA, 4Institut fu¨r Zytobiologie, Philipps-
Universita¨t-Marburg, Marburg, GERMANY
Developing red blood cells (RBC) are the most avid consumers
of iron (Fe) in the organism and synthesize heme at a breakneck
rate. Delivery of iron to erythroid cells occurs following the bind-
ing of Fe2-transferrin (Tf) to its cognate receptors on the cell
membrane. The Tf-receptor complexes are then internalized via
endocytosis, and iron is released from Tf by a process involving
endosomal acidification. Iron, following its reduction to Fe2
+ by
Steap3, is then transported across the endosomal membrane by
the divalent metal transporter, DMT1. However, the post-
endosomal path of Fe in the developing RBC remains elusive or
is, at best, controversial. It has been commonly accepted that a
low molecular weight intermediate chaperones Fe in transit from
endosomes to mitochondria and other sites of utilization;
however, this much sought iron binding intermediate has never
been identified. We have formulated a hypothesis that in
erythroid cells a transient mitochondrion–endosome interaction is
involved in Fe translocation to its final destination. This hypo-
thesis is based on our earlier finding that in Hb-synthesizing cells
Fe acquired from Tf continues to flow into mitochondria even
when the synthesis of protoporphyrin IX is suppressed. In this
study we have collected strong experimental evidence supporting
this hypothesis: We have shown that Fe, delivered to mitochon-
dria via the Tf pathway, is unavailable to cytoplasmic chelators.
Moreover, we demonstrated that Tf-containing endosomes move
and contact mitochondria in erythroid cells, that vesicular move-
ment is required for iron delivery to mitochondria and that ‘free’
cytoplasmic iron is not efficiently used for heme biosynthesis.
Furthermore, performing flow cytometry on cell lysates from
reticulocytes incubated with two different fluorescent markers for
endosomes and mitochondria, we identified three distinct popula-
tions: endosomes, mitochondria, and a population of particles
labeled with both fluorescent markers. The size of the double-
labelled population increases with the incubation time and
plateaus in 30 minutes. Re-incubation of the reticulocytes with
unlabelled Fe2-Tf leads to a time-dependent decrease, and
ultimate disappearance, of the double-labelled population, indi-
cating a reversible nature of organel interactions. Hence, the
‘chaperone’-like function of endosomes may be one of the mecha-
nisms that keeps the concentrations of reactive Fe2
+ at extremely
low levels in oxygen-rich cytosol of erythroblasts.
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3.3. Turnover and Recognition of Carbohydrates
IL 3.3–1
Interactions between bacterial lectins and host
carbohydrates
A. Imberty
CERMAV-CNRS, Glycobiologie Mole´culaire, Grenoble cedex 9,
FRANCE
Recent interest in bacterial lectins demonstrated their role in host
recognition, biofilm formation, tissue adhesion and virulence.
Pseudomonas aeruginosa and Burkholderia cenocepacia are oppor-
tunistic pathogens responsible for lung infections. Both bacteria
contain several calcium-dependant lectins that demonstrate high
affinity for diverse oligosaccharides that are present on human
tissues. We used combined titration microcalorimetry, x-ray crys-
tallography and molecular modeling approaches to decipher the
thermodynamical and structural basis for high affinity binding of
bacterial lectins to host carbohydrates [1]. First antibacterial tests
in animal models infected with P. aeruginosa have been success-
fully conducted. The complete characterization of carbohydrate
specificity, affinity and atomic details of interaction between the
two P. aeruginosa lectins and their ligands allowed for the design
and synthesis of high affinity glycomimetics and glycodendrimers
that can act as antiadhesive compounds [2].
References:
1. Imberty A, Wimmerova M, Sabin C and Mitchell EP. Struc-
tures and roles of Pseudomonas aeruginosa lectins. In Protein-
Carbohydrate Interactions in Infectious Disease (Bewley, C.
ed.), pp. 30–48, 2006; The Royal Society of Chemistry,
Cambridge.
2. Imberty A, Chabre YM and Roy R. Glycomimetics and
glycodendrimers as high affinity microbial antiadhesins.
Chemistry 2008; 14, 7490–7499.
IL 3.3–2
Glycation and post-translational processing of
human interferon-gamma expressed in
Escherichia coli
I. Ivanov and R. Mironova
Molecular Biology, Gene Regulations, Sofia, BULGARIA
Non-enzymatic glycosylation (glycation) is a multistep chemical
reaction between free amino groups in biomolecules (mainly Lys
e-amino groups in proteins) and reducing sugars. It starts with
formation of Schiff bases, which are further converted to
Amadori products and advanced glycation end-products (AGEs).
This process takes place in humans and causes severe complica-
tions in diabetic and uremic patients, whereas in normal subjects
contributes to senescence and ageing. Because glycation is a slow
process, it has always been regarded as typical for the long-living
organisms affecting their long-living proteins (hemoglobin,
crystalline, etc.) only. Surprisingly, we found that glycation takes
place also in E. coli and affects both host and recombinant pro-
teins (Mironova et al., Mol. Microbiol. 2001; 39, 1061–1068).
Employing fluorescent spectroscopy (to measure AGEs specific
fluorescence), Western blotting (using AGEs specific monoclonal
antibodies) and ESI-mass spectrometry, we proved that the
recombinant human interferon-gamma (rhIFN-g) expressed in E.
coli is glycated. The presence of reactive Amadori products and
AGEs makes the protein chemically unstable. Due to this it is
involved in spontaneous dimerisation (although devoid of Cys
residues) and chemical proteolysis. Target sites of the latter were
identified by ESI-MS and N-terminal sequencing. Our analysis
revealed four major (Arg1402Arg141, Phe1372Arg138,
Met1352Leu136 and Lys1312Arg132) and two minor
(Lys1092Ala110 and Arg902Asp91) cleavage sites. Tryptic pep-
tide mapping indicated that the covalent dimers originating dur-
ing storage were formed mainly by lateral cross-linking of the
monomer subunits. Bioassay showed that the proteolysis lowered
rhIFN-g antiviral activity and the covalent dimerisation led to its
complete abolishment. Our recent studies showed that other
recombinant interferons (both alpha and beta) produced in E.
coli are also glycated and that their immunogenicity and loss of
activity is related with their glycation. Searching for inhibitors of
glycation applicable during E. coli fermentation, we found that
the most potent anti-glycating compounds are aminoguanidine,
acetylsalicylic acid (ASA), vitamin B 1 (thiamine), vitamin B 6
(pyridoxamine), L-arginine, etc.
IL 3.3–3
Frontiers of human glycosylation disorders
H. Freeze
Burnham Institute for Medical Research, Sanford Children’s
Health Research Center, La Jolla, CA, USA
All cells are coated with a dense forest of sugar chains or
glycans. About 1–2% of the human genome encodes proteins
that synthesize or recognize a vast and complex array of glycans
that are usually attached to proteins or lipids. In just over a dec-
ade, mutations in over 30 different genes were shown cause a
spectrum of human genetic, mostly autosomal recessive, disor-
ders. The clinical spectrum is nearly as diverse and heterogeneous
as the glycans themselves. One group, called the Congenital
Disorders of Glycosylation (CDG), is caused by mutations in
genes that mostly affect the N-glycosylation pathway located
in the endoplasmic reticulum and Golgi apparatus. Defects in
monosaccharide precursor activation and interconversion, trans-
port of activated nucleotide sugars into the Golgi, glyco-
syltransferases, glycosidases, chaperones, trafficking proteins, and
pH regulators all contribute to the disease burden. Many of these
disorders also affect multiple glycosylation pathways. As physi-
cian awareness of these rare disorders grew, more patients were
identified, focusing interest in two areas: therapy and model
systems to better understand the nature of the deficiencies.
Nearly all patients have hypomorphic, rather than null alleles,
making a traditional? gene knockout mouse? lethal in utero. It is
challenging to find an appropriate, viable phenotypic model to
study therapy. It requires the right combination of genetic defi-
ciencies and environmental insults to tease out the subtle interac-
tions and identify therapeutic opportunities. We will present a
few examples of this and suggest where the diagnostic and
therapeutic frontiers may lead us.
IL 3.3–4
When PNGase-F fails to deglycosylate native
N-glycoproteins? NMR and modeling studies
J. P. Kamerling
Bijvoet Center, Department of Bio-Organic Chemistry, Utrecht
University, Utrecht, THE NETHERLANDS
In glycoanalysis protocols, glycoprotein N-glycans are generally
released with peptide-N4-(N-acetyl-b-glucosaminyl) asparagine
amidase F (PNGase-F). As the enzyme is an amidase, it cleaves
the NH-CO linkage between the Asn side chain and the Asn-
bound GlcNAc residue. Usually, the enzyme has a low activity,
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or is not active at all, on native glycoproteins. Stereochemical rea-
sons for being inactive in case of native human chorionic gonado-
tropin a-subunit (ahCG) and native bovine pancreatic
ribonuclease B (RNase-B) will be explained. For ahCG, bearing
complex- and hybride-type N-glycans at its two N-glycosylation
sites, holds that Asn52 is completely accessible to digestion by
PNGase-F under native conditions, but Asn78 not. Using NMR
spectroscopy and molecular modeling it could be demonstrated
that the Asn78-linked GlcNAc residue is tightly packed against
the protein, being an integral part of the structure of the a-sub-
unit. The remainder of the N-glycan at Asn78 is largely extended
in solution (as is the complete N-glycan at Asn52). RNase-B with
oligomannose-type N-glycans at Asn34, can not be de-N-glycosy-
lated under native conditions. However, native RNAse-BS, gener-
ated by subtilisin digestion of native RNase-B, which comprises
amino acid residues 21–124 of RNase-B, is sensitive to PNGase-F
digestion. NMR analyses indicated that the N-glycan at Asn34 is
more mobile in RNase-BS than in RNase-B. MD simulations
showed that the region around Asn34 in RNAse-B is not very
flexible, whereby the a-helix of the amino acid residues 1–20 has a
stabilizing effect. In RNase-BS, the a-helix formed by amino acid
residues 23–32 is significantly more flexible.
IL 3.3–5
Enzymes in the synthesis of new unique
carbohydrate structures and their mimetics
V. Kren1, K. Slamova1, R. Gazak1, P. Bojarova1, K. Krenek1
and K. Bezouska2
1Center for Biocatalysis and Biotransformation, Institute of
Microbiology, Prague, CZECH REPUBLIC, 2Laboratory of
Protein Architecture, Institute of Microbiology, Prague, CZECH
REPUBLIC
We have previously described several interesting aspects of the
use of beta-N-acetyl-hexosaminidases (glycosylhydrolase family
20) in oligosaccharide synthesis. These enzymes can catalyze
‘reverse hydrolysis’ and transglycosylation reactions yielding new
oligosaccharide structures. Generally, beta-N-acetylhexosaminid-
ases are able to hydrolyze both beta-GlcNAc and beta-GalNAc
moieties (so called ‘wobbling’ specifity). This enzyme is able to
‘wobble’ also at other positions of glycon, namely at C-6 moiety.
Modified carbohydrate donors and acceptors were prepared by
standard chemical procedures or by a combination with another
enzyme system, e.g., galactose oxidase, laccase or lipase/protease.
Modification in this glycon part is tolerated usually not only for
the hydrolytic mode of enzyme action, but also in the synthetic
reactions. We have demonstrated that C-6 acylation or oxidation
to aldehyde in the gluco- series creates substrates for beta-N-acet-
ylhexosaminidase enabling the synthesis of non-natural glycosides
(glycomimetics). Synthesis of some novel hexosamine derivatives
prepared by enzymatic and/or chemical ways will be described.
New modified substrates were tested for the cleavage by the beta-
N-acetylhexosaminidases (panel of 20 fungal hexosaminidases)
for inhibitory activity and also for the use in the synthetic
reactions. Molecular modeling (docking of modified substrates)
supported by the ‘wet’ experiments was used to probe active site
of beta-N-acetylhexosaminidase from Aspergillus oryzae. Series of
new glycosides and glycomimetics (non-natural carbohydrate
structures) were tested for their immunomodulatory activity
towards activating receptors of NK cells, such as NKR-P1 and
CD69.
OP 3.3–1
The activity of glycosidases in tobacco leaves
under stress conditions
H. Ryslava1, B. Holakovska1, J. Trefancova1, V. Doubnerova1,
P. Spoustova2, H. Synkova2 and N. Cerovska3
1Department of Biochemistry, Faculty of Science, Charles
University in Prague, Prague, CZECH REPUBLIC, 2Laboratory
of Stress Physiology, Institute of Experimental Botany, Academy
of Sciences of the Czech Republic, Prague, CZECH REPUBLIC,
3Laboratory of Virology, Institute of Experimental Botany,
Academy of Sciences of the Czech Republic, Prague, CZECH
REPUBLIC
Generally, glycosidases degrade polysaccharides, oligosaccharides
and saccharide chains of glycoproteins in plants. They are known
to hydrolyse glycosides to change inactive storage form to active
one. Some of them are considered as pathogenesis related protein
expressed under stress conditions. In this work, we focused on a
group of exoglycosidases in plants exposed to biotic stress.
Tobacco plants (Nicotiana tabacum L.) infected by Potato virus Y
and ipt transgenic plants with enhanced level of endogenous
cytokinines were our experimental models. Transgenic plants
exhibited lower photosynthesis, but were less sensitive to
potyviral infection. We found that the activity of b-glucosidase
(EC 3.2.1.21) was lower in both infected and transgenic plants,
which was in agreement with an increase of inactive forms of
cytokinines. The increase in activity of another glycosidase,
b-hexosaminidase (EC 3.2.1.52), was caused particularly by pot-
yviral infection. Both enzymes were purified and characterized
considering substrate specificity, kinetic constants, pH and
temperature stability.
Acknowledgements: This work was supported by the grants of
Ministry of Education of the Czech Republic MSM0021620808
and 1M0505.
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3.4. Cytochromes P450 and Xenobiochemistry
IL 3.4–1
Searches for cellular functions of new (and
old) cytochrome P450 enzymes
F. Guengerich, Z. Tang, Q. Cheng and G. Salamanca-Pinzon
Biochemistry, Vanderbilt University, Nashville, TN, USA
One of the central problems in biochemical research is elucida-
tion of the functions of uncharacterized proteins. Reflecting the
general case for all genes, fewer than one-half of the human cyto-
chrome P450 (P450) proteins have established functions and the
situation regarding these orphan P450s is even less clear with
microbial P450s. We have a number of human and microbial
P450s using heterologous expression, use of the tissue where the
P450 is expressed as a source of substrates, and developed a bat-
tery of HPLC-mass spectrometry (MS) methods for interrogation
of function, including substrate analysis of chromatographic data
and 18O2-labeling/detectin. The latter approach (Anal. Chem.
79, 3355, 2207) was validated using P450 7A1 and human liver
extracts. We used this approach to identify several fatty acids as
endogenous hepatic substrates of P450s 1A2, 2C8, and 2C9.
These approaches are now being applied to other human P450s,
e.g. 2S1, 2S1, 20A1, and others. These approaches have been
applied to the bacterial Streptomyces coelicolor P450 154A1 and
a transgenic knockout. Using this analysis, we identified a
substrate of possible terpenoid origin, characterized using UV,
high resolution MS and UV and NMR spectroscopy. Other
approaches include rapid screening methods to identify pro-car-
cinogens that might be activated by these orphan P450s.
Acknowledgement: Supported in part by USPHS grants R37
CA090426 and P40 ES000267.
IL 3.4–2
Structural genomics of human drug
metabolizing P450 monooxygenases
E. Johnson
The Scripps Research Institute, La Jolla, CA, USA
Crystal structures of the principal human drug metabolizing
P450s reveal distinct active site architectures that underlie the
individual contributions of each enzyme to xenobiotic oxidations.
The more conserved and rigid structural features support heme
binding and redox partner interactions, whereas flexibility of the
substrate-binding site contributes to broad substrate recognition
as well as substrate access to the active site cavity. P450/substrate
interactions are largely hydrophobic leading to substrate selectiv-
ity based on predominately on size and fit. Chemical complemen-
tarities also contribute substrate positioning as well as enzyme
selectivity. Although cavity size reflects generalized trends in sub-
strate characteristics for each enzyme, it is also clear that rela-
tively small substrates can be efficiently oxidized by enzymes with
larger active site cavities. This can reflect specific interactions that
position the molecule appropriately for catalysis as well as occu-
pancy of the active site by more than one substrate molecule so
that one molecule facilitates oxidation of the other. Further anal-
ysis of structures obtained for individual P450s complexed with
structurally distinct substrates also demonstrates plasticity for
some active sites, which can adapt in response to specific sub-
strates. This promiscuous nature of xenobiotic metabolizing
P450s complicates strategies for the prediction of substrate bind-
ing in silico. It is expected that additional structures together
with advances in computational approaches will improve the
potential for in silico applications. Acknowledgement: Supported
by US NIH grant GM031001.
IL 3.4–3
Cytochrome P450s as biomarkers for
individualised drug therapy: genetic and
epigenetic aspects
M. Ingelman-Sundberg
Karolinska Institute, Stockholm, SWEDEN
Human drug metabolising cytochrome P450 enzymes exhibit a
pronounced interindividual variability in expression because of
CNVs and activating or inactivating mutations. This affects drug
therapy and influences response rates and occurrence of adverse
drug reactions. Pharmacogenomic biomarkers can facilitate an
individualized drug therapy and among them are mutations in
the 450 genes. The gene expression is to a great extent also deter-
mined by gene methylation which regulates the expression of
CYP1A1, CYP1A2, CYP1B1, CYP2E1 and CYP2W1. In addi-
tion in the CYP2 family the CYP2A6, CYP2C19, CYP2D6,,
CYP2J2, CYP2R1, and CYP2S1 genes contain putative impor-
tant CpG islands which suggest a potential role of DNA methyl-
ation in their regulation and micro RNA dependent control of
translation. Recently CYP1B1 was shown to be controlled by
miR 27b and putative micro RNA regulation motifs The miR-
148a-dependent decrease in PXR protein attenuates the induction
of CYP3A4 mRNA and protein levels indicating that this could
contribute to the basis for the interindividual variation in
CYP3A4 expression. Gene methylation determines the tumor
specificity in CYP2W1 expression, is of importance for expression
of CYP1B1 in prostate tumor tissue and is also of crucial impor-
tance for tissue specificity of P450 gene expression. Furthermore
tumor associated gene methylation is of importance for control
of CYP1A1 expression In the lecture an overview will be given
about functionally important mechanisms for pharmacogenomics.
epigenetic and post-transcriptional mechanisms controlling the
expression of drug metabolising P450s will be given.
IL 3.4–4
Changing substrate specificity and activity of
bacterial and mitochondrial P450 systems
R. Bernhardt
Biochemistry, Saarland University, Saarbru¨cken, GERMANY
Besides playing an important role in drug metabolism, cyto-
chromes P450 are pivotal for the biosynthesis of steroid
hormones. Steroids play an important role as hormones in mam-
mals. In addition to this, many steroids are interesting pharma-
ceutical target substances for the production of different types of
drugs. Since selective transformations of steroids are a difficult
task, the pharmaceutical industry has rationalized the importance
of microbial steroid transformations. CYP106A2 from Bacillus
megaterium ATCC 13368 is one of the few known bacterial
steroid converting cytochromes P450 and hydroxylates many
3-oxo-delta-4-steroids mainly in 15 beta-position. Here we report
on the creation of mutants of this enzyme with improved activity
and changed selectivity of hydroxylation. To check mutants pro-
duced by directed evolution, a whole-cell screening system, where
Adx and AdR (as redox partners transferring electrons from
NADPH to the P450) were co-expressed in Escherichia coli, has
been developed. We were able to select mutants with consider-
ably improved activity and with changed selectivity of hydroxyl-
ation. This way, a system for creating libraries of steroid
molecules with hydroxyl groups in different positions seems to be
feasible. In addition, the regio-selectivity of steroid hydroxylation
was changed in mitochondrial P450s. The results of these experi-
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ments turned out to be helpful for the design of selective and spe-
cific inhibitors of the steroid hydroxylases studied. Overproduc-
tion of aldosterone leads to hypertension and congestive heart
failure. Therefore, CYP11B2 became a new target for drug devel-
opment. We established an effective screening system and were
able to identify new specific and selective inhibitors of CYP11B2.
IL 3.4–5
Flexibility and plasticity of the structures of
cytochromes P450 as a property determining
their function
P. Anzenbacher1, E. Anzenbacherova2, T. Hendrychova3,
M. Otyepka3, J. Hudecek4, P. Hildebrandt5 and R. Lange6
1Pharmacology, Palacky University, Olomouc, CZECH
REPUBLIC, 2Medicinal Chemistry and Biochemistry, Palacky
University, Olomouc, CZECH REPUBLIC, 3Physical Chemistry,
Palacky University, Olomouc, CZECH REPUBLIC,
4Biochemistry, Charles University, Prague, CZECH REPUBLIC,
5Max Volmer Laboratory Biophysikalische Chemie, Technische
Universitat Berlin, Berlin, GERMANY, 6Universite de Montpellier
2, INSERM Unite 710, Montpellier, FRANCE
Versatility of functions as well as of substrates of cytochromes
P450 should be reflected in their ability to accommodate mole-
cules of various size and shape. Active sites of cytochromes P450
hence differ in their flexibility and plasticity of the corresponding
parts of the structure. Examples discussed here are cytochromes
P450 known to metabolize various drugs and their analogs,
namely, cytochromes P450 3A4, 2C9 and 2D6. Experimental data
obtained by spectroscopic methods (absorption spectroscopy at
high hydrostatic pressure and resonance Raman data) are corre-
lated with results of molecular dynamic simulations carried out
using the AMBER package with parm99 force field. Starting
structures were essentially based on these taken from the PDB
database; simulations were made at normal (0.1 MPa) and high
pressure (300 MPa). The results indicate a decrease in radius of
gyration as well as the overall B-factor decrease under high pres-
sure. A correlation has been found between the experimentally
obtained coefficient describing a shift of the Soret band with
pressure (related to compressibility of the active site) and coordi-
nation numbers of water molecules and backbone atoms in the
active site around the axial ligand (carbon monoxide). The data
show that the spectral changes under pressure reflect structural
changes in the close proximity (< 0.5 nm) of the heme. The com-
pressibility of the active site apparently increase with number of
water molecules in the active site, and decrease with number of
non-polar protein backbone atoms close to the heme. Raman
spectral data reflect the situation in the active site by presence of
heme vinyl vibrations assigned to two vinyl conformations, with
two conformations present in the spectrum indicating a more
flexible structure in the active site as e.g. in the case of CYP3A4.
The data both experimental and obtained from the simulations
hence document an essential necessity of plasticity/flexibility of
enzyme active site for proper functioning of an enzyme, here
cytochrome(s) P450.
Acknowledgements: Support from Czech Ministry of Educa-
tion grants MSM6198959216 and LC512 is gratefully acknowl-
edged.
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SYMPOSIUM 4: CELLULAR AND SUBCELLULAR BIOCHEMISTRY
4.1. Cell Differentiation
IL 4.1–1
Epigenetic regulation of gene expression by
the Myb Oncoprotein and the E2F-RB tumor
suppressor complex
J. Lipsick1, H. Wen1, L. Andrejka1, J. Ashton1 and R. Karess2
1Pathology and Genetics, Stanford University, Stanford, CA, USA,
2Centre National de la Recherche Scientifique (CNRS), Centre de
Ge´ne´tique Mole´culaire, Gif sur Yvette, FRANCE
The Drosophila Myb oncoprotein, the E2F2 transcriptional
repressor, and the RBF and Mip130/LIN-9 tumor suppressor
proteins reside in a conserved Myb-MuvB (MMB)/dREAM
complex. We have found that Myb is required in vivo for the
expression of Polo kinase and components of the spindle assem-
bly checkpoint (SAC). Surprisingly, the highly conserved
DNA-binding domain was not essential for assembly of Myb
into MMB/dREAM, for transcriptional regulation in vivo, or for
rescue of Myb-null mutants to adult viability. E2F2, RBF, and
Mip130/LIN-9 acted in opposition to Myb by repressing the
expression of Polo and SAC genes in vivo. Remarkably, the
absence of both Myb and Mip130, or of both Myb and E2F2,
caused variegated expression in which high or low levels of Polo
were stably inherited through successive cell divisions in imaginal
wing discs. Restoration of Myb resulted in a uniformly high level
of Polo expression similar to that seen in wild-type tissue,
whereas restoration of Mip130 or E2F2 extinguished Polo expres-
sion. Our results demonstrate epigenetic regulation of gene
expression by Myb, Mip130/LIN-9, and E2F2-RBF in vivo, and
also provide an explanation for the ability of Mip130-null
mutants to rescue the lethality of Myb-null mutants in vivo.
IL 4.1–2
Understanding early haematopoietic
development using human embryonic stem
cell as a model
M. Ledran1, A. Krassowska2, L. Armstrong3, I. Dimmick3,
J. Renstrom4, S. Yung3, M. Santibanez-Coref3, E. Dzierzak5,
M. Stojkovic6, R. Oostendorp7, L. Forrester8 and M. Lako3
1Human Genetics, Newcastle Upon Tyne, UK, 23John Hughes
Bennett Laboratories, Queens Medical Research Institute, Edin-
burgh, UK, 3Human Genetics, Newcastle, UK, 4Klinikum rechts
der Isar, Medizinische Klinik und Poliklinik, Munchen, GER-
MANY, 5Erasmus University Medical Centre, Department of Cell
Biology and Genetics, Rotterdam, THE NETHERLANDS,
6Centro de Investigacio´n Prı´ncipe Felipe, Centro de Investigacio´n
Prı´ncipe Felipe, Valencia, SPAIN, 7CKlinikum rechts der Isar,
Medizinische Klinik und Poliklinik, Munchen, GERMANY, 83John
Hughes Bennett Laboratories, Queens Medical Research Institute,
Edinburgh, UK
Transplantation of haematopoietic stem cells (HSCs) in leukae-
mia treatment requires high quality bone marrow, mobilised
peripheral blood or umbilical cord blood however these are in
short supply. Directed differentiation of hESC offers an attrac-
tive alternative. The potential of hESC to differentiate towards
haematopoietic lineages was investigated by co-culturing hESC
with monolayers of cells derived from mouse aorta-gonad-meso-
nephros and fetal liver region or with stromal cell lines derived
from these tissues (EL08.1D2, AM20.1B4 and UG26.1B6). The
hESC derived differentiating cells were able to form early
haematopoietic progenitors that peaked at day 18–21 of
differentiation and corresponded to the highest CD34 expression.
The hESC derived haematopoietic cells were capable of primary
and secondary haematopoietic engraftment into immunocompro-
mised NOD/LtSz-Scid IL2Rcnull recipients at levels higher
(0.11–16.26%) than described previously. Large scale transcrip-
tional analysis combined with blocking and stimulation experi-
ments identified TGFb1 and TGFb3 as positive enhancers of
human ESC haematopoietic differentiation. Addition of TGFb1
or TGFb3 to differentiating hESC in the absence or presence of
stromal cells resulted in a significant increase in haematopoietic
differentiation, thus suggesting a hitherto undiscovered role for
TGFb1 and TGFb3 in human ESC differentiation to haemato-
poietic lineages. Overall, our data presents an important step
towards deriving functional HSCs from hESC.
IL 4.1–3
Bone development and disease regulated by
AP-1 (Fos/Jun)
E. Wagner, A. Bozec and L. Bakiri
CNIO, Cancer Cell Biology Programme, Madrid, SPAIN
AP-1 proteins such as Fos and Jun are prototypic oncogenes reg-
ulating cell proliferation, differentiation and cell transformation
in various organs. We have been defining the specific functions of
various Fos proteins, e.g. Fos, Fra-1 and in particular Fra-2 in
bone development and disease using gain-of-function and loss-
of-function experiments in mice. The role of c-Fos as a differenti-
ation-specific transcription factor for osteoclasts, the bone
resorbing cells, is well established, whereas the functions of Fra-1
and Fra-2 are less well understood. It appears that Fra-1 mainly
controls matrix gene expression (1), whereas Fra-2 is important
for chondrocyte differentiation (2). We have recently shown that
newborns lacking Fra-2 have increased size and numbers of osteo-
clasts in vivo likely caused by impaired LIF/LIFR signalling and
hypoxia. Interestingly, newborns lacking LIF also display giant
osteoclasts and LIF is a transcriptional target of Fra-2. Fra-2 and
LIF-deficient bones are both hypoxic and express increased levels
of HIF1a and Bcl-2. Furthermore, Fra-2 and LIF deficiency
affects HIF1a through transcriptional modulation of the
HIF-prolyl-hydroxylase PHD2 (3). Moreover, Fra-2 deficient
osteoblasts display a differentiation defect in vivo and in vitro
(unpublished), which appears to be cell autonomous and
LIF-independent. Preliminary data demonstrating direct tran-
scriptional regulation of osteoblast-specific genes such as collagen
type 1 (col1a 2) and osteocalcin by Fra-2 will be discussed. These
findings indicate that despite sequence homology, the Fos proteins
c-Fos, Fra-1 and Fra-2 play specific roles in bone development
and disease. The identification of the molecules/pathways operat-
ing downstream of Fos proteins as well as novel AP-1 target genes
in osteoblast and osteoclast differentiation will certainly lead to
new insights into the molecular mechanisms coordinating bone
cell differentiation under normal and pathological conditions.
References:
1. Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner
L, Amling M & Wagner EF. EMBO J. 2004; 21: 2789–2799.
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2. Karreth F, Hoebertz A, Scheuch H, Eferl R & Wagner EF.
Development 2004; 131: 5717–5725.
3. Bozec A, Bakiri L, Hoebertz A, Eferl R, Schilling AF,
Komnenovic V, Scheuch H, Priemel M, Stewart CL, Amling
M & Wagner EF. Nature 2008; 10: 454, 221–225.
IL 4.1–4
Origin and mode of function of bone resorbing
osteoclasts
P. Jurdic
Institut de Ge´nomique Fonctionnelle de Lyon, Universite´ de Lyon,
Lyon, FRANCE
As every tissue, bone is composed of cells and of an extracellular
matrix and has to be renewed along life. Bone homeostasis is
maintained through a finely tuned remodeling process involving
degradation by osteoclasts and formation by osteoblasts.
Osteoclasts derive from hematopoietic lineage. They are multi-
nucleated cells, formed by fusion of monocyte/macrophage in the
presence of M-CSF and RANKL. Throughout the differentiation
process they express a series of markers, which characterize the
osteoclast phenotype, but the hallmark of osteoclasts is their
unique ability to resorb mineralized calcium apatite. We have
shown in vitro that immature immune Dendritic Cells (DC), can
transdifferentiate into resorbing osteoclasts bearing all character-
istic and functional markers of osteoclasts We have postulated
that transdifferentiation could specifically be induced in response
to inflammatory conditions. Indeed, in our experiments, synovial
fluid, from patients with rheumatoid arthritis, potentiate transdif-
ferentiation whereas it has recently been shown that DC can
transdifferentiate into osteoclasts in vivo. Results from our tran-
scriptomic analysis comparing DC- versus monocyte-derived
osteoclastogenesis has revealed that DC are more closely related
to osteoclasts than are monocytes. From these data we have
hypothesized that there must exist several osteoclast subpopula-
tions and/or different osteoclatogenesis pathways from different
progenitors, according to microenvironment conditions. Osteo-
clasts can adhere to several substrates on which they form
specific distinct F-actin structures. When adherent on glass they
exhibit podosomes formed by an F-actin core, surrounded by
several focal adhesion proteins. Osteoclasts adhering to mineral-
ized extracellular matrix become apico-basically polarized, and
form a different actin-containing structure called sealing zone
(SZ) that delineates the ruffled border, a site of active membrane
traffic and transport, where protons and proteases are secreted in
order to dissolve mineral. We have shown that podosome
patterning dynamically evolves during osteoclastogenesis and in
mature osteoclasts, they are arranged at the cell periphery as a
characteristic belt reminiscent of the sealing. However, it remains
to be understood how a bone adhering osteoclast activates its
cellular machinery to become polarized, to condense its actin
structure into a sealing zone and to resorb mineralized extracellu-
lar matrix.
OP 4.1–1
Role of reactive oxygen species as signal
molecules in adult stem cells
C. Piccoli, A. D’Aprile, R. Scrima, M. Ripoli, G. Quarato,
D. Boffoli and N. Capitanio
Biomedical Sciences, University of Foggia Medical School, Foggia,
ITALY
Consolidated evidence highlights the importance of redox signal-
ling in the homeostasis of cell adaptative biology processes, like
the balance between self-renewal and differentiation of the stem
cells. In this study we investigated how changes in the oxidative
metabolism may modify the fate of adult hematopoietic stem
cells (HSC). In particular it is shown that circulating human
HSC are endowed with a panel of constitutively active NADPH-
oxidases (NOX) comprising the cell membrane-localized catalytic
subunits of the NOX1, NOX2 and NOX4 isoforms together with
the accessory subunits and a splicing variant of NOX2. It is sug-
gested that NOX isoforms in HSCs act as environmental oxygen
sensor, generating low level of reactive oxygen species (ROS)
which likely serve as second messengers. In addition it is shown
that NOX-produced ROS in HSCs stabilize under normoxic con-
dition the hypoxia-inducible factor (HIF-1alpha). The control is
exerted at post-translational level through the down-regulation of
the von Hippel-Lindau protein which mediates proteasome-
degradation of HIF. Although HIF is the master transcription
factor mediating cell adaptation to hypoxia recent evidence sup-
ports its involvement in activation of signalling pathway as
Notch and control of the expression of Oct4. Notch and Oct4
are transcription factors involved in regulating stem cell self-
renewal and preservation of pluri/multipotency. Our findings are
hence discussed in the context of the recruitment of progenitor/
stem cells to injured ischemic tissues and in the control of the
maintenance on the undifferentiated state in mobilized peripheral
blood circulating HSC with the aim to provide applicative
insights to cell-based therapy/regenerative medicine.
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4.2. Biochemistry of Melanins and Melanosomes
IL 4.2–1
Chemical and biophysical properties of
eumelanin and pheomelanin
T. Sarna
Biophysics, Jagiellonian University, Krako´w, POLAND
Melanin – one of the most common biological pigments – in
human, is present in the skin, hair, eye, inner ear and some
neurons of the midbrain. Although melanogenesis has not been
completely determined, it is apparent that the process involves
both enzyme-catalyzed and non-enzymatic reactions of key mela-
nin precursors. The oligomeric/polymeric product is deposited on
protein matrix of distinct pigment granules, the melanosomes.
There are two main melanin pigments – eumelanin and pheomel-
anin, which are formed in the absence and presence of cysteine
or glutathione, respectively. These melanins are built of different
monomer units, they exhibit slightly different optical properties
and distinct photochemical reactivity, and their paramagnetic
properties are quite distinguishable. Both types of melanin are
synthesized, to a different degree, in melanocytes of the human
skin, choroid and iris of the eye, but only eumelanin is present in
the retinal pigment epithelium. While eumelanin is commonly
viewed as an efficient photoprotective agent, the biological role
of pheomelanin remains ambiguous. Indeed, it was demonstrated
that under some experimental conditions, pheomelanin could act
as a photosensitizer. However, the exact molecular mechanisms
by which eumelanin protects pigmented cells against damage
induced by solar radiation and pheomelanin aggravates the
photodamage, are not fully understood. This paper will critically
review relevant data and discuss chemical and physical basis of
the postulated biological functions of eumelanin and pheomela-
nin, particularly in the human eye.
Acknowledgement: Supported by the Ministry of Science and
Higher Education (DS11).
IL 4.2–2
Signaling from human melanocortin 1 receptor
variants associated with red hair and skin
cancer
J. Garcia-Borron, C. Herraiz, B. Sanchez-Laorden,
A. Perez-Oliva and C. Jimenez-Cervantes
Biochemistry Molecular Biology and Immunology, Universidad de
Murcia, Murcia, SPAIN
The melanocortin 1 receptor (MC1R) is a G protein-coupled
receptor (GPCR) expressed in melanocytes, where it stimulates
melanogenesis and increases the ratio of black eumelanins to yel-
lowish-reddish pheomelanins. MC1R belongs to the melanocortin
receptor subgroup of GPCRs. These receptors signal primarily to
the cAMP pathway, but they also mediate other signaling events
such as activation of ERK1 and ERK2 MAP kinases. In the
mouse, efficient MC1R signalling due to gain-of-function muta-
tions is associated with eumelanogenesis and darker coats. Con-
versely, absent or poor signaling due to loss-of-function
mutations or expression of endogenous peptide inhibitors results
in the production of pheomelanins. Human MC1R is unusually
polymorphic, and several variant alleles are associated with
pheomelanin-rich red hair, abundant freckles, inability to tan
efficiently upon sun exposure, high sensitivity to ultraviolet radia-
tion-induced skin damage and increased skin cancer risk (the
RHC phenotype). The RHC variants R151C, R160W and
D294H are particularly penetrant and frequent. These variants
signal efficiently to the ERK module, but poorly to cAMP. This
disparate effect on signaling to ERK and cAMP challenges
current concepts of functional coupling in the melanocortin
receptor family. On the other hand, reduced signaling to cAMP
from the R151C and R160W variants is due to aberrant intra-
cellular trafficking with intracellular retention in different sub-
cellular compartments. Analysis of the trafficking patterns of
these alleles provides mechanistic insights on the functioning of
arginine-based sorting motifs. These findings illustrate the
potential of pigmentation phenotypes as indicators of general
physiological processes used in other systems in mammals.
IL 4.2–3
Physiological and pathological functions of
melanosomes and their exploitation
J. Borovansky1 and P. A. Riley2
1Department of Biochemistry & Exptl Oncology, 1st Faculty of
Medicine, Charles University, Prague, CZECH REPUBLIC,
2Totteridge Institute for Advanced Studies, London, UK
In vertebrates melanin is synthesized in specialised membrane-
bound intracellular organelles known as melanosomes. They con-
tain the apparatus of melanogenesis and melanin is deposited on
a protein matrix within these organelles. An important physiolog-
ical role of melanosomes is the segregation of reactive intermedi-
ates of melanogenesis that are potentially hazardous to the cell.
In mammals the biosynthesis of melanin occurs in two classes of
cells: the retinal pigment epithelium and melanocytes. Melano-
cytes are specialized dendritic cells that either retain the melano-
somes or distribute them to adjacent cells, as in the skin and
hair. The physiological significance of fully-melanized melano-
somes rests on the physical characteristics that endow melanin
with (i) broad optical absorbance and photon/phonon conver-
sion; (ii) facile redox exchange (iii) cation binding and (iv) affinity
for polycyclic compounds. The visible absorbance of melanin is
exploited in surface colouration for camouflage or display. The
UV absorbance is involved in photoprotection. The redox prop-
erties of melanin permit the pigment to function as a scavenger
or generator of free radicals. Cation binding by melanin may
provide an excretory pathway for metals. Recent work has shown
that catechols may play a role in intracellular calcium homeo-
stasis. Exploitation of melanosomal properties has principally
been in relation to the possibility of utilizing the melanogenic
pathway as a targeting strategy for anti-melanoma chemotherapy
where several approaches have been investigated. Melanosomal
proteins are of diagnostic use in pathology and constitute
potential targets for future immunotherapy.
IL 4.2–4
Mutator phenotypes in pigment cells and
mechanism(s) of their DNA damage
S. Pavel1 and N. Smit2
1Dermatology, Leiden University Medical Centre, Leiden, THE
NETHERLANDS, 2Clinical Chemistry, Leiden University Medical
Centre, Leiden, THE NETHERLANDS
The existence of mutator phenotypes, the pre-cancer cells that
may acquire large number of mutations, is becoming largely
accepted. The mutator phenotypes can arise by simple (random)
mutations that drive carcinogenesis by highlighting new emerging
pathways that generate the hypermutability status. We propose
that dysplastic naevus cells are the mutator type of cells. In these
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cells, the increased rate of genetic changes may eventually lead to
the transformation to melanoma. Many clinical observations
agree that the presence of so called dysplastic naevi on the skin is
an important risk factor for developing melanoma. Moreover,
these pigmented naevi are also known as potential melanoma pre-
cursors. We provided some evidence that dysplastic naevus cells
suffer from chronic oxidative stress. They produce in their
melanosomes more phaeomelanin than do normal melanocytes.
Melanosomes are specific sources of oxidative imbalance in
pigment-forming cells. Normal melanocytes partly get rid of these
oxidative ‘packages’ by transporting them to the keratinocytes.
That is not possible in naevus cells. The accumulation of melano-
somes in naevus cells can increase the risk of oxidative damage.
Their preference for phaeomelanogenesis lowers the antioxidative
capacity by increased consumption of thiols (cystein). Our experi-
ments with comet assay show that nuclei of dysplastic naevus cells
are more fragmented than nuclei of normal melanocytes. The use
of formamido-pyrimidine-DNA nuclease revealed that the DNA
of dysplastic naevus cells displayed also more oxidative DNA
damage. We propose that the existence of chronic oxidative
imbalance forms the basis for mutator phenotype of these
pigment cells.
IL 4.2–5
Too much or too little BETA-catenin represses
melanoblast proliferation
V. Delmas1, A. Herbette1, D. Champeval1, L. Denat1,
S. Martinozzi1, C. Alberti1, R. Kemler2, R. Ballotti3, C. Goding4
and L. LaRue1
1Developmental Genetics of Melanocytes, Institut Curie, Orsay,
FRANCE, 22Max-Planck Institut fu¨r Immunbiologie, Freiburg,
GERMANY, 3INSERM, Biologie et Pathologies des Cellules
Melanocytaires: de la Pigmentation Cutane´e au Melanome, Nice,
FRANCE, 4Ludwig Institute for Cancer Research, Oxford
University, Oxford, UK
During development, the canonical Wnt/b-catenin pathway
governs cell fate, polarity, proliferation and death in various cell
lineages. In the melanocyte lineage, Wnt/b-catenin signalling has
been shown to induce melanoblast determination and differentia-
tion. Little is known about the function of b-catenin and its asso-
ciation with other cellular mechanisms in the establishment of
the melanocyte lineage. We have produced mice with various
levels of b-catenin in melanoblasts, in a C57BL/6 background.
Far fewer melanoblasts were generated in the absence of b-cate-
nin production (Tyr::Cre/;bcatfloxDex2-6/floxDex2-6 = bcatnull) than
in wild-type conditions. bcat-null mice thus had a white trunk
and a grey head. Surprisingly, the number of melanoblasts pro-
ducing more b-catenin (Tyr::bcatact/ = bcatact) than normal was
not higher, as expected, but lower. bcatact mice were hypo-
pigmented. No apoptosis or transdifferentiation of melanoblasts
was detected, suggesting an effect on proliferation. bcatact
embryos had fewer melanoblasts than normal in both the dermis
and the epidermis, whereas the number of bcatnull melanoblasts
was much lower than normal in epidermis but similar to that in
the wild type in the dermis. These results account for the pheno-
types of these two new mouse mutants. The full molecular
picture remains unclear, but it is becoming evident that the four
main targets of b-catenin (Mitf-M, Myc, cyclin D1 and Brn2)
and their multiple interactions are involved in melanoblast
proliferation.
OP 4.2–1
Suicide-inactivation of tyrosinase by catecholic
substrates
C. Ramsden
Chemistry, Keele University, Stoke-on-Trent, Keele, UK
Tyrosinase (E.C. 1.14.18.1), a mono-oxygenase with a binuclear
copper catalytic center, is the principal enzyme of melanogenesis
and catalyses the oxidation to the corresponding ortho-quinones
of both monohydric phenols (cresolase activity) and dihydric
phenols (catecholase activity). The enzyme is characterised by sui-
cide-inactivation in the presence of catecholic substrates. A mech-
anism to account for this has recently been proposed based on
cresolase oxidation of catecholic substrates resulting in the gener-
ation of a zero-valent copper atom which is lost from the active
site, a process known as reductive elimination. This unusual
inactivation mechanism predicts certain features that are the
topic of recent studies which have shown that cresolase activity is
necessary for suicide-inactivation to be expressed. Marquardt
optimisation of oximetric data obtained with the substrate,
4-methylcatechol, using a mathematical model of the oxidation
kinetics, yields a ratio of comparative catechol oxidation and
enzyme inactivation rates of 1:1530 and the model closely fits the
inactivation data obtained in experiments in which successive
tyrosinase additions are made. Structure-activity analysis permits
a number of inferences to be made regarding the structural
features of catechols affecting the inactivation, including substitu-
tions that prevent cresolase activity and thus abolish the inactiva-
tion. Additional data are presented relating to other catecholic
substrates that are consistent with the mechanistic model of
suicide-inactivation advanced.
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4.3. Extracellular Matrix and Cell Adhesion
IL 4.3–1
Deciphering the mechanisms of fibronectin
fibrillogenesis and its role in angiogenic tumor
progression
E. Van Obberghen-Schilling, B. Cseh, E. Serres, F. Stanchi and
D. Grall
University of Nice-Sophia Antipolis, CNRS UMR6543, Nice,
FRANCE
The extracellular matrix (ECM) provides both an adhesive
substrate and a platform for integrin-dependent signalling events
that regulate a host of cellular functions. Altered matrix and cell-
ECM interactions contribute widely to neoplastic, inflammatory
and infectious diseases. Both genetic and pharmacological
evidence points to fundamental role for fibronectin (FN) and its
receptor alpha5beta1 integrin in vascular physio/pathology.
Secreted FN is assembled into a 3D fibrillar network by an inte-
grin-dependent process termed FN fibrillogenesis. Our recent
findings in endothelial cells indicate that production and secretion
of cellular FN isoforms is tightly coupled to fibrillar assembly
and this process is determinant for integrin signalling, the estab-
lishment of endothelial cell polarity and plexus organization.
Thus, elucidating the precise mechanisms that underlie FN fibril-
logenesis should be important for determining rational strategies
for more effective anti-antiangiogenic/anti-tumoral approaches.
To this end, we have studied integrin-based signaling in angio-
genic endothelial cells with a focus on Integrin-linked Kinase
(ILK), a cytoplasmic partner of the beta integrin subunits. ILK
and cytoplasmic adaptors of the PINCH and parvin families
form a ternary complex termed IPP that localizes in integrin
adhesions and drives focal to fibrillar adhesion maturation and
FN fibrillogenesis. Molecular mechanisms underlying FN fibrillo-
genesis and functional dissection of the IPP complex will be
discussed.
IL 4.3–2
Extracellular matrix and tumor stroma in
cancer progression
R. Chiquet-Ehrismann1, M. Degen1, F. Brellier1, E. Martina1,
A. Merlo2, M. Lino2 and C. Ruegg3
1Growth Control, Friedrich Miescher Institute for Biomedical
Research, Basel, SWITZERLAND, 2Neuro-Oncology, University
Hospital, Basel, SWITZERLAND, 3CPO, University of Lausanne,
Lausanne, SWITZERLAND
Epithelial tissues depend on normal stromal cells and the base-
ment membrane for maintenance of tissue homeostasis. These
interactions continue to be important in epithelial pathologies.
During carcinogenesis tumor-associated cells of the stromal com-
partment express pro-proliferative paracrine signals for epithelial
cells and stimulate angiogenesis. Therefore, understanding the
mechanisms of the complex crosstalk between the cancerous
epithelial cells and the tumor stroma might lead to novel
approaches for cancer therapies which target the functions of
the activated stromal cells. A prominent extracellular matrix
protein specifically present in tumor stroma is tenascin-C
(TNC). Interestingly, TNC was shown to be expressed around
angiogenic vessels in many tumors and to promote angiogenesis
in cell culture studies. Furthermore, TNC added to a fibronectin
substratum stimulated cancer cell growth and migration in vitro.
Therefore, TNC is a candidate molecule mediating the
pro-tumorigenic effects of tumor stroma. Glioblastomas are
highly invasive and aggressive brain tumors that show limited
response to conventional therapies. We observed in human glio-
blastoma high Notch2 protein levels to coincide with expression
of TNC. Expression of activated forms of Notch2 in glioma
cells triggered RBPJk-dependent induction of TNC transcrip-
tion. Furthermore, transfection of activated Notch2 increased
endogenous TNC protein production. Since increasing amounts
of TNC stimulated glioma cell migration, this may represent a
mechanism for the invasive properties of glioma cells controlled
by Notch and defines a novel oncogenic pathway in gliomagene-
sis to be targeted for therapeutic intervention in glioblastoma
patients. Recently, we determined the presence of a novel tenas-
cin family member, tenascin-W (TNW), in the stroma of breast
and colon cancers and elevated levels of TNW were found in
the sera of colon cancer patients. In vitro, TNW did not inter-
fere with cancer cell adhesion to fibronectin, but promoted
migration of breast cancer cells towards fibronectin. These data
imply that TNW expression in the activated tumor stroma facili-
tates tumorigenesis by supporting the migratory behavior of
cancer cells.
IL 4.3–3
Human Embryonic stem cells and bone
regeneration
M. Wendel, R. Sugars and E. Ka¨rner
Department of Odontology, Karolinska Institutet, Huddinge,
SWEDEN
The establishment of human embryonic stem cell (HESC) lines
and recent progress in the area of medical research offer the
possibility to understand early developmental processes, thus
contributing to the improvement of strategies for regenerative
medicine. Our work aims to grow HESCs in laboratory condi-
tions and to investigate various mechanisms by which stem cells
differentiate into bone producing cells, osteoblasts. We have
earlier been able to show that differentiation of pluripotent
HESC to an osteogenic lineage does not require initiation via
embryoid bodies (EB) formation, and that HESCs produce a
mineralized matrix possessing all the major bone markers in
mono-layer cultures. Thereby, providing a suitable model for
the development of bone regeneration strategies. Moreover,
enhanced differentiation of HESCs, induced by genetic modifi-
cation could potentially generate a vast number of diverse cell
types. To date, attempts to promote osteogenesis by means of
gene transfer into HESCs using the early bone ‘master’ tran-
scription factor osterix (Osx) have not been reported. We
attained HESC subpopulations expressing two significantly dif-
ferent levels of Osx, following lentiviral gene transfer. We show
that the high Osx levels induced the commitment towards the
hematopoietic-endothelial lineage-by up-regulating the expres-
sion of CD34 and Gata1. However, low levels of Osx up-regu-
lated collagen I, bone sialoprotein and osteocalcin. Conversely,
forced high level expression of the homeobox transcription
factor HoxB4, a known regulator for early hematopoiesis, pro-
moted osteogenesis in HESCs, while low levels of HoxB4 lead
to hematopoietic gene expression.
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IL 4.3–4
Extracellular matrix in bone and cartilage
pathologies – Regulatory and structural roles
of collagen XIII in bone and muscle
T. Pihlajaniemi1, A. Heikkinen1, R. Keski-Filppula1, H. Tu1,
M. A. Fox2 and J. R. Sanes3
1Oulu Center for Cell-Matrix Research, University of Oulu, Oulu,
FINLAND, 2Department of Anatomy and Neurobiology, Virginia
Commonwealth University Medical Centre, Richmond, VA, USA,
3Harvard University, Department of Molecular and Cellular
Biology and Center for Brain Science, Cambridge, MA, USA
The extracellular matrix plays a crucial role in controlling cell
differentiation and function in multicellular animals. Collagens
are known to be essential in maintaining the integrity of tissues.
However, collagens can also serve as reservoirs for growth fac-
tors and can modulate cell signaling critical for tissue morpho-
genesis and homeostasis. Collagen XIII is a transmembrane
protein, which is found in adhesive structures in tissues, and it is
thought to serve structural roles. It can also be shed by propro-
tein convertases, and the shed ectodomain can affect the migra-
tion and proliferation of cultured cells. In human skeletal tissues
collagen XIII is found in the periosteum, in the mesenchymal
cells forming the reticulin fibres of the bone marrow and in the
proliferative and hypertrophic chondrocytes of the growth plate.
Findings with a novel gene-targeted reporter mouse line revealed
periosteum and muscle fibres as the major sites of expression.
The roles of collagen XIII in osteoblast differentiation, and in
bone formation and remodeling will be discussed. In skeletal
muscle, collagen XIII was identified as a previously unrecognized
component of the neuromuscular junction. Results obtained with
collagen XIII null mice indicate that collagen XIII affects both
presynaptic and postsynaptic development in a manner that sug-
gests specific roles at different developmental stages. Moreover,
the results are suggestive of distinct roles for the transmembrane
and shed forms of the collagen in the neuromuscular junction.
IL 4.3–5
Extracellular matrix in tooth enamel formation
B. Ganss
CIHR Group in Matrix Dynamics, University of Toronto, Toronto,
ON, CANADA
Dental enamel is the hardest mineralized tissue found in mam-
mals. Covering the outer layer of teeth, this remarkable, natural
bioceramic is designed to last a lifetime under extreme mechani-
cal, chemical and physical stress in a microorganism-infested
environment. Ultimately consisting of a complex hydroxyapatite
(HAP) meshwork, enamel is formed by a controlled biomineral-
ization process under the guidance of several structural proteins
such as amelogenin, ameloblastin and enamelin, which are
expressed and secreted by ameloblasts. The formation of enamel
is a multi-step process: During the secretory stage, structural pro-
teins accumulate and provide a three-dimensional scaffold for the
initiation and elongation of HAP crystallites. During the transi-
tion stage, ameloblasts reduce their synthetic activity and HAP
crystals grow primarily in width. The structural proteins, together
with water and other organic components, are then removed by
specific proteolytic enzymes such as matrix metalloproteinase-20
(MMP-20; enamelysin) and kallikrein-4 (KLK-4) during the final
enamel maturation phase. We have recently discovered another
enamel-specific protein, which we have named amelotin. Amelo-
tin is predominantly expressed during the transition and matura-
tion stages of amelogenesis. The secreted protein forms large
aggregates that accumulate at the interface between the basal
ameloblast cell surface and the mineralized enamel. We have con-
ducted and present here several studies to characterize the amelo-
tin protein biochemically and to elucidate its biological role in
transgenic mouse models. Understanding the mechanism of
enamel formation will not only help diagnose and treat related
pathologies, but also assist in the development of novel biomate-
rials.
OP 4.3–1
The role of lumican in human colon cancer
cells migration
A. Radwanska1, D. Baczynska1, A. Gajda1, Y. Wegrowski2 and
M. Malicka-Blaszkiewicz1
1Department of Cell Pathology, Faculty of Biotechnology,
University of Wroclaw, Wroclaw, POLAND, 2Department of
Medicine Laboratory of Medical Biochemistry and Molecular
Biology, University of Reims-Champagne-Ardenne, Reims,
FRANCE
The interactions of cells with the extracellular matrix (ECM) pro-
teins are essential for cells survival and motility. It has been
reported that lumican, the member of small leucine-rich proteo-
glycans family of ECM, plays a regulatory role in cancer cells
adhesion and migration. Remodeling of actin cytoskeleton,
induced in response to the external stimuli, is crucial for cell
motility and intracellular signal transduction. As we have previ-
ously shown, lumican decreases human melanoma A375 cells
migration ability and induces actin cytoskeleton rearrangement
(Radwanska et al., 2008 Life Sci. 83). However, the level of lumi-
can expression in colorectal cancer tissues was found to correlate
with tumor metastatic capacity. We have focused on the role of
lumican in colon cancer LS180 cells invasiveness and its effect on
proliferation rate and actin cytoskeleton organization. Lumican
expression level, as analyzed by real-time PCR and western blot-
ting, was strongly elevated in selected LS180 cells sublines (EB3,
5W, 3LNLN) with higher metastatic potential. The transfection
of LS180 cells with human lumican cDNA verified that the cells
overexpressing lumican are characterized by increased ability to
invade matrigel-coated Transwell filters. It was accompanied by
these cells higher proliferation rate. The changes in actin
cytoskeleton organization in lumican-transfected LS180 cells are
followed by the changes of cell shape: the cells are spread and
morphologically similar to the highly invasive sublines (5W and
3LNLN), presenting numerous cellular protrusions and actin
stress fibers. These results confirm the correlation between
lumican expression level and human colon adenocarcinoma cells
invasive potential.
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4.4. The Cell Nucleus: Structure, Function and Dynamics
IL 4.4–1
Using multi-dimensional proteomics to define
the complete protein composition of mitotic
chromosomes
W. Earnshaw, S. Ohta, J. Bukowski-Wills, F. Alves, L. Sennels
and J. Rappsilber
Wellcome Trust Centre for Cell Biology, University of Edinburgh,
Edinburgh, UK
Mitotic chromosomes pose an intriguing problem for proteomic
analysis, as they do not have a single defined protein composi-
tion. Upon nuclear envelope breakdown at prometaphase,
numerous cytoplasmic and nuclear proteins associate with the
chromosomes, some passively and some in order to perform a
variety of essential functions. We have used a multidimensional
SILAC approach to develop a strategy for identification of struc-
tural proteins of chromosomes. An initial mass-spectrometry
based proteomic analysis of chicken DT40 cell mitotic chromo-
somes identified 2991 proteins in purified chromosomal fractions.
Roughly 2000 of these are likely to be present in < 30 copies per
chromatid. Of the identified proteins, 105 had previously been
annotated as centromere proteins and 12 as telomere proteins.
This large number of centromere proteins was due to the fact
that our analysis identified multiple variant forms of a number of
the proteins. Our subsequent analysis utilized three classifiers in a
combination of novel SILAC-based approaches to sort proteins
into groups. These included the comparison of the abundance of
proteins found on chromosomes versus in post-chromosomal
supernatants; the exchange of proteins between chromosomes
and cytosol; and the dependence of protein association with
mitotic chromosomes upon the presence of a functional conden-
sin complex. Analysis of these three qualifiers in three dimensions
identifies a space containing of true chromosomal proteins,
within which lie 49 novel uncharacterized proteins. Our prelimin-
ary studies of this group to date have identified ten novel centro-
mere proteins. This multi-dimensional profiling analysis can in
principle be applied to any high-order structural complexes that
can be enriched but for not purified to homogeneity.
IL 4.4-2
The mammalian genome: its duplication,
organization and mobility
M. C. Cardoso
Technische Universita¨t Darmstadt, Department of Biology,
Darmstadt, GERMANY
We are interested on how genetic and epigenetic information is
replicated every time a cell divides and how the epigenetic infor-
mation is accessed and ‘‘translated’’ to define specific cell types
with specific sets of active and inactive genes, collectively called
the epigenome. We are using a combination of in vivo approaches
including time lapse microscopy and photodynamic assays and,
more recently, single molecule microscopy and particle tracking.
Nuclear DNA is organized together with structural proteins into
dynamic higher order chromatin structures. Chromatin can thus
be broadly subdivided into eu- and heterochromatin, depending
on its condensation state, transcriptional activity and the modifi-
cation of associated chromatin organizing proteins. Whereas
euchromatin is generally assumed to be actively transcribed and
replicated early in S phase, heterochromatin is more condensed
and replicates later during S phase. Using a combination of
knock out cell lines and chemical inhibitors we are probing the
epigenetic features regulating the timing of replication of faculta-
tive and constitutive heterochromatin in mammalian cells. It is
unclear whether and how changes in the chromatin compaction
state, in particular the heterochromatic state, affect the mobility
of chromatin, its organizing proteins and the access of proteins
to chromatin. To address these questions, we are using a combi-
nation of live-cell chromatin labels and high-speed single mole-
cule tracking microscopy in living mammalian cells. Our results
indicated that all nuclear subcompartments were easily and simi-
larly accessible for an average-sized probe protein (streptavidin)
and even condensed heterochromatin did neither exclude single
molecules nor impede their passage. The only significant differ-
ence was a higher frequency of transient trappings in heterochro-
matin lasting though, only tens of milliseconds. The streptavidin
molecules, however, did not accumulate in heterochromatin sug-
gesting comparatively less free volume. These data suggest that
genome metabolism may not be regulated at the level of physical
accessibility but rather by local concentration of reactants and
availability of binding sites. Finally, we labeled different chroma-
tin subsets by fluorescent nucleotide incorporation during DNA
replication and tracked their mobility throughout the cell cycle
by particle tracking. We will discuss our chromatin mobility data
and its interdependency of nuclear metabolism and topology.
IL 4.4–3
Nucleoplasmic lamin complexes regulate
tissue progenitor cells
R. Foisner, I. Gotic, N. Naetar, J. Braun, U. Pilat and R. Spilka
Max F. Perutz Laboratories, Medical University Vienna, Vienna,
AUSTRIA
Lamins are nuclear intermediate filament proteins in multicellular
eukaryotes that form a scaffolding network at the nuclear enve-
lope. While B-type lamins are ubiquitously expressed, A-type
lamins are only expressed at later stages of development. Intrigu-
ingly, mutations in the LMNA gene were linked to human
diseases, whose pathologies range from striated muscle defects to
premature ageing syndromes. The molecular pathomechanisms,
how mutations in lamins can give rise to the diverse pathologies
are poorly understood. We show that in addition to the major
lamin structures at the nuclear envelope a small pool of lamin A/
C is located in the nuclear interior in proliferating cells in culture
and in tissues. The specific lamin A-binding protein, lamina-asso-
ciated polypeptide 2 alpha (LAP2a), is required for the localiza-
tion of this lamin A/C pool in the nuclear interior. The
intranuclear LAP2a-lamin A/C complex regulates retinoblastoma
protein (Rb), a major cell cycle regulator protein involved in con-
trolling proliferation and differentiation of cells. Knockdown of
LAP2a in mice impaired the Rb pathway in postnatal regenera-
tive tissues and caused accumulation of proliferating early pro-
genitor cells in skin and intestine and of immature erythroblasts
in the hematopoietic system due to an inefficient cell cycle arrest.
Based on these findings, we propose that disease-causing muta-
tions in lamins may disturb the balance between proliferation
and differentiation of early progenitor cells, and impair tissue
homeostasis in patients.
Acknowledgements: This study was supported by the Austrian
Science Research Fund and the EURO-Laminopathies research
project of the European Commission (Contract LSHM-CT-2005-
018690).
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IL 4.4–4
Protecting genome integrity by DNA damage
signalling and repair
J. Bartek
Institute of Cancer Biology, Danish Cancer Society, Copenhagen,
DENMARK
The lecture will first provide some background information on
DNA damage response (DDR) pathways and their biological
significance, followed by examples from our recent work on the
following issues: (i) evidence supporting the emerging role of the
DNA damage signalling cascades in coordination of cell cycle
checkpoints and DNA repair mechanisms, and including unpub-
lished insights into the critical role of protein ubiquitination in
key DDR processes, documented by identification of new DDR
components through our pangenomic siRNA-based screens; (ii)
novel insights into the spatio-temporal control and dynamics of
responses to DNA double strand breaks – the most dangerous
type of DNA lesion, emphasizing the distinct behavior of various
classes of DDR components, as monitored by live-cell imaging
approaches in human cell nuclei in real time; (iii) new data
extending our concept of the DDR machinery as an inducible
biological barrier against activated oncogenes and progression of
human tumours, followed by a brief outline on emerging applica-
tions of these concepts for biomedicine, particularly personalized
treatment of cancer.
OP 4.4–1
The dynamics of single mRNP nucleo–
cytoplasmic transport and export in living cells
Y. Shav-Tal, S. Suliman, R. Ben-Yishay, S. Yunger and A. Mor
Bar-Ilan University, The Mina & Everard Goodman Faculty of
Life Sciences, Ramat-Gan, ISRAEL
Transcribed mRNAs are released from the transcription site and
travel through the nucleoplasm en route to the nuclear pores.
The in vivo kinetics of mRNP export on the single mRNA level
are uncharacterized. We generated a human cell system that
allowed us to follow in vivo as single mRNPs traveled through
the nucleoplasm, and translocated through the nuclear pore to
emerge in the cytoplasm. To detect real-time single mRNP export
we generated several gene constructs that transcribed large
mRNAs, based on different versions of the large human dystro-
phin mRNA. These genes were under the transcriptional control
of the ecdysone-inducible system. In order to detect the mRNPs
in single living cells, the 3¢UTR of the mRNAs contained a series
of 24 MS2 repeats. These were bound by YFP-MS2 proteins to
yield tagged mRNP complexes, which were detected using live-
cell fluorescence microscopy. Using rapid imaging, deconvolution
and tracking techniques we could follow single mRNPs as
they reached the nuclear envelope, unfolded, traveled through the
pore, and restructured on the cytoplasmic side. We quantified
the kinetics of single mRNP export, the diffusion properties of
the traveling mRNPs before and after export, and the inter-chro-
matin regions in which they traveled. We examined these kinetic
properties with respect to the presence or lack of an intron within
the mRNA transcripts. Our data show that mRNA average
transport time from the site of transcription to the nuclear
envelope occured within ~20 minutes, while a shorter time-scale
(seconds) was required for mRNP restructuring and export.
IL 4.4–5
Keeping track of multiple forms of actin
in- and outside the nucleus
U. Aebi1, C. A. Schoenenberger1, U. Schroeder1, U. Silvan1,
C. Mittelholzer1, S. Buchmeier2, B. Jockusch2, J. Stetefeld3 and
P. Burkhard4
1ME Mueller Institute, Biozentrum University Basel, Basel,
SWITZERLAND, 2Department of Cell Biology, Technical
University, Braunschweig, GERMANY, 3Department of Chemistry,
University of Manitoba, Winnipeg, CANADA, 4The Institute of
Materials Science, University of Connecticut, Storrs, USA
With the role of actin in chromatin remodeling, transcription and
RNA processing now being widely accepted, the quest for its
oligomeric/polymeric form(s) in the nucleus has become a major
challenge (Jockusch et al. Trends. Cell. Biol. 2006; 22: 391).
Because of its high degree of structural plasticity, actin may
assume forms in the nucleus that are distinct from those observed
in the cytoplasm. To this end, we have shown with monoclonal
antibodies (mAbs) that different forms of actin exist in different
cellular locations (Schoenenberger et al. J Struct Biol. 2005; 152:
157). Moreover, uncommon forms of actin like the lower dimer
(LD), bipolar filaments, ribbons, tubes and sheets have been
observed in vitro (Steinmetz et al., J Struct Biol. 1997; 119: 295).
To identify and characterize the different oligomeric/polymeric
forms of actin in vivo, in particular those in the nucleus, we chose
to tailor form-specific anti-actin mAbs by repetitive antigen dis-
play on de novo designed virus-like peptide nanoparticles (Raman
et al., Nanomed. 2006; 2: 95; Schroeder et al. J Mol Biol, in
press). Immuno-fluorescence studies on cells revealed that several
of these actin-form specific mAbs labeled actin-containing struc-
tures predominantly residing in either the cytoplasm or the
nucleus. Also by repetitive antigen display, we obtained a
polyclonal rabbit anti-actin serum that upon depletion with
monomeric G-actin became exclusively LD-specific. Taken
together, our results suggest that oligomeric/polymeric actin
forms exist in the nucleus that clearly differ from their cytoplas-
mic counterparts and may require association with nucleus-
specific actin binding proteins.
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4.5. Function and Dysfunction of Mitochondria
IL 4.5–1
Human complex I: from gene cloning towards
remedy
J. Smeitink
Radboud University Medical Centre, Nijmegen Centre for
Mitochondrial Disorders, Nijmegen, THE NETHERLANDS
Deficiencies of human complex I (NADH:ubiquinone oxidore-
ductase; E.C. 1.6.5.3), the first multi-protein enzyme complex of
the mitochondrial oxidative phosphorylation system, are the most
frequently encountered defects of mitochondrial energy metabo-
lism. Affected patients often suffer from severe fatal multi-system
disorder. Complex I consists of 45 subunits, 7 encoded by the
mitochondrial genome, the remainder by the nuclear genome. In
the past decade we have cloned most of the nuclear complex I
structural genes, described the first nuclear mutations, proposed
a model for complex I assembly and studied in detail the cell
biological consequences of complex I disease. These advances
have lead to greatly increased possibilities for definite diagnosis
of complex I deficiency and have also made prenatal diagnosis
possible for affected families. Despite this very significant
progress there is still no cure for human complex I deficiency or
other types of mitochondrial diseases. The pathophysiology link-
ing the mutated complex I genes to the disease phenotype are
poorly understood. In this lecture I will review the results of
complex I genetic, biochemical and cell biological studies in man
and mice and show how these are instrumental in the develop-
ment of future therapies.
IL 4.5–2
Mitochondrial spare respiratory capacity and
the life and death of neurons
D. Nicholls
Lund University, Neuronal Survival Unit, Lund, SWEDEN
Mitochondrial dysfunction is implicated in many forms of cell
death, particularly in the central nervous system. The mitochon-
dria are required at the same time to generate ATP for the cell,
sequester excess cytoplasmic Ca2+, and both produce and detox-
ify superoxide free radicals. The electron transport chain and
proton circuit are central in keeping these three balls in the air at
the same time.We have investigated the bioenergetics of the
in situ mitochondria in cultured neurons exposed to pathological
glutamate concentrations to model glutamate excitotoxicity and
have revised the conventional view that mitochondrial calcium
loading results in increased oxidative stress that damages the
mitochondrion and ultimately the cell. Instead, a central role is
played under these conditions by limitations in mitochondrial
and cellular ATP generating capacity. Sodium and calcium enter-
ing via the N-methyl-D-aspartate receptor impose a large ener-
getic load on cells and can use the entire respiratory capacity of
the in situ mitochondria. As a result, even modest restrictions in
mitochondrial capacity – caused by low concentrations of elec-
tron transport chain inhibitors such as rotenone, as in models of
Parkinson’s disease; low concentrations of uncouplers, to test the
so-called neuroprotective mild uncoupling hypothesis; or preexist-
ing oxidative stress – greatly potentiate glutamate excitotoxicity.
Our findings may lead to a reevaluation of the potential for mild
uncoupling to provide a neuroprotective role in aging-related
neurodegenerative disorders because the deleterious consequences
of restricting ATP generating capacity greatly outweigh the
negligible effect on oxidative stress.
IL 4.5–3
Sulfur toxicity in a human mitochondrial
disorder
V. Tiranti1, I. Di Meo1, C. Viscomi1, T. Hildebrandt2,
M. Rimoldi3, A. Prelle4 and M. Zeviani1
1Istituto Neurologico Carlo Besta, Molecular Neurogenetics,
Milano, ITALY, 2Biochemistry Institute, Heinrich-Heine-
University, Dusseldorf, GERMANY, 3Istituto Neurologico Carlo
Besta, Biochemistry and Genetics, Milano, ITALY, 4Dino Ferrari
Center, Division of NeurologyOspedale Maggiore Policlinico,
Milano, ITALY
Ethylmalonic encephalopathy (EE) is an autosomal recessive,
invariably fatal disorder characterized by early-onset encephalop-
athy, microangiopathy, chronic diarrhoea, defective cytochrome
oxidase (COX) in muscle and brain, high levels of C4 and C5
acylcarnitines in blood, and high excretion of ethylmalonic acid
(EMA) in urine.ETHE1, a gene encoding a b-lactamase-like,
iron-coordinating metalloprotein, is mutated in EE. Bacterial
ETHE1-like sequences are in the same operon of, or fused with,
RDS, the gene encoding rhodanese, a sulfurtransferase. Both
ETHE1 and rhodanese are mitochondrial matrix proteins in
eukaryotes.We created and characterized an Ethe1-less mouse
that manifested the EE cardinal features. We found that thiosul-
fate was excreted in massive amount in urines of both Ethe1–/–
mice and EE patients. High thiosulfate and sulfide levels were
present in Ethe1–/– mouse tissues. Sulfide is a powerful inhibitor
of COX and terminal b-oxidation, with vasoactive and vasotoxic
effects that explain the microangiopathy in EE patients. Sulfide is
detoxified by a mitochondrial pathway that includes a sulfur di-
oxygenase (SDO). SDO activity was absent in Ethe1–/– mice,
whereas ETHE1 overexpression in HeLa cells and E. coli mark-
edly increased it. Therefore, ETHE1 is a mitochondrial SDO
involved in catabolism of sulfide, which accumulates to toxic lev-
els in EE.The toxic mechanism underpinning EE makes effective
therapy a realistic goal. Relevant to this issue is to understand
the major source of H2S in ETHE1 mutant patients. Exogenous
versus endogenous H2S production can orient rational therapeu-
tic strategies, based for instance on drugs that reduce the H2S-
producing bacterial contingent in the former case, or on H2S
clearance by bone marrow transplantation in the latter.
IL 4.5–4
Mitochondria-targeted rechargeable
antioxidant SkQ1 prevents senescence in
mammals
V. Skulachev
Belozersky Institute, Bioenergetics, Moscow, RUSSIA
Cationic derivative of plastoquinone SkQ1 was synthesized and
tested on BLM, mitochondria, cells and organisms. It is found
that SkQ1 penetrates BLM and accumulates in mitochondria
electrophoretically and due to high distribution coefficient (DC)
in lipid/water systems. Assuming electric potential on plasma
membrane and inner mitochondrial membrane as 60 and 180 mV
respectively and DC = 13,000:1, one can predict that SkQ1 can
accumulate in inner leaflet of inner mitochondrial membrane up
to 130 min times. In mitochondria, 0.1 nM SkQ1 is shown to
prevent lipid peroxidation accompanying aging of mitochondria
in vitro. In cell cultures, SkQR1 specifically stains mitochondria
and arrests ROS-induced apoptosis. SkQ1 increases the median
lifespan of podospora, ceriodaphnia, drosophila and mouse
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(in the latter case, by factor 2). In mammals, the effect of SkQ1
on aging is accompanied by inhibition of development of cataract,
retinopathy, glaucoma, balding, canities, osteoporosis, involution
of thymus, hypothermia, torpor, chromosome aberrations, peroxi-
dation of lipids and proteins, etc. With drops containing
250 nM SkQ1, vision is restored to 67 of 89 animals (dogs, cats,
and horses) that became blind because of retinopathies. More-
over, the SkQ1 pretreatment of rats decreases the ROS- or ische-
mia-induced heart arrhythmia. SkQs strongly reduce damaged
area in myocardial infarction or stroke and prevents death of
animals from kidney ischemia. In mice without p53,
5 nmol SkQ1/kg · day inhibit appearance of lymphomas to the
same degree as million-fold higher dose of conventional anti-
oxidant NAC. Thus, SkQ1 looks promising as tool to treat
senescence and age-related diseases.
Reference:
1. Skulachev et al. Biochim. Biophys. Acta., 2009, doi: 10.1016/
jbbabio.2009.12.008
IL 4.5–5
Complex I of the respiratory chain, from
physiological regulation to pathological
hereditary dysfunctions
S. Papa1 and B. Policlinico2
1Department of Medical Biochemistry Biology, University of Bari,
Bari, ITALY, 2Institute of Bioenergetics and Biomembranes,
National Research Council, Bari, ITALY
The functional capacity of complex I is regulated by the cAMP
cascade. Phosphorylation by the cAMP-dependent protein kinase
(PKA) of the subunit of the complex encoded by the nuclear
NDUFS4 gene promotes its mitochondrial import, enhances the
NADH-ubiquinone oxidoreductase activity and prevents ROS
production (1). The transcription factor CREB moves from the
cytosol to mitochondria where, once phosphorylated by PKA,
promotes the expression of the ND1, ND2 and ND6 mitochon-
drial genes of complex I (1). The NDUFS4 gene has been found
to be a hotspot for mutations associated with mitochondrial
encephalopathy. Mutations of this gene in neurological patients
resulted in defective complex assembly, depression of the catalytic
activity, suppression of cAMP-dependent regulation and accumu-
lation of unproductive alternative transcripts (2). In a patient
with PINK1 familial Parkinson, homoplasmic mutations in the
ND5 and ND6 mitochondrial genes of the complex have been
found, resulting in early onset of the disease (2).
References:
1. Papa S, De Rasmo D, Scacco S, Signorile A, Technikova-
Dobrova Z, Palmisano G, Sardanelli AM, Papa F, Panelli D,
Scaringi R & Santeramo A. Mammalian complex I: A regula-
ble and vulnerable pacemaker in mitochondrial respiratory
function. Biochim. Biophys. Acta. 2008; 1777: 719–728.
2. Papa S, Petruzzella V, Scacco S, Sardanelli AM, Iuso A,
Panelli D, Vitale R, Trentadue R, De Rasmo D, Capitanio N,
Piccoli C, Papa F, Scivetti M, Bertini E, Rizza T & De
Michele G. Pathogenetic mechanisms in hereditary dysfunc-
tions of complex I of the respiratory chain in neurological
diseases. Biochim. Biophys. Acta. 2009; Jan 10; [Epub ahead of
print]
IL 4.5–6
Respiratory active mitochondrial
supercomplexes
J. A. Enriquez, R. Acı´n-Pe´rez, P. Fernande-Silva and
A. Perez-Martos
Zaragoza University, Biochemistry and Molecular and Cellular
Biology, Zaragoza, SPAIN
The structural organization of the mitochondrial respiratory
complexes as four big independently moving entities connected
by the mobile carriers CoQ and cytochrome c has been chal-
lenged recently. Blue-Native gel electrophoresis reveals the pres-
ence of high molecular weight bands containing several
respiratory complexes and suggesting an in vivo assembly status
of these structures (respirasomes). However, no functional evi-
dence of the activity of supercomplexes as true respirasomes has
been provided yet. We have observed that: (1) supercomplexes
are not formed when one of their component complexes is
absent; (2) there is a temporal gap between the formation of the
individual complexes and that of the supercomplexes; (3) some
putative respirasomes contain CoQ and cytochrome c; (4)
isolated respirasomes can transfer electrons from NADH to O2,
that is, they respire. Therefore, we have demonstrated the exis-
tence of a functional respirasome and propose a new structural
organization model that accommodates these findings.
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4.6. RNA Turnover and Quality Control
IL 4.6–1
SMG6 is the catalytic endonuclease that
cleaves mRNAs containing nonsense codons
in metazoa
E. Izaurralde, E. Huntzinger, I. Kashima and N. Wittkopp
Max Planck Institute for developmental Biology, Biochemistry,
Tuebingen, GERMANY
Messenger RNAs harbouring nonsense codons (or PTCs) are
degraded by a conserved quality-control mechanism known as
nonsense-mediated mRNA decay (NMD), which prevents the
accumulation of truncated and potentially harmful proteins. In
D. melanogaster, degradation of PTC-containing messages is initi-
ated by endonucleolytic cleavage in the vicinity of the nonsense
codon. The endonuclease responsible for this cleavage has not
been identified. Here, we show that SMG6 is the long sought
NMD endonuclease. First, cells expressing an SMG6 protein
mutated at catalytic residues fail to degrade PTC-containing
messages. Moreover, the SMG6-PIN domain can be replaced
with the active PIN domain of an unrelated protein, indicating
that its sole function is to provide endonuclease activity for
NMD. Unexpectedly, we found that the catalytic activity of
SMG6 contributes to the degradation of PTC-containing
mRNAs in human cells. Thus, SMG6 is a conserved endonucle-
ase that degrades mRNAs terminating translation prematurely in
metazoa.
IL 4.6–2
Running rings around RNA: a bacterial Ro and
a Y RNA function in noncoding RNA
maturation and degradation
S. Wolin1, E. Wurtmann2 and X. Chen2
1Yale University School of Medicine, Cell Biology and Molecular
Biophysics and Biochemistry, New Haven, USA, 2Yale University
School of Medicine, Cell Biology, New Haven, USA
The Ro autoantigen is a ring-shaped protein that is present in
many animal cells and also some prokaryotes. In animal cell
nuclei, Ro binds misfolded noncoding RNAs and likely functions
in RNA quality control. Structural studies have revealed that the
single-stranded 3¢ ends of misfolded RNAs insert into the Ro
central cavity, while associated helices contact a basic platform
on Ro’s outer surface. Because the binding of Ro to misfolded
RNA is largely sequence–nonspecific, Ro may scavenge RNAs
that fail to bind their specific RNA-binding proteins. Since Ro
can associate with a variety of RNAs that contain both a single-
stranded 3¢ end and helices, it is likely to have additional roles in
cells. Consistent with this idea, Ro contributes to survival after
ultraviolet irradiation in both mammalian cells and the stress-
resistant eubacterium D. radiodurans. All species that contain
Ro also contain one or more ~100 nt RNAs called Y RNAs that
bind to the outer surface of the ring. Studies in bacteria have
revealed that one role of Y RNAs is to regulate access of other
RNAs to Ro. To learn more about Ro and Y RNAs, we have
been examining their roles in D. radiodurans. Previously, we
found that Ro and two exonucleases are required for efficient
maturation of 23S rRNA in this bacterium. We have now
obtained evidence for an additional role for Ro. Evidence will be
presented that Ro and a Y RNA form a complex with an exonu-
clease that functions in stress-induced RNA degradation. Taken
together, our data suggest that binding of Ro to its various RNA
targets may enhance RNA decay by exonucleases.
IL 4.6–3
RNA-protein cross-linking and deep
sequencing reveal novel ncRNAs and Pol III
substrates for the nuclear RNA surveillance
machinery
D. Tollervey
University of Edinburgh, Wellcome Trust Centre for Cell Biology,
Edinburgh, UK
The RNA binding proteins Nrd1 and Nab3 function in transcrip-
tion termination by RNA Pol II, particularly on snRNA and
snoRNA genes, mediated via interactions with the CTD. They
also participate in nuclear RNA surveillance and ncRNA degra-
dation, acting together with the exosome and the Trf-Air-Mtr4
polyadenylation (TRAMP) complexes. To better understand the
signals for surveillance and ncRNA degradation, we identified
in vivo binding sites for Nrd1, Nab3 and Trf4 using cross-linking
and cDNA sequencing (CRACS) techniques in combination with
Solexa sequencing. Analysis of several million target sequences
over the entire yeast genome identified (1) expected substrates;
(2) unknown but anticipated substrates; (3) unexpected targets.
Expected targets included snRNAs, snoRNAs, characterized
ncRNAs and the NRD1 and NAB3 mRNAs that are known to
be autoregulated. Unknown but anticipated targets were novel
ncRNAs, and we identified several hundred potential ncRNAs
that lie antisense to protein coding genes. Numerous mRNAs
were also apparently targeted the nuclear RNA surveillance sys-
tem, but there was little overlap between these and the putative
antisense transcripts, suggesting that mutually exclusive expres-
sion may be common. The most notable unexpected targets were
many transcripts generated by RNA Pol III, which were surpris-
ing because all previous data had linked Nrd1 and Nab3 to only
to surveillance of RNA Pol II transcripts. Identified targets
included truncated, polyadenylated 5S rRNA and many different
tRNA precursors. These were generally unspliced and/or
3¢ unprocessed, often with non-templated poly(A) tails character-
istic of TRAMP activity and in some cases lacking RNA editing
events, demonstrating that defective pre-tRNAs are targeted by
the nuclear surveillance machinery. Northern analyses demon-
strated that unspliced pre-tRNA accumulated in strains depleted
of Nrd1 or Nab3, confirming their functional roles in pre-tRNA
surveillance. These observations reveal an unexpected degree of
overlap between nuclear surveillance of Pol II and Pol III
transcripts.
IL 4.6–4
Molecular mechanisms of RNA degradation by
the exosome
E. Conti1, F. Bonneau1, J. Ebert1, J. Basquin1 and E. Lorentzen2
1Max-Planck-Institute for Biochemistry, Structural Cell Biology,
Martinsried, GERMANY, 2Birkbeck College, Structural Biology,
London, UK
The eukaryotic RNA exosome is an essential exonuclease respon-
sible for the processing and degradation of a wide range of tran-
scripts. It is a multi-protein complex whose components bear
similarities with those of nucleases found in archaea and eubacte-
ria. Structural studies of bacterial polynucleotide phosphorylase
(PNPase), archaeal and human exosomes exosomes have revealed
a common ring-shaped architecture, indicative of a shared
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ancestry. However, the catalytic mechanisms have diverged. The
archeal exosome degrades RNA via a phosphorolytic activity
residing in one of its subunits. We have previously shown that
the RNA substrate is threaded through the central channel of the
S. solfataricus exosome, towards the cavity where the active site
is located. The equivalent eukaryotic core is inactive and relies
on the binding of additional subunits, the hydrolytic nucleases
Rrp44 and Rrp6, to catalyze RNA degradation. In this work, we
have addressed the question of whether the S. cerevisiae exosome
core, lacking the phosphorolytic active site, has evolved into a
simple docking platform for recruiting nucleases, or whether it
also plays an active role in substrate binding.
IL 4.6–5
Structural rearrangements in transfer-
messenger RNA in the process of trans-
translation – protein synthesis quality control
system in bacteria
O. Dontsova1, O. Shpanchenko1, A. Bogdanov1, E. Bugaeva2,
A. Golovin3 and L. Isaksson4
1Lomonosov Moscow State University, Chemistry, Moscow,
RUSSIA, 2Lomonosov Moscow State University, Belozersky
Institute, Moscow, RUSSIA, 3Lomonosov Moscow State
University, Department of Bioengineering and Bioinformatics,
Moscow, RUSSIA, 4Stockholm University, Department of Genetics
Microbiology and Toxicology, Stockholm, SWEDEN
Trans-translation is a process which switches the synthesis of a
polypeptide chain encoded by a nonstop messenger RNA to the
mRNA-like domain of tmRNA. Initially trans-translation was
described as a mechanism for the removing from the cell poten-
tially hazardous incomplete proteins by addition to them encoded
by tmRNA signal peptide that recognized by proteases. Now
trans-translation seems to be involved in translational control. It
has been shown that mRNAs that are known to promote ribo-
some stalling such as transcripts containing cluster of rare codons
or poor termination signal also cause trans-translation. Thus
tmRNA performs general translation quality control: any transla-
tion arrest with empty ribosomal A-site is treated as a potentially
hazardous event, and the probability of triggering trans-transla-
tion apparently depends on the duration of arrest. The mRNA
whose translation has caused the arrest and the protein synthe-
sized from this mRNA are degraded. Although significant pro-
gress has been made in studying of trans-translation the
molecular basis of this process is not well understood. We have
developed an approach which allows isolation of the tmRNA-
ribosomal complexes arrested at a desired step of tmRNA
passage through the ribosome, obtained tmRNA-ribosomal com-
plexes with an equimolar ratio of tmRNA to the ribosome and
blocked at the position of the second, forth, fifth and eleventh
codon in mRNA-like domain and examined tmRNA structure
using biochemical and structural approaches. Computer modeling
has been used to develop a model for spatial organization of the
tmRNA inside the ribosome at different stages of trans-transla-
tion and to propose the mechanism of the template switching
process.
OP 4.6–1
The importance of RNase II in RNA
recognition, RNA binding and RNA
degradation
A. Barbas1, R.G. Matos1, M. Amblar2, F.P. Reis1,
E. Lo´pez-Vinas3, P. Gome´z Puertas3 and C.M. Arraiano1
1ITQB/UNL, Control of Gene Expression, Oeiras, PORTUGAL,
2Instituto de Salud Carlos III, Centro Nacional de Microbiologı´a,
Madrid, SPAIN, 3Instituto de Salud Carlos III, Centro de Biologia
Molecular Severo Ochoa, Madrid, SPAIN
RNA degradation plays a fundamental role in all biological pro-
cesses, since the fast turnover of mRNA permits rapid changes in
the pattern of gene expression. Ribonucleases (RNases) are essen-
tial enzymes that process and degrade RNA, being one of the
main factors responsible for the determination of the levels of
functional mRNA in the cells. Escherichia coli RNase II is the
prototype of a widespread family of exoribonucleases and RNase
II homologues can be found in all kingdoms of life. Our struc-
tural and biochemical data together allowed explaining the
dynamic RNA degradation by RNase II, and elucidated RNA
translocation and enzyme processivity. We have performed a
functional characterization of several highly conserved residues
located in the RNB catalytic domain in order to address their
precise role in the RNase II activity. Our results showed that
although not directly involved in the RNA binding, highly con-
served aspartates 201, 207 and 210 are contributing to the stabil-
ization of the RNA-protein complexes. Moreover, we showed
thatthese residues are not equivalent in their role in catalysis,
confirming that Asp209 is in fact the only critical residue for
RNase II activity. We have also identified Tyr253 as the residue
that is responsible for setting the end-product of RNase II,
accentuating the importance of this residue in the stabilization of
the 3¢-end of the RNA molecule. We also analyzed which resi-
dues were responsible for substrate specificity, and verified that
both Glu390 and Tyr313 play an important role in the discrimi-
nation of RNA versus DNA. Our results also show that Arg500
is crucial for RNase II activity but not for RNA binding. Inter-
estingly, the substitution of Glu542 by Ala lead to a 120 fold
increase of the exoribonucleolytic activity, and improved signifi-
cantly substrate binding, turning RNase II into a super-enzyme.
RNase II is still an enzyme full of surprises. Rrp44/Dis 3 is
RNase II-family enzyme that is the catalytic subunit of the exo-
some, a multiprotein complex involved in RNA processing degra-
dation and surveillance. Recently we have actively participated in
the discovery that Rrp44 includes a PIN domain that acts as an
endonuclease. All the results here stated have improved substan-
tially the model for the mechanism of RNA degradation, and
will be crucial for the fully understanding of the processes of
RNA maturation, quality control and RNA decay mediated by
RNase II.
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4.7. Nervous System Stem Cells
IL 4.7–1
Human difference starts with neural stem cells
P. Rakic
Yale University School of Medicine, Department of Neurobiology
and Kavli Institute for Neuroscience, New Haven, USA
Although the basic principles of brain development may be simi-
lar in all vertebrates, the modifications of developmental events
during millennia of mammalian evolution produce not only
quantitative but also qualitative changes to its cellular structure
and synaptic circuitry. The origin of these species-specific distinc-
tions can be traced to either the new or phylogenetically con-
served genes that act at the time of the neural stem cell’s exit
from the mitotic cycle and generate a different outcome, depend-
ing on the evolutionary context. Thus, our strategy has been to
explore and compare early embryonic development of the crown-
ing achievement of evolution, the cerebral cortex, in rodents,
non-human primates and human. We have found that paradoxi-
cally, the duration of the neuronal stem cell cycle is about four
times longer in human and macaque monkeys than in rodents,
posing logistical problems in constructing a larger neocortex.
There are also marked differences in the onset of the divergence
of the neural stem and the radial glial cells that in primates
express GAFP at the start of corticogenesis and some of which
stop dividing while serving as guides for migrating neurons in the
large and convoluted cerebrum. We have also identified in human
a class of early generated predecessor cortical cells, as well as a
population of thalamic neurons that originate from the gangli-
onic eminence that have not been observed in rodents. In addi-
tion, subclasses of cortical interneurons that in primates originate
in the subventricular zone of the dorsal telencephalon and the
subpial granular layer in the neocortical marginal zone do not
exist in rodents. Furthermore, corticoneurogenesis in primates is
completed before birth, but it is followed by overproduction and
elimination of synapses during prolonged childhood, puberty and
adolescence. Finally, lack of neuronal turnover and neurogenesis
in the adult primate cortex occurs concomitantly with their
diminished capacity for regeneration. Thus, the search for causes
and designs of therapies for human neuropsychiatric disorders
needs to take into consideration these species-specific distinc-
tions.Supported by NINDS, NIMH, NIDA and the Kavli Institute
for Neuroscience at Yale.
IL 4.7–2
Adult neurogenesis, neurodegeneration, and
aging
G. Kempermann
CRTD, Genomics of Regeneration, Dresden, GERMANY
Adult hippocampal neurogenesis contributes to hippocampal
function by allowing a particular type of structural plasticity,
presumably necessary to allow life-long adaptation of the mossy
fiber connection to the functional demands encountered by the
individual. As far as we know today, the new neurons add flexi-
bility to the learning response and are particularly relevant in
re-learning situations. At the same time, activity regulates adult
neurogenesis. With age, adult neurogenesis decreases but remains
present at very low levels throughout life. Activity counteracts
this decrease and maintains an increased potential for adult
neurogenesis, which can be used, if appropriate stimuli are pres-
ent. From this it appears that adult neurogenesis might contrib-
ute to a structural reserve, a ‘‘neurogenic reserve’’ in the adult
hippocampus. Neurodegenerative disorders appear to interfere
with this process but on the other hand the potential for plastic-
ity contributed by adult neurogenesis allows compensation in
cases of degeneration.
IL 4.7–3
Specification and integration of cerebellar
GABAergic neurons
F. Rossi
Neuroscience Institute of Turin (NIT), Neuroscience University of
Turin, Turin, ITALY
The local GABAergic network in the cerebellum is composed by
different types of cortical and deep nuclear inhibitory inter-
neurons, generated from late embryonic to early postnatal life,
according to an inside–out sequence. Unlike other cerebellar cell
types, which derive from fate-restricted progenitors, precursors of
inhibitory interneurons share a common lineage and maintain
their multipotency up to late phases of postnatal development.
However, the mechanisms giving rise to the different interneuron
classes remain unknown. Namely, it is not clear whether mature
interneuron phenotypes are specified in germinal zones or at their
final destination sites in the cortex or nuclei. In order to clarify
this point, we analysed the proliferation and the migratory
pathways of interneuron precursors in wild type and transgenic
Pax2-GFP and GAD67-GFP mice, that finely characterize this
cell population during earlier and later stages of development,
respectively. We found that inhibitory interneuron precursors
exclusively proliferate in the periventricular zone and along the
folial white matter tracts of postnatal cerebellum, migrating to
the cortex as post-mitotic cells. To ask whether transplanted
precursors entrain in the same developmental mechanisms we
considered their behaviour at short time-intervals after graft in
hosts of different ages. Donor cells integrate in the host prolifera-
tive sites and follow the usual migratory routes of the local inhib-
itory interneurons, joining a final layer position which is strictly
dependent on the host age. In particular, grafted interneurons
consistently acquire positions and phenotypes that match those
adopted by host interneurons born on the day of transplantation.
Interestingly, donor cells acquire host-specific identities even
when grafted as postmitotic neurons, indicating that fate specifi-
cation of cerebellar interneurons occurs after the progenitors
have left the cell cycle. On the whole, our results indicate that
grafted interneuron precursors fully integrate into the host neuro-
genic mechanisms in which different phenotypes are generated by
temporally patterned signals acting on cells that remain multi-
potent even after leaving the cell cycle.
IL 4.7–4
Lack of adult brain neurogenesis and its
effects (or lack of thereof) on mouse learning
and memory
L. Kaczmarek
Nencki Institute of Experimental Biology, Molecular Neurobiology,
Warsaw, POLAND
Adult brain neurogenesis is phenomenon by which new neurons
are being added to the adult brain in a process that has been sug-
gested to affect brain plasticity, i.e. an ability to respond differen-
tially to changes in an external environment. We have reported
on knockout mice that due to the lack of cell cycle regulatory
protein, cyclin D2 miss the adult brain neurogenesis almost com-
pletely (Kowalczyk et al., J Cell Biol 2004). We have extended
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the analysis of the newly born neurons in the adult brains of
those animals and observed in cyclin D2 KO hippocampi
< 10% of BrdU-positive cells and even less of doublecortin-posi-
tive early neurons as compared to their wild-type siblings. To
investigate the effect of this most severe impairment of adult
brain neurogenesis on learning and memory, cyclin D2 KO mice
and their wild type siblings were tested in several behavioral
paradigms including those in which the role of adult neurogenesis
has been postulated. The knockout mice showed no impairment
in sensorimotor tests with only sensory impairment in an olfac-
tion-dependent task. However, KO mice showed proper proce-
dural learning as well as learning in a context (including remote
memory), cue and trace fear-conditioning, Morris water maze,
novel object recognition test, and in a multifunctional behavioral
system - Intellicages. Cyclin D2 KO mice also demonstrated cor-
rect reversal learning. Our results suggest that adult brain neuro-
genesis is not obligatory for learning, including the kinds of
learning where the role of adult neurogenesis has previously been
strongly suggested.
IL 4.7–5
Stem cells and treatment of brain and spinal
cord injury
E. Sykova
Institute of Experimental Medicine ASCR, Neuroscience, Prague,
CZECH REPUBLIC
Mesenchymal stem cells (MSCs), olfactory ensheathing glia
(OEGs) and neural progenitor cells (PNCs) have the capacity to
migrate towards lesions and induce better regeneration. MSCs,
OEGs or PNCs labeled in culture with iron-oxide nanoparticles
were transplanted into rats in a stroke model or with a spinal
cord compression lesion (SCI). In vivo MRI, used to track their
migration and fate, proved that MSCs, OEGs as well as PNCs
migrated into the lesion. We compared the effects of implanted
PNCs, OEGs or MSCs with the implantation of a mononuclear
fraction of bone marrow cells (BMCs) or the injection of granu-
locyte colony-stimulating factor (G-CSF). Seven days after SCI,
the rats received either PNCs, MSCs, OEGs, BMCs or G-CSF
intravenously or intraspinally. All implanted animals had signifi-
cantly smaller lesions and higher BBB scores. In other studies,
hydrogels or nanofiber scaffolds seeded with stem cells were
implanted into rats with SCI. In both acute and chronic SCI,
implants reduced scar formation, bridged the lesion and increased
functional recovery. Autologous BMC implantation was also
used in a Phase I/II clinical trial in patients with acute and
chronic SCI (n = 34). The results show that implantation is safe
and has a beneficial effect if administered in the first 4 weeks
after injury, close to the injury site. We conclude that stem cells,
with or without scaffolds, improve regeneration by the rescue
and replacement of local neural cells, by bridging gaps after SCI
and by mechanically supporting ingrowing cells and axons.
OP 4.7–1
Drosophila cells with neurotrophic factor
genes influences a development of
mammalian neural tissue
G. Pavlova, N. Kanaikina, I. Nikitina and A. Revishchin
Institute of gene biology, neurobiology, Moscow, RUSSIA
A possibility to direct behaviour of mammalian neural stem/
progenitor cells by co-culturing with embryonic tissue bearing
human neurotrophic factor genes (NGF,BDNF or GDNF) has
been studied. In vitro co-culture system contains dorsal root
ganglion (DRG) of newborn rat and embryonic nerve cells bear-
ing humanneurotrophic genes, that were located 0.2–0.5 mm
apart of DRG. Locally implantedcells could direct a growth of
rat DRG axons. The outgrowth (directed toward transfected
cells) initiates after 1–2 hours, while in control it was started on
the third/forth day. These findings suggest that co-cultures of rat
DRG and genetically modified cells provides a powerful tool to
study survival and integration of neuronal population. Other
experiments analyzed effects of expression of neurotrophic
factors on preventing glial scar formation after xenotransplanta-
tion. HEK293 were transfected with GDNF expressing vectors,
and the cells were transplanted into caudatum–putamen of CBA
mice. Transplanted cells survived in recipient brain for 18 days.
Immunohistochemical analysis of brain sections stained for the
scar (actin, fibronectin, and collagen type IV) showed that
GDNF decrease glial post-traumatic reaction. Other genetic con-
struct has temperature-regulated Drosophila HSP70 promoter
with BFP reporter gene in mouse ESC; fluorescence appeared
only at 39C. Both strategies of gene activation could be used in
gene therapy experiments.
Acknowledgement: The work has been supported by
Rosnauka 02.512.11.2224, RFBR 07-04-12120, 07-04-00835.
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SYMPOSIUM 5: SIGNAL TRANSDUCTION
5.1. Cytoskeleton Dynamics
IL 5.1–1
Mechanism of actin-dependent nuclear
positioning in cell polarization and migration
G. Gundersen1, G. Luxton1, E. Folker1 and E. Gomes2
1Columbia University, Pathology & Cell Biology, New York, NY,
USA, 2Univ Paris 06, Institut Myologie, Paris, FRANCE
In many directionally migrating cell types, the centrosome is
positioned between the nucleus and the leading edge and this is
thought to direct membrane traffic toward the leading edge.
Surprisingly, in fibroblasts, centrosome reorientation results from
active movement of the nucleus away from the leading edge,
while the centrosome remains stationary in the cell center
(Gomes et al., Cell 2005). Cdc42 regulates myosin activation and
actin retrograde flow that are necessary for nuclear movement,
but how actin might engage the nucleus was unclear. Using
siRNA and dominant negative approaches, we found that the
outer and inner nuclear membrane proteins, nesprin2G and
SUN2, respectively, were necessary for nuclear movement.
Rescue experiments showed that the actin-binding CH domains
of nesprin2G were essential for nuclear movement. Imaging
studies revealed that nesprin2G and SUN2 accumulated along
moving actin cables that contacted the nucleus. FRAP experi-
ments showed that nesprin2G within these arrays was immobi-
lized relative to bulk nesprin2G. We refer to these novel
membrane assemblies as TAN lines for transmembrane actin-
associated nuclear lines. TAN line movement was coincident with
nuclear movement and treatments that disrupted TAN lines
inhibited nuclear movement. Nesprin2G TAN lines still formed
in SUN2 depleted cells, but in these cells, TAN lines moved over
an immobile nucleus. Interfering with either nesprin2G or SUN2
also inhibited directional migration into wounds. Our results
establish a novel molecular mechanism for coupling actin fila-
ments to move nuclei and suggest that migrating cells may
actively determine the position of their nucleus for efficient cell
migration.
IL 5.1–2
Centrosome dynamics in C. elegans embryos
A. Hyman, M. Decker, G. Greenan and S. Jeansch
Max Planck Institute of Molecular Cell Biology and Genetics,
Dresden, GERMANY
Centrosomes duplicate once per cell cycle by duplication of their
centrioles. Centrioles then assemble different components, in the
form of pericentriolar material, which act as down stream effec-
tors of centrosome function. In C. elegans embryos, centrosomes
are required to build a mitotic spindle. Our work shows that the
size of the centrosome sets the length of the mitotic spindle. Dur-
ing development, centrosome size varies, and this is apparently
partially responsible for setting spindle length during early devel-
opment. I will discuss ways in which embryos set the size of the
centrosomes.
IL 5.1–3
Cell-matrix adhesions as mechano-chemical
environmental sensors
B. Geiger1, S. Winograd-Katz1, M. Prager-Khoutorsky1,
T. Volberg1, A. Bershadsky1, I. Patela2 and O. Medalia3
1Weizmann Institute of Science, Department of Molecular Cell
Biology, Rehovot, ISRAEL, 2University of Heidelberg & MPI for
Metals Research, Institute for Physical Chemistry, Stuttgart,
GERMANY, 3Ben Gurion University of the Negev, Department of
Life Sciences, Beer-Sheva, ISRAEL
Cell adhesion to the extracellular matrix is a complex process,
regulated at multiple levels, and at a wide range of spatial and
temporal scales. Cells can differentially sense and respond to dif-
ferent chemical signals induced by specific components of the
extracellular matrix, as well as to a variety of physical cues,
including external or internal forces, surface rigidity, topography
and fine texture. These structural and signaling activities are exe-
cuted by multi-molecular protein complexes known, collectively,
as the ‘integrin adhesome network’. In this lecture, I will describe
our attempts to unravel the molecular structure and signaling
activities of different types of integrin adhesions, in order to
define their roles, and the possible mechanisms underlying the
effects of micro- and nano-scale perturbations on the adhesion
process. In my talk, I will particularly focus on siRNA-based
screens for molecules that participate in the organization and sig-
naling activity of these adhesions, as well as on correlated
microscopy, in which the same specimens are examined by fluo-
rescence microscopy and cryo-transmission electron microscopy.
Applying novel experimental approaches to studies of focal adhe-
sions may provide new insights into the molecular organization
and nano-scale structure of these cellular adhesion sites, and their
sensory and signaling activities.
IL 5.1–4
Pushing with actin in cell migration
J. V. Small, E. Urban, S. Auinger and G. Resch
Institute of Molecular Biotechnology, Cytoskeleton group, Vienna,
AUSTRIA
Eukaryotic cells initiate movement by extending cytoplasmic pro-
cesses as sheets (lamellipodia), rods (filopodia) or blebs, singly,
alternately or in combination. Of these, lamellipodia appear
essential for the migration process. The extension of lamellipodia
and filopodia is based on the polymerisation of actin, with the
insertion of actin monomers at the interface between filament
plus ends and the leading membrane front. The currently propa-
gated model of lamellipodia protrusion is one in which actin fila-
ments form branched, dendritic arrays, whereby the Ap2/3
complex initiates and stablises the branch sites. Primary evidence
for this model comes from electron microscopy of platinum repli-
cas of cytoskeletons that were dehydrated and critical point
dried. We have applied electron tomography to cytoskeletons
dried in deep negative stain, or vitreously frozen, to reinvestigate
lamellipodia architecture. Our findings show: (i) that a high
degree of three dimensionality is preserved in the negatively
stained preparations; (ii) that the double helical structure of actin
filaments can be resolved in negative stain tomograms of the
Symposium Abstracts
FEBS Journal 276 (Suppl. 1) 5–84 (2009) ª 2009 The Authors Journal compilation ª 2009 Federation of European Biochemical Societies 41
lamellipodium cytoskeleton, indicative of a high degree of
structural preservation; (iii) actin filaments are not branched in
lamellipodia. The features of actin filament arrays in lamellipodia
will be presented and the implications discussed.
OP 5.1–1
Characterization of MUF1, a binding partner of
atypical Rho GTPases of the RhoBTB family
K. Schenkova´1, M. Kopp2, S. Ramos2 and F. Rivero1
1The Hull York Medical School University of Hull, Centre for
Biomedical Research, Hull, UK, 2University of Cologne, Center for
Biochemistry Medical Faculty, Cologne, GERMANY
Rho proteins have been implicated mainly in the regulation of
the cytoskeleton, but also in vesicle trafficking, phagocytosis and
transcriptional activation. RhoBTB proteins constitute a subfam-
ily of atypical Rho GTPases represented by three isoforms in
vertebrates. They consist of a GTPase domain followed by a pro-
line-rich region and two BTB domains. BTB domains, including
those of RhoBTB, are involved in the formation of cullin
3-dependent ubiquitin ligase complexes therefore the function of
RhoBTB proteins seems to be distinct from that of the classical
Rho GTPases. In our working model RhoBTB proteins play a
role in targeting of substrates for ubiquitinylation and degrada-
tion via cullin 3-dependent ubiquitin ligase complexes, but the
substrates remain unknown. As a first step towards understand-
ing the function of RhoBTB we performed a two hybrid screen-
ing on a mouse brain cDNA library and identified MUF1
(LLR41) as a potential interaction partner. We confirmed the
interaction using immunoprecipitation. MUF-1 is ubiquitously
expressed, with the highest expression in testis. MUF1 is a
leucine rich repeat containing protein that, interestingly, also con-
tains a BC-box that serves as a linker in multicomponent, cullin
5-based ubiquitin ligases. This raises the question whether MUF1
and RhoBTB3 are together involved in multiprotein complexes
containing cullin 3 and cullin 5 simultaneously. We envision two
possible models: (i) MUF1 is ubiquitylated by a Cul3 complex
dependent on RhoBTB, which acts as the substrate specific adap-
tor. (ii) RhoBTB is ubiquitylated by a Cul5 complex dependent
on MUF1, which acts as the substrate specific adaptor.
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5.2. Reactive Oxygen Species in Cell Signalling
IL 5.2–1
Gas sensing by potassium channels: oxygen,
carbon monoxide and redox
P. Kemp, S. Brazier, V. Telezhkin, R. Mears, C. Mu¨ller,
S. Hanmer, W. Wilkinson and D. Riccardi
Cardiff University, School of Biosciences, Cardiff, UK
The enzymatic breakdown of cellular heme by the activity of
hemeoxygenases leads to the endogenous production of carbon
monoxide. This gas is a potent second messenger with a steadily
growing number of identified molecular targets, including ion
channels such as the large-conductance, calcium- and voltage-
activated potassium (BKCa) channel (Williams et al., Science
2004; 306: 2093–2097) and the amiloride-sensitive epithelial
sodium channel (Wang et al., Proc Natl Acad Sci U S A 2009;
106: 2957–2962). Hemeoxygenases are oxygen-dependent
enzymes, and their production of carbon monoxide is limited by
oxygen availability, suggesting that they can act as ion channel
oxygen sensors. Carbon monoxide activates the human BKCa
channel alpha-subunit (KCNMA1) in a calcium-dependent man-
ner, and this activation is completely absent when the C-terminal
tail of BKCa is substituted by an homologous region of mSlo3
(Williams et al., Pflugers Arch 2008; 456: 561–572). Furthermore,
a chimera in which the so-called ‘calcium bowl’ region of BKCa
is swapped with the homologous region of mSlo3 is also com-
pletely insensitive to carbon monoxide. Within that region,
sequence alignment of the BKCa channel alpha-subunit with
mSlo3 shows that there is only one cysteine which is unique to
the BKCa alpha-subunit. Mutagenesis of that single cysteine resi-
due (to glycine) greatly attenuates both the oxygen- and carbon
monoxide-sensitivity of BKCa channels. This cysteine is also
redox-sensitive, suggesting that redox and gas signalling converge
at a single residue within the C-terminal tail of the BKCa channel
alpha-subunit. Furthermore, using low concentrations of cyanide,
as a substituent for metal ions in a potential transition metal
cluster, we observed that carbon monoxide regulation of BKCa
channels in inside-out membrane patches was ablated. Taken
together, these observations lend support to the idea that BKCa
channels might bind carbon monoxide in a manner analogous to
the transition metal-dependent co-ordination of this gas by sev-
eral well characterised enzymes, including carbon monoxide
dehydrogenase (Jeoung & Dobbek, Science 2007; 318: 1461–
1464). Such a mechanism may go some way to explaining the
molecular basis of how this particular ion channel demonstrates
enzyme-linked oxygen and carbon monoxide sensitivity.
IL 5.2–2
Oxygen and reactive oxygen species as signals
for wound repair
C. K. Sen
Ohio State University Medical Center, Medical Center, Columbus,
OH, USA
In the United States, chronic wounds affect 6.5 million patients.
It is claimed that an excess of US$25 billion is spent annually on
treatment of chronic wounds and the burden is rapidly growing
due to increasing health care costs, an aging population and a
sharp rise in the incidence of diabetes and obesity worldwide.
One factor that is centrally important in making the wound envi-
ronment receptive to therapies is correction of wound hypoxia.
Wound tissue oxygen not only provides energy for tissue repair
but it also supports reactive oxygen species (ROS) production
required for wound healing. The wound fluid is the most oxi-
dant-rich fluid in the body. At the wound site, phagocytic cells
generate oxidants to fight infection and cleanse the wound tissue.
Lower level oxidants generated by non-phagocytic cells, on the
other hand, support numerous processes including cell prolifera-
tion and migration necessary for angiogenesis as well as re-epi-
thelialization. Recent observations in our laboratory resulted in
the first publication demonstrating that cellular redox signaling is
regulated by microRNAs (miRs). miRs are small noncoding
RNAs that regulate gene expression at the post-transcriptional
level by either degradation or translational repression of a target
mRNA. Encoded in the genome of most eukaryotes, miRs have
been proposed to regulate specifically up to 90% of human genes
through a process known as miR-guided RNA silencing. The sig-
nificance of miR in regulating cutaneous wound healing will be
presented.
IL 5.2–3
The cellular functions of eukaryotic GSH and
thioredoxin pathways revisited
C. Kumar, A. Igbaria, B. D’Autreaux and M. B. Toledano
IBITECS, LSOC, CEA-Saclay, Gif-sur-Yvette, FRANCE
The tripeptide GSH is considered as having a unique cellular
redox buffering function, capable of maintaining reduced the
thiol-redox cellular balance, and also to eliminate electrophilic
compounds including ROS and RNS species. This function is in
keeping with the characteristics of GSH of being the most abun-
dant low molecular thiol of eukaryotic cells and having a rela-
tively low redox potential. Nevertheless, redox buffering might
not explain all GSH cellular functions, and in particular its essen-
tial nature in both yeast and mammals. We have used S. cerevi-
siae as a model eukaryote to explore the essential function(s) of
GSH, exploring the cellular defects ensuing (i) the deletion of the
GSH biosynthetic gene c-glutamyl cysteine synthase (GSH1) that
leads to GSH depletion and cell death, and (ii) an artificial
increase in its concentration up to 80 mM, which also eventually
leads to cell death. Data gathered using a combination of global
and cell biological approaches lead to the conclusion that the
essential requirement of GSH is due to its role in the maturation
of cytoplasmic Fe-S clusters proteins. Toxicity of GSH at ele-
vated concentrations also associates with a major alteration of
iron metabolism, which also relate to defective assembly of Fe-S
at monothiol Grxs, and to a major block of secretion due to ER
reductive stress. Surprisingly, both GSH cellular depletion and its
presence at toxic concentrations do not appear to alter thiol-
redox control in the cytoplasm. We will discuss the respective
cellular functions of the GSH and thioredoxin pathways in
eukaryotes.
IL 5.2–4
Hypercholesterolemia-induced oxidative stress
related chances in the brain of rabbits
N. Kartal-Ozer1, T. Grune2, F. Tamtu¨rk1, T. Jung2 and
N. Aytan1
1Marmara University Faculty of Medicine, Department of
Biochemistry, Istanbul, TURKEY, 2University of Hohenheim,
Institute of Biological Chemistry and Nutrition, Stuttgart,
GERMANY
Hypercholesterolemia, a major risk factor for age related
diseases such as atherosclerosis and Alzheimer’s disease (AD).
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Changes in human plasma cholesterol levels results from the
interaction between multiple genetic and environmental factors.
The accumulation of excess cholesterol in blood vessels leads to
atherosclerosis. Studies show that differential expression of oxi-
dative stress proteins, lipid metabolism related enzymes and
receptors response to atherogenic diet. Excess brain cholesterol
has been associated with increased formation and deposition of
amyloid-b peptide from amyloid precursor protein which may
contribute to the risk and pathogenesis of AD. More than 50
genes have been reported to influence the risk of late-onset AD.
Several of these genes might be important in cholesterol metabo-
lism and transport. On the basis of these results, an in vivo study
has been carried out. Rabbits were fed with cholesterol supple-
mented diet or cholesterol supplemented diet plus alpha tocoph-
erol, after 4 weeks brains were removed. Formation of
malondialdehyde in serum, a marker of lipid peroxidation, was
tested. Protein carbonylation, HNE-proteins and 3-nitrotyrosi-
nated proteins and proteosome function evaluated in the brain
of hypercholestrolemic rabbits. The results indicate a cellular
mechanism for hypercholesterolemia induced AD similar changes
will be discussed.
Acknowledgements: This work is supported by COSTB35
Action, TUBITAK SBAG-COSTB35-5(106S121), MU BABKO-
SAG-DKR-290506-0091 and the Braun Stiftung.
IL 5.2–5
Nox family of NADPH oxidases: sources of
reactive oxygen
M. Geiszt
Semmelweis University, Department of Physiology, Budapest,
HUNGARY
Reactive oxygen species (ROS) play a central role in many physi-
ological processes including host defense, hormone biosynthesis,
fertilization and cellular signalling. When exposed to foreign
pathogens, phagocytic cells – such as neutrophil granulocytes –
produce large amounts of superoxide, the precursor of ROS.
ROS have a pivotal role in the killing of the invading microor-
ganisms. ROS operate like a ‘double edged sword’, meaning that
they are essential for killing the foreign pathogens, however they
are also harmful to the host tissues, and their overproduction has
been implicated in the pathogenesis of several inflammatory dis-
eases, including inflammatory bowel disease, rheumatoid arthritis
and kidney diseases. In phagocytic cells, the precursor of ROS is
superoxide (O2
)), produced by the NADPH oxidase enzyme,
which transfers one electron from NADPH to molecular oxygen.
The ‘heart’ of this enzyme is a heme-binding, flavoprotein Nox2
(formerly known a gp91phox), which catalyzes the final steps of
electron transfer. It was known for decades that besides phago-
cytes, several other types of mammalian cells synthesize and
release ROS, which can serve various biological functions, includ-
ing oxygen sensing, vascular regulation, hormone synthesis and
fertilization. The enzymatic basis of non-phagocytic ROS-produc-
tion was unknown. In the last few years, several enzymes were
identified at the molecular level, which are now thought to be
responsible for ROS production observed in diverse tissues.
These enzymes show a high degree of homology to the phagocy-
tic NADPH oxidase and are now designated the Nox family of
NADPH oxidases. The Nox family of NADPH oxidases consists
of the following members: Nox1, Nox2, Nox3, Nox4, Nox5,
Duox1 and Duox2. The discovery of this enzyme family has
revolutionized ROS-research since we can now assign a specific
source of ROS in several tissues, including colon, kidney, heart,
lung, thyroid and immune organs. In my lecture I will discuss
our current knowledge on six new members of the Nox family,
with a special emphasis on Duox enzymes.
OP 5.2–1
Role of Noxes and ROS in Resveratrol-
mediated inhibition of Akt phosphorylation in
Ang II or EGF-activated vascular smooth
muscle cells
C. E. Schreiner, A. G. Atanasov, E. H. Heiss and V. M. Dirsch
University of Vienna, Department for Pharmacognosy, Vienna,
AUSTRIA
Resveratrol (RV) inhibits the angiotensin (Ang) II- and epider-
mal growth factor (EGF)-induced phosphorylation of Akt in vas-
cular smooth muscle cells (VSMC). For the Ang II-induced
transactivation of the EGF-receptor NADPH oxidase (Nox)-
derived reactive oxygen species (ROS) are important and also the
EGF-receptor is reported to use ROS to transduce growth sig-
nals. We therefore examined whether RV inhibits Akt phosphor-
ylation in Ang II or EGF-activated VSMC via an antioxidant
mechanism including Nox proteins. We found increased intracel-
lular ROS level in Ang II- but also in EGF-activated VSMC.
The same concentration of RV (50 lM) that inhibits Akt kept
ROS even below control levels in Ang II-and EGF-activated
VSMC. To investigate, whether Nox1 or Nox4 is pivotal for Ang
II or EGF signaling we inhibited Nox1 by a specific blocking
peptide leading to inhibited Akt phosphorylation after Ang II
but not after EGF stimulation. A Nox4 knock-down by siRNA
did not block either signal. Moreover, pre-treatment with the
antioxidant N-acetyl cystein (NAC) and the flavoprotein inhibi-
tor DPI inhibited Ang II-but not EGF-mediated Akt phosphory-
lation. This confirms that Ang II signaling requires ROS to
transactivate the EGF receptor. The signaling downstream of the
EGF receptor towards Akt, however, seems to occur largely inde-
pendent from ROS. These data suggest that RV inhibits EGF
signaling to Akt in a redox-independent manner whereas Ang II-
mediated Akt phosphorylation could be affected by inhibition of
ROS originating from Nox1. However, there must be an addi-
tional activity of RV since the Nox1 knock-down cannot mimic
the high specificity of RV towards Akt.
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5.3 Gaseous Signaling
IL 5.3–1
Mitochondria, nitric oxide and cell
bioenergetics
S. Moncada
University College London, Wolfson Institute for Biomedical
Research, London, UK
At physiological concentrations nitric oxide (NO) inhibits
mitochondrial cytochrome c oxidase in competition with oxygen.
We have developed a technique based on visible light spectros-
copy and used it to demonstrate that endogenous NO enhances
reduction of the electron transport chain, thus enabling cells to
maintain their VO2 at low oxygen concentrations. This favours
the release of superoxide anion, which initiates the transcriptional
activation of NF-kB as an early stress signalling response. We
have also used this technique to demonstrate that NO is inacti-
vated by cytochrome c oxidase in its oxidised state and have pro-
posed that cessation of such inactivation at low oxygen
concentrations may account for hypoxic vasodilatation. Many
cells respond to a decrease in oxygen availability via stabilisation
of hypoxia-inducible factor-1a (HIF-1a), whose accumulation is
normally prevented by the action of prolyl hydroxylases. We
have found that inhibition of mitochondrial respiration by low
concentrations of NO leads to inhibition of HIF-1a stabilisation.
This prevents the cell from registering hypoxia at low oxygen
concentrations, which would otherwise result in upregulation of
defensive genes, including those for glycolysis and angiogenesis.
Furthermore, inhibition of mitochondrial respiration in hypoxia
leads to redistribution of available oxygen toward non-respira-
tory oxygen-dependent targets. In addition to its interaction with
cytochrome c oxidase, NO can signal for mitochondrial biogene-
sis via a cyclic GMP-dependent mechanism. Furthermore,
increases in NO beyond physiological levels lead to persistent
inhibition of other key enzymes in the mitochondria and this
may account for NO-dependent initiation of cell pathology.
IL 5.3–2
Designer nitric oxide synthases for
understanding the production of gaseous
signals
B. S. Masters1, L. J. Roman1 and P. Martasek2
1University of Texas Health Science Center at San Antonio,
Biochemistry, San Antonio, TX, USA, 2Charles University, First
Faculty of Medicine, Pediatrics, Prague, CZECH REPUBLIC
Nitric oxide synthases (coded by three NOS genes) are dimeric
enzymes that contain heme, flavins (FAD and FMN), tetrahydro-
biopterin, and a single tetrahedrally coordinated Zn atom, all of
which are required for the production of nitric oxide (NO). The
heme-binding (oxygenase) domain and the flavin-binding (reduc-
tase) domains are joined by a calmodulin-binding sequence neces-
sary for the catalytic function of NOS. The molecular
conformations of these dimeric structures are unknown due to
the lack of holoenzyme structures. The quest for the intrinsic and
extrinsic factors that control NOS function has been facilitated
by molecular dissection and genetic engineering of the structures,
permitting production of the separate domains of the enzymes,
which have provided insights into their regulation. The interac-
tions initiated by calmodulin binding in the case of the constitu-
tive NOS isoforms, neuronal (NOSI) and endothelial (NOSIII),
will be discussed with particular attention to the intrinsic molecu-
lar inserts, the autoregulatory insert in the FMN-binding domain
and the C-terminal extensions. The production of NO and
uncoupled reduced oxygen species under various conditions will
be addressed. A model of these interactions will be presented as
a plausible explanation of the mechanism of time- and structure-
dependent production of the gaseous signaling molecule, NO.
Acknowledgements: Supported by US National Institute of
General Medical Sciences GM081568 and GM052419 to BSSM
(The Robert A. Welch Distinguished Professor in Chemistry,
AQ-0012).
IL 5.3–3
Nitric oxide–carbon monoxide interaction and
oxidative stress in obesity and diabetes
N. G. Abraham
Departments of Pharmacology and Medicine, New York Medical
College, Valhalla, NY, USA
We examined the effect of interaction of HO-1 gene expression
and NOS protein during an increase in oxidative stress in obese/
diabetic models. We hypothesized that upregulation of HO-1-
derived CO reduces oxidative stress and increases eNOS, peNOS
via an increases in pAMPK-pAKT cross talk in obese
diabetic mice. Obese, ob, lean mice were divided into groups
compromising lean, lean-inducers of HO-1, L-4F-treated, ob,
ob-L-4F-treated. Food intake, blood glucose levels, CO, eNOS,
pAMPK-pAKT and insulin receptor phosphorylation. Subcuta-
neous fat tissue (SAT) and visceral adipose tissue (VAT) were
determined by MRI. The effect of HO-1 expression-derived CO
and bilirubin on adiponectin levels and adipogenesis was also
examined in human adipocytes stem cells. Both SAT and VAT
global volumes decreased in ob-L-4F treated animals. Decreased
levels of eNOS, peNOS, pAKT and pAMPK in vascular endo-
thelium in ob mice were reversed by HO-1 expression. Upregula-
tion of HO-1 produced adipose remodeling and increases peNOS
levels in adipocytes. The anti-obesity effects of HO-1-derived CO,
bilirubin are manifest by a decrease in visceral fat content with
reciprocal increases in EC-SOD, eNOS, peNOS, adiponectin,
pAMPK and pAKT. The increase in peNOS resulted in restora-
tion of vascular function and increased phosphorylation of insu-
lin receptors with improved insulin sensitivity.
IL 5.3–4
Carbon monoxide-releasing molecules:
anti-ischemic and anti-inflammatory properties
R. Motterlini
Italian Institute of Technology, Department of Drug Discovery and
Development, Genova, ITALY
Heme oxygenase-derived carbon monoxide (CO) serves as signal-
ing mediator in a wide array of physiological functions to the
extent that the beneficial effects observed when small amounts of
CO gas are administered to mammalian organisms may be
exploited for therapeutic purposes. In this context, the develop-
ment of carbon monoxide-releasing molecules (CO-RMs) repre-
sents a pharmaceutical stratagem for the safe delivery of CO in
the treatment of various pathological disorders. Transition metal
carbonyls and boranocarbonates have been identified as ideal
scaffolds for the synthesis of water-soluble compounds that
release controlled amounts of CO within biological systems. Spe-
cifically, CORM-3 (ruthenium tricarbonyldichloro glycinate) and
CORM-A1 (sodium boranocarbonate), which possess different
chemical reactivities and kinetics of CO release, have been tested
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in various models of disease. The results collected to date indi-
cate that CO-RMs are pharmacologically active as they exert
vasodilatory, anti-ischemic and anti-inflammatory effects and can
protect tissues against oxidative stress. Although the mechanism
of action of CO-RMs remains to be fully elucidated, we have
proposed that a dynamic interaction of CO with specific intra-
cellular metal centers may be the common denominator for the
diversified beneficial effects mediated by this gaseous molecule.
Circumstantial evidence points to mitochondria as plausible, and
perhaps, preferential targets of the signals transduced by CO.
Thus, CO-RMs may help to identify cellular components that are
responsive to CO and facilitate the therapeutic delivery of this
gas in a safe, measurable and controllable fashion.
IL 5.3–5
Endothelial cells - new territory for heme
oxygenase-1 biochemistry
A. Jozkowicz, H. Taha and J. Dulak
Jagiellonian University Faculty of Biochemistry Biophysics and
Biotechnology, Department of Medical Biotechnology, Krako´w,
POLAND
Heme oxygenase-1 (HO-1) possesses potent pro-angiogenic prop-
erties in addition to well-recognized anti-inflammatory, anti-
oxidant and anti-apoptotic effects. Angiogenic factors, such as
VEGF and SDF-1, mediate their activities through induction of
HO-1, making it an attractive target for therapeutic intervention.
However, the real significance of HO-1 in the vessels remains to
be assessed in human subjects. To better understand whether
HO-1 is merely a marker of oxidative injury or a prerequisite
mediator of endogenous protection against more severe insults,
we compared primary human endothelial cells of different HO-1
promoter variants, checking their angiogenic potential, inflamma-
tory response, and sensitivity to oxidative stress. A (GT)n repeat
in the human HO-1 promoter shows length polymorphism and
can modulate the level of gene transcription. We propose classifi-
cation of the alleles into three groups: S (most active, GT £ 23),
M (moderately active, GT = 24–28), and L (least active,
GT ‡ 29). Presence of S allele was associated with higher basal
HO-1 expression and stronger induction in response to oxidants
or inflammatory mediators. Cells carrying S allele displayed high-
est concentration of total glutathione and more favorable oxida-
tive status determined by GSH: GSSG ratio. Accordingly, they
survived better when exposed to oxidative stress. Moreover, they
proliferated more efficiently in response to VEGF, although the
VEGF-induced migration and sprouting of capillaries were not
influenced. Presence of S allele was also associated with higher
basal or LPS-stimulated production of TNF, IL-1b, IL-6,
ICAM-1 and E-selectin. Thus, the lesson from promoter
polymorphism supports a cytoprotective, proangiogenic and
anti-inflammatory role of HO-1 in the vessel wall in humans.
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5.4 Signalling in Plants
IL 5.4–1
Cytokinin signal perception and transduction
T. Schmu¨lling
Freie Universita¨t Berlin, Institute of Biology/Applied Genetics,
Berlin, GERMANY
Cytokinins are a class of plant hormones that regulate numerous
developmental and physiological processes. The cytokinin signal
is perceived by membrane-located sensor histidine kinases which
transfer the signal through a His-Asp-phosphorelay into the cell
nucleus. There response regulator proteins are activated and
function as transcription factors. Among higher eukaryotes this
signaling system is unique to plants. It was shown that the three
cytokinin receptors of Arabidopsis differ in their ligand binding
specificities. Steps have been made towards structural character-
ization of the ligand-binding CHASE domain. Domain swap and
promoter swap experiments revealed that signal recognition and
regulation of receptor expression contribute to signal specifica-
tion. Protein interaction maps have been established for many of
the ca. 30 proteins of the signaling system. Immediate early target
genes of the signal pathway were identified and progress towards
identification of cis regulatory elements will be reported. The
functions of the pathway in plant development and the perspec-
tive of its modulation for biotechnological purposes will be
discussed and exemplified.
IL 5.4–2
Plant phospholipases and phosphatidic acid-
mediated signaling in stress responses
X. Wang
University of Missouri-St. Louis/Danforth Plant Science Center,
Biology, St. Louis, MO, USA
Phospholipases produce various lipid messengers, such as phos-
phatidic acid (PA), lysophospholipids (lysoPLs), free fatty acids,
and diacylglycerol (DAG). The activation of phospholipases often
occupies a critical and early step in a specific signaling cascade.
Phospholipases are grouped into four major classes, phospholi-
pase D (PLD), phospholipase C (PLC), phospholipase A2 (PLA2),
and phospholipase A1 (PLA1), according to the site of hydrolysis
of glycerophospholipids. Within each class, the enzymes can be
further divided into families or subfamilies accordingly to their
sequence similarities, biochemical properties, and biological func-
tions. Distinct differences exist in the occurrence and functions of
various phospholipases between plants and animals. PLD consti-
tutes a major phospholipase family in plants. Plants contain more
genes and types of PLDs than animals do, and different PLDs
and their derived PA are involved in a wide range of signaling
processes in plants. Each of the dozen Arabidopsis PLDs charac-
terized displays distinguishable properties in activity regulation
and/or lipid preferences. The molecular and biochemical hetero-
geneities of the plant PLDs play important roles in the timing,
location, and amount of PA produced. PLD-catalyzed production
of PA has been shown to play important roles in plant growth,
development, and response to various stresses, including drought,
salinity, freezing, and nutrient deficiency. PLD and PA affect cel-
lular processes through different modes of action, including direct
target protein binding and biophysical effects on cell membranes.
A better understanding of the mechanism by which specific phos-
pholipases and lipid messengers mediate given plant responses will
provide insights into the molecular processes that connect the
stimulus perception on membranes to intracellular actions and
physiological responses.
IL 5.4–3
Regulation of epidermal cell-pattern by
secretory peptides
T. Kakimoto
Department of Biology, Osaka University, Osaka, JAPAN
Regulation of the number and placement of cells is critical for
proper development of multicellular organisms. During develop-
ment of plant leaf epidermis, a protodermal cell first makes a fate
decision of whether or not to be the meristemoid mother cell
(MMC), which undergo asymmetric cell division forming a
meristemoid and its sister cell. A meristemoid eventually differen-
tiates into guard cells of a stoma, and the sister cell either under-
goes additional asymmetric cell division or differentiate into a
pavement cell. We found two closely related secretory peptides
that regulate epidermal cell placement or number. EPF1 is
expressed in the meristemoids, guard mother cells and guard
cells. It regulates the plane of asymmetric cell division in a cell
neighboring to a cell that expresses EPF1. This in turn results in
proper placement of epidermal cells. EPF2 is expressed in MMCs
and meristemoids, and negatively regulates successive formation
of MMC. This feedback-regulation limits epidermal cell-density.
The coding sequences are responsible for the difference in the
functions of EPF1 and EPF2.
IL 5.4–4
Regulation of cellular polarity
S. Yalovsky
Department of Plant Sciences, Tel Aviv University, ISRAEL
Development in multicellular organisms depends on the ability of
individual cells to transport small molecules in a polar fashion.
In plants, polar auxin transport and distribution are required for
almost every aspect of plant development. The Rho associated
small GTPases ROPs are master regulators of cell polarity. In
my talk I will discuss some the mechanisms of ROP membrane
targeting and partitioning and the involvement of a ROP associ-
ated protein in the regulation of cell polarity and polar auxin
transport.
IL 5.4–5
Cellular mechanism of polar auxin transport
E. Zazimalova
Institute of Experimental Botany, Laboratory of Hormonal
Regulations, Prague, CZECH REPUBLIC
Cell-to-cell polar auxin transport plays a key role in control of
spatial and temporal aspects of plant growth and development.
Auxin polar transport machinery consists of a balanced system
of passive diffusion into cells of non-dissociated auxin molecules,
as well as activities of auxin importers and exporters. For physi-
cal–chemical reasons, it is the activity and subcellular localization
of auxin exporters (efflux carriers) which is crucial for both quan-
tity and direction of auxin flow, respectively. At present, in
Arabidopsis there are two main candidates for auxin exporters –
plant-specific PIN-FORMED proteins (PINs) and multidrug-
resistance-like P-glycoprotein transporters (MDR/PGPs/ABCB),
and one main candidate family for auxin importers (influx carri-
ers) – permease-like AUX1/LAX proteins. We have transformed
tobacco cells of BY-2 line (Nicotiana tabacum L., cv. Bright-
Yellow 2) with various genes of PIN-, MDR/PGP/ABCB- and
AUX1-type. After their overexpression, we have characterized
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concomitant changes in cell morphology and development
together with biochemical characteristics of intracellular auxin
accumulation. Detailed kinetic characterization of auxin trans-
port using various auxins and their structurally-related analogues,
selected on the basis of their ability to induce the auxin-respon-
sive reporter DR5rev::GFP in the roots of Arabidopsis seedlings,
revealed that the auxin transport machinery is specific to those
compounds which were able to induce DR5rev::GFP reporter
and showed other auxin-like properties (as e.g. growth-regulatory
activity in suspension-cultured tobacco cells, inhibition of endo-
cytosis, etc.). On the basis of quantitative data measured by the
auxin-accumulation assay, we have constructed a mathematical
model of auxin flow through a single cell; this model has a poten-
tial to predict auxin concentrations in cell compartments and it
can complement the already existing models of auxin flow on the
tissue and organ levels.
Acknowledgement: This work was supported by the Ministry
of Education, Youth and Sports of the Czech Republic, project
LC06034.
OP 5.4–1
Exo84 subunit of exocyst tethering complex in
Arabidopsis
V. Zarsky1, M. Fendrych2, L. Synek2, M. Hala2, M. Potocky2,
R. Cole3 and J. Fowler3
1Charles University, Department of Plant Physiology, Prague,
CZECH REPUBLIC, 2Institute of Experimental Botany,
Laboratory of Cell Biology, Prague, CZECH REPUBLIC,
3Oregon State University, Department of Botany and Plant
Pathology and Center for Genome Research and Biocomputing,
Corvallis, OR, USA
The exocyst is an octameric protein complex crucial for polarized
secretion in yeast and animal cells. It is an effector of Rho and
Rab GTPases, tethers vesicles to their target membranes and pre-
cedes the SNARE module assembly. Recently it wash shown that
the exocyst functions as a complex in plant cells, however, the
question whether the Exo84 subunit (critical for yeast and
Drosophila exocyst) is part of the complex was not completely
answered in this study. The Exo84 family is present in Arabidop-
sis; we revealed structural similarity of the Exo84 proteins
between plant and Opisthokonta using bioinformatics approach.
We localised subunits of the exocyst complex using GFP fusions;
the Exo84 localises to membrane associated spots which partially
co-localise with microtubules and Golgi apparatus. We present a
phylogenetic and genetic analysis of the Arabidopsis Exo84
family. Arabidopsis encodes three Exo84 homologues. Public
microarray data implicate distinct functions of these homologues
in plant development. Using T-DNA insertion mutants we show
that all members of the Exo84 family are fundamental for
Arabidopsis development. Moreover, concluding from the sever-
ity of the insertion phenotypes, we propose that some of the
T-DNA mutant alleles of the Exo84b subunit might interfere
with proper exocyst assembly/action. These might prove useful in
future work as the precise mode of action of the exocyst complex
and the inter-exocyst subunit relations are not completely under-
stood.
Acknowledgement: Grant support – V.Z. MSMT Kontakt
ME841, MSM LC06034 ‘‘EMOROST’’, MSM LC06004 and
MSM0021620858. J. F. was supported by the US National
Science Foundation (#IBN-0420226).
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5.5. Small GTPases in Cell Function and Disease
IL 5.5–1
Spatio-temporal control of small G protein
function during phagocytosis
E. Caron
Imperial College London, Cell and Molecular Biology, London,
UK
Phagocytic uptake is a highly ordered and stringently controlled
process that allows the internalization of particles over 300 nm in
diameter (e.g. cell debris, microorganisms and apoptotic cells).
Driven by the local three-dimensional re-organisation of the actin
cytoskeleton and plasma membrane, it is orchestrated by small
GTP-binding proteins. The best-studied phagocytic receptors are
the Fcc receptor and Complement receptor 3 (aka CR3, Mac-1,
aMb2 integrin). Phagocytosis through these two types of recep-
tors differ in terms of specific subsets of G proteins involved, as
shown in the past using dominant negative and/or bacterial
toxins, and ultrastructures formed. We have recently used RNA
interference and cells derived from knock-out animals to obtain a
better understanding of the specific Rho proteins involved during
phagocytosis and clarify their role in local actin polymerization.
How the function of Rho proteins at the membrane of phago-
cytic cups is regulated in space and time, and how this relates to
other actin-dependent cellular processes will be the focus of the
presentation.
IL 5.5–2
Effects of Rho-deamidating and
Rho-gluosylating bacterial protein toxins on
G2-M transition and cytokinesis
H. Genth1, M. May1, I. Just1 and G. Schmidt2
1Hannover Medical School, Toxicology, Hannover, GERMANY,
2University of Freiburg, Pharmacology/Toxicology, Freiburg,
GERMANY
The permanent renewal of epithelial surfaces is one of the host
defence mechanisms to limit bacterial colonization within the
mammalian host organism. Two microbes that colonize epithelial
surfaces are Clostridium difficile (colon) and uropathogenic strain
of E. coli (UPEC, urothelium). Both microbes produce protein
toxins that target low molecular weight GTP-binding protein of
the Rho subfamily. The C. difficile toxins Toxin A (TcdA) and
Toxin B (TcdB) mono-glucosylate and thereby inactivate RhoA,
Rac1, and Cdc42. Cytotoxic necrotizing factors (CNF) deamidate
and thereby constitutively activate Rho proteins. Recent reports
by several labs provide evidence on the role of Rho proteins in
G2M transition and cytokinesis. We here analyze the toxins’
effects on G2-M transition and cytokinesis in Hela cells synchro-
nized using the thymidine double block technique. We show that
either activation of Rho proteins by E. coli CNF1 or inactivation
of Rho proteins by TcdB results in a comparable outcome i.e.
delayed G2-M transition and inhibited cytokinesis. Modulation
of Rho activity by the toxins thus limits proliferation of epithelial
cells. This leads to the model that toxins inhibit the renewal of
epithelial surfaces, in order to favor the colonization of the
producing microbe.
IL 5.5–3
Roles of Rho GTPases in cell adhesion and
migration
A. Ridley
King’s College London, Randall Division of Cell and Molecular
Biophysics, London, UK
Rho GTPases are found in all eukaryotes and regulate actin and
microtubule dynamics, thereby contributing to multiple cellular
functions, including cell migration, vesicle trafficking, and
transcriptional regulation. We are investigating the roles of the 20
different mammalian Rho family members and their interacting
partners in leukocyte adhesion to and migration across
endothelial cells, and in cancer cell migration and cell–cell adhe-
sion. For example, we have shown that Rac1 and Rac2 each play
distinct roles in regulating macrophage shape, cytoskeletal
organisation and invasion, but that Rac proteins are not essential
for macrophage migration. In addition, we are studying the
regulation and function of Rnd proteins, which are less well-
characterised members of the Rho family and are unusual in that
they do not hydrolyse GTP. Instead, we have found that Rnd3/
RhoE is regulted by expression levels, phosphorylation and locali-
sation. The mechanisms underlying the roles of different Rho pro-
teins in mammalian cell migration and adhesion will be discussed.
IL 5.5–4
Rho GTPases and cell adhesion: upstream and
downstream signaling
K. Burridge, A. Dubash, R. Garcia-Mata and
E. Monaghan-Benson
University of North Carolina, Cell and Developmental Biology,
Chapel Hill, NC, USA
Rho GTPases regulate many cell activities including cell adhe-
sion, cell migration and the organization of the cytoskeleton.
With respect to adhesion, a reciprocal relationship exists in which
Rho proteins regulate the assembly and disassembly of cell-
matrix and cell–cell adhesions, but in which engagement of many
cell adhesion molecules also regulates the activities of Rho pro-
teins. We have studied how integrin-mediated adhesion regulates
RhoA activity. Initially, integrin engagement activates Src leading
to the phosphorylation and activation of p190RhoGAP. This
depresses RhoA activity, allowing cells to spread. Over time, inte-
grin engagement stimulates RhoA activity, which promotes the
generation of traction forces on the underlying matrix. Pursuing
how integrin engagement stimulates RhoA activity, we have
found that integrin engagement activates the guanine nucleotide
exchange factors Lsc and LARG. With cell–cell adhesion we are
studying how Rac1 regulates the integrity and permeability of
endothelial junctions. Surprisingly, Rac1 has been found to both
increase and decrease endothelial permeability depending on the
source of stimulation. With sphingosine-1-phosphate, many
groups have shown that activation of Rac1 leads to decreased
endothelial permeability and enhanced barrier function, whereas
with VEGF the activation of Rac1 increases permeability and
decreases barrier function. Examining the basis for VEGF-
induced permeability, we have found that, downstream from
VEGF, Rac1 stimulates NADPH oxidase to generate reactive
oxygen species (ROS). In turn, ROS elevate the tyrosine phos-
phorylation of junctional proteins, decreasing junctional stability
and increasing permeability.
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OP 5.5–1
Activation of endogenous RhoG by epidermal
growth factor (EGF)
T. Samson1, C. Welch2, E. Benson1, K. Hahn2 and K. Burridge1
1University of North Carolina, Cell and Developmental Biology,
Chapel Hill, NC, USA, 2University of North Carolina, Department
of Pharmacology, Chapel Hill, NC, USA
RhoG belongs to the Rac-like subgroup of Rho GTPases and is
involved in diverse cellular functions, like macropinocytosis,
caveolar endocytosis, neurite outgrowth and cell survival. The
current understanding of the upstream regulation of RhoG is
limited, as only a few guanine-nucleotide exchange factors
(GEFs) and GTPase-activating proteins (GAPs) for RhoG have
yet been described. Furthermore, stimuli like serum treatment or
integrin engagement which are known to activate other Rho
GTPases were described not to influence RhoG activity. Here we
show that stimulation of epithelial cells with epidermal growth
factor (EGF) induces a strong and rapid increase of the endo-
genous level of active RhoG (RhoG.GTP). The kinetics of RhoG
activation after EGF treatment parallel the previously described
activation of Rac1 upon EGF treatment. Interestingly, activation
of RhoG by EGF appears to be specific to this growth factor, as
we did not observe RhoG activation after VEGF-treatment of
endothelial cells or PDGF-treatment of fibroblasts, even though
Rac1 was activated by these growth factors. Further, we found
that the activation of RhoG and Rac1 do not depend on each
other, as each GTPase is still activated by EGF when the other
one is knocked-down by RNA interference. Using a set of
siRNAs which target GEFs known to activate RhoG or appear
likely to have exchange specificity for RhoG, we found that the
activation of RhoG by EGF is complex and regulated by multi-
ple GEFs. Our current research focuses on understanding the
underlying signaling pathways and on characterizing biological
functions regulated by EGF induced RhoG activity.
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5.6. Signaling in Host-Pathogen Interactions
IL 5.6–1
Calcium signaling and Shigella invasion of
epithelial cells
B. Liu1,2, L. Combettes1, G. Tran Van Nhieu2
1Inserm-Paris XI University, U757, Orsay, FRANCE, 2Inserm-
College de France, U971, Paris, FRANCE
Shigella, the causative agent of bacillar dysentery, induces its
internalization into epithelial cells by locally reorganizing the
actin cytoskeleton. Bacterial invasion is determined by a T3SS.
Upon cell contact, two T3S substrates the IpaB and IpaC
proteins assemble into a pore-forming translocator in host cell
membranes that allows the injection of bacterial effectors inside
host cells. Initial bacterial signaling has been linked to the carb-
oxyterminal domain of IpaC and activation of Src family kinases
(Mounier et al., 2009), but the precise sequence of signaling
events leading to actin polymerization is still unclear. During
invasion, Shigella induces transient increases in global intracellu-
lar Ca2+ concentration in a T3SS-dependent manner, that are
not required for bacterial invasion (Tran Van Nhieu et al., 2003).
This has been recently confirmed in unpublished collaborative
work from the proponents of this proposal, showing that cell
treatment with thapsgargin, an inhibitor of the ATPase involved
in the replenishing of intracellular Ca2+ pools, in the absence of
extracellular Ca2+ abrogate bacterial-induced variations in global
intracellular concentration, but does not inhibit Shigella invasion.
Interestingly, however, preliminary results indicate that Shigella
invasion induces a redistribution of the inositol 1,4,5-trisphos-
phate (IP3) receptor (IP3R). Furthermore, expression of an
IP3-5-phosphatase that prevents variations in IP3 levels or
siRNA knocking out of IP3Rs resulted in inhibition of Shigella-
induced actin reorganization during invasion. Because IP3-signal-
ing is required for local Ca2+ increase, these results suggest
that local but not global Ca2+ increases regulate cytoskeletal
reorganization during bacterial invasion.
IL 5.6–2
Role of a-hemolysin induced Ca2+ signaling in
the progression of uropathogenic E. coli
infection within the urinary tract
A. Richter-Dahlfors1, K. Melican1, J. Boekel1, L. Ma˚nsson1,
R. M. Sandoval2, G. A. Tanner3, O. Ka¨llskog4, F. Palm4 and
B. A. Molitoris2
1Karolinska Institutet, Dept. of Neuroscience, Stockholm,
SWEDEN, 2Dept. of Medicine, Indiana Center for Biological
Microscopy, Indiana University, Indianapolis, IN, USA, 3Dept. of
Cellular and Integrative Physiology, Indiana University,
Indianapolis, IN, USA, 4Uppsala University, Dept. of Medical Cell
Biology, Uppsala, SWEDEN
The study of bacteria-host interaction is the key to understanding
the complexity of microbial pathogenesis. By combining the
power of multiphoton-based live animal imaging with the preci-
sion of micro-puncture, we have developed a system that allows
us to visually track a progressing infection from the first interac-
tions between host and pathogen. The live model allows for
study in the most clinically relevant setting with the full comple-
ment of integrating factors accounted for. Using GFP+ express-
ing clinical uropathogenic E. coli (UPEC) we have followed the
progressing pathophysiology of pyelonephritis, in high resolution,
within a single live animal. A combination of the intravital imag-
ing with complementary physiological and molecular techniques
has revealed a previously undescribed innate vascular response to
mucosal infection. The extremely rapid host response to mucosal
infection was highlighted by the triggering of a cascade of events
within 3–4 hours of infection. Epithelial signalling produced an
increase in cellular O2 consumption and affected microvascular
flow via the induction of clotting, causing localized ischemia.
Subsequent ischemic damage dramatically affected pathophysiol-
ogy. Infection with an isogenic mutant strain lacking expression
of the exo-toxin a-hemolysin (Hly) displayed a dramatic delay in
the onset of vascular dysfunction. Hly is known to induce Ca2+
oscillations in primary renal proximal tubule cells, the same cells
they come into contact with in our in vivo model. These oscilla-
tions were shown to induce inflammatory signalling, a known
factor in the initiation of the clotting cascade. These results give
an in vivo role to in vitro findings, demonstrating down-stream
effects of this signalling which are only observable in this living
model. Suppression of this clotting response by heparin treatment
resulted in fatal urosepsis. This work describes a rapid vascular
response as a new factor in the early innate response to bacteria–
host interaction in the kidney. Bacterial virulence factors, such as
Hly, are shown to influence the kinetics of this response in vivo.
IL 5.6–3
Cellular regulation of calcium; a life and death
messenger
M. Bootman and L. Roderick
The Babraham Institute, Research, Babraham, UK
Calcium is a prominent cellular messenger that has roles in pro-
cesses as diverse as fertilisation, gene transcription, metabolism
and cell death. Cellular calcium signals vary in their spatial prop-
erties, kinetics, amplitude and frequency. No two cell types dis-
play exactly similar calcium signals. Rather, cells employ
components from a substantial tool kit of possible calcium
signalling elements. By expressing various components from the
tool kit, cells can generate calcium signals with characteristics
that fit the cells’ physiological functions. Although specific, the
calcium signalling proteome employed by a single cell type is not
generally invariant. Depending on prevailing conditions, forms of
stimulation or stress, the calcium signalling proteome within cells
can be remodelled, leading to calcium signals with distinctive
properties. Furthermore, although calcium signalling proteomes
are designed to fit the physiological functions of a particular cell
type, they can be hijacked by pathological processes and thereby
promote deleterious outcomes. A well-known example of remod-
elling of a calcium signalling proteome occurs during cardiac
hypertrophy and heart failure. Cardiac myocytes are post-mitotic,
so the contractile portion of the heart cannot grow through cell
division. Rather, when the body is subject to increased haemo-
dynamic demand, the cardiac myocytes enlarge (hypertrophy)
and express proteins not found in control conditions. Depending
on the stimulus causing hypertrophy, this change in myocyte
function can be beneficial (more blood pumping) and reversible.
However, with prolonged haemodynamic demand, or with other
triggers, hypertrophy can take adopt an irreversible pathological
form that culminates in heart failure.
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IL 5.6–4
Calcium signalling and viral infections
P. Paterlini-Bre´chot
Universite´ Paris Descartes, INSERM U807, Paris, FRANCE
Viruses need cell machinery for their multiplication and ‘‘survi-
val’’. We first investigated the role of calcium signalling in the
biological effects of two viral proteins involved in liver carcino-
genesis. HBV X expression was found to be associated with ele-
vation of cytosolic calcium, and decreased calcium in
mitochondria, while ER calcium remains unchanged. HBV X-
induced elevation of cytosolic calcium follows HBV X-induced
caspase 3 mediated cleavage of PMCA (Plasma Membrane Cal-
cium ATPase), decreasing its calcium pumping activity. This
mechanism modulates the level of cytosolic calcium potentially
leading to apoptotic cell death. We then showed that HCV core
expression determines ER stress which, in turn, induces ER cal-
cium depletion, caspases and Bax activation, and apoptotic cell
death. Thus, two viral proteins involved in liver carcinogenesis
were shown to deregulate the control of cell viability by modify-
ing calcium signalling. We have then tested the hypothesis that
modulation of subcellular calcium concentrations by specific
drugs can have an impact on HCV protein expression and HCV
replication. We studied the Huh7 cell line stably expressing the
full length HCV genome and a more recent system to generate
infectious virus particles in cell culture by modulating intracellu-
lar calcium concentrations with CsA (3 lM during 4 h) and
DEBIO-025 (0.3 lM). The amount of viral RNA was evaluated
by real-time quantitative RT-PCR (GAPDH normalization).
Aequorin measurements confirmed that the virus, independently
from all treatment, disturbs intracellular calcium concentrations.
Pharmacological modulation of calcium homeostasis was shown
to affect HCV replication showing an impact of intracellular cal-
cium modulation on viral multiplication.
OP 5.6–1
Dissecting signal transduction pathways on
host–Plasmodium interactions
C. Garcia1, M. Nathansom2 and R. Sartorello1
1Biosciences Institute, Physiology, Sao Paulo, BRAZIL, 2Yale
University, Cell Biology, New Haven, CT, USA
During evolution, parasites have adapted to subvert the host
endocrine regulation to coordinate its cell cycle and proliferation.
We want to understand how Plasmodium signalling pathways
interact with one another to put in action a response during its
complex life cycle. We have proposed a novel mechanism that
allows the intracellular protozoan Plasmodium to use host
melatonin and its derivatives to synchronize intraerythrocytic
malaria parasites in a Ca2+-dependent manner (Hotta et al,
2000; Beraldo and Garcia 2005). We have investigated the func-
tion of a RACK orthologue in Plasmodium. In mammalian cells
RACK is responsible for stabilizing PKC in its active form as
well as to bind to IP3 receptors and modulate calcium release.
We reported previously that Plasmodium falciparum expresses an
ortholog of RACK1, named PfRACK (Madeira et al, 2003). This
protein is constitutively expressed along the intraerythrocytic
cyle, and can be considered a target for antimalarial drug devel-
opment. We have used codon-optimized form of the PfRACK
gene to express this protein in the HEK 293 and PC12 mamma-
lian cell lines and primary hepatocytes. Endogenous RACK1
expression was also knocked down. By time-lapse confocal
microscopy, we observed that ATP (100 lM)-induced Ca2+ sig-
nals were reduced by 83.3 + 3.8% in HEK 293 cells expressing
PfRACK and by 89.6 + 7.8% in cells expressing PfRACK and
treated with siRNA for mammalian RACK1. We also performed
experiments using a permeable caged InsP3. Upon 2-photon en-
caging, the InsP3 failed to increase Calcium in cells expressing
PfRACK. Confocal immunolocalization showed partial co-locali-
zation of PfRACK with its mammalian ortholog.
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5.7. Plasma Membrane and Cell Signaling
IL 5.7–1
Lipid rafts and membrane organization
K. Simons, D. Lingwood, U. Coskun and M. Grzybek
Max Planck Institute of Molecular Cell Biology and Genetics,
Dresden, GERMANY
The lipid raft concept introduces into membrane organization the
capability of dynamic sub-compartmentalization. Our present
concept of lipid rafts is that they are dynamic nano assemblies of
sphingolipids, cholesterol and proteins that dissociate and associ-
ate on a rapid timescale. These assemblies can be induced to coa-
lesce to form raft clusters and these are the platforms that
function in membrane trafficking, cell polarization and signaling.
Amazingly, the plasma membrane can also be induced to sepa-
rate into two phases of micrometer size in which the raft phase
includes transmembrane proteins and excludes the transferrin
receptor. A difficult issue in understanding membrane structure
and function is how membrane proteins interact with lipids. With
respect to understanding how proteins associate with rafts it is
fairly straight-forward to understand that proteins with attached
saturated acyl chains such as GPI-anchored proteins can be asso-
ciated with liquid-ordered raft assemblies. Transmembrane
proteins, however, do pose a problem. When they cross the
bilayer the transmembrane domains should disrupt the packing
of the liquid-ordered domain. The EGF receptor is one of the
best studied receptors and is involved in membrane signaling and
cancer. The EGF receptor has been shown to associate with rafts
and this association modulates its activity. Moreover, ganglio-
sides seem to modulate the receptor activity. We have now
directly shown that the purified EGF receptor reconstituted into
proteoliposomes is inhibited by the ganglioside GM3. This
ganglioside abolishes the autophosphorylation activity of the
purified EGF receptor in proteoliposomes with a liquid-ordered
lipid compostion. Our working model is that binding of raft
lipids make transmembrane proteins raftophilic.
IL 5.7–2
Plasma membrane signalosomes – structure-
function relationships
P. Draber
Institute of Molecular Genetics, Laboratory of Signal Transduc-
tion, Prague 4, CZECH REPUBLIC
The earliest known biochemical event that occurs after ligand
binding to the multichain immune recognition receptors (MIRRs)
is tyrosine phosphorylation of the receptors and formation of sig-
naling units – signalosomes. In mast cells and basophils activated
via the high-affinity IgE receptor (FceRI), this step is mediated
by Src family protein tyrosine kinase (PTK) Lyn. The mechanism
of this step has been extensively studied; consequently, three
major models are considered. (i) The transphosphorylation model
is based on observations that small fraction of Lyn kinase is
weakly, albeit constitutively bound to FceRI. When FceRI is
aggregated, Lyn kinase bound to one receptor can phosphorylate
the immunoreceptor tyrosine-based activation motifs (ITAMs) on
an adjacent receptor and initiate thus the signaling pathway.
(ii) An alternative model suggests that Lyn is not pre-associated
with the FceRI but instead is separated from it into membrane
microdomains called membrane rafts; this prevents FceRI phos-
phorylation. After activation, the aggregated FceRI associates
with membrane rafts, and only this fraction of the FceRI is tyro-
sine phosphorylated. This model is supported by experiments in
which FceRI in activated cells exhibited enhanced association
with detergent-resistant membranes (DRMs). (iii) The third
model postulates that FceRI triggering is regulated by an inter-
play between PTKs and protein tyrosine phosphatases (PTPs).
Cell activation initiates a local increase in reactive oxygen species
(ROS) which react with cysteine in the active site of PTPs; in this
way the enzymatic activity of PTPs is inhibited. This leads to a
local change in the equilibrium between PTKs and PTPs, and
enhances phosphorylation of the receptor. This model is sup-
ported by experiments indicating that ROS induces rapid phos-
phorylation of the receptor in the absence of its aggregation, as
determined by electron microscopy on isolated membrane sheets.
Importantly, ROS-induced phosphorylation of the receptor is
observed even in the absence of its association with DRMs, sug-
gesting the presence of preformed receptor/PTK/PTP complexes.
A variation of this model presumes decreased access of PTPs,
but not PTKs, to the ITAMs as a result of activation-induced
conformational changes of the receptor. Our results based on
analysis of tyrosine phosphorylation of the FceRI in antigen- or
pervanadate-activated cells support the third model.
Acknowledgement: Supported by project 301/09/1826.
IL 5.7–3
Lateral compartments in the yeast plasma
membrane: how are they formed and what are
they good for?
W. Tanner1, G. Grossmann1, V. Stradalova2, J. Malinsky2 and
M. Opekarova3
1Institute of Cell Biology and Plant Physiology, University of
Regensburg, Regensburg, GERMANY, 2Institute of Experimental
Medicine, Academy of Sciences of the Czech Republic, Prague,
CZECH REPUBLIC, 3Institute of Microbiology, Academy of
Sciences of the Czech Republic, Prague, CZECH REPUBLIC
The plasma membrane of S. cerevisiae is subdivided into at least
two stable lateral compartments. One consists of 50–80 patches of
about 300 nm in diameter and is called MCC (Membrane Com-
partment of Can1, the arginine permease). The other one, MCP
(Membrane Compartment of Pma1, the H+-ATPase) fills the
space in between the MCC patches (1,2). Nine membrane proteins
and 12 cytosolic ones are localized within or in close vicinity to
the patches; the latter holds also for the so-called ‘eisosome’ (3,4).
MCC is enriched in ergosterol; the localization of several MCC
proteins is affected by the membrane potential (5). Besides lipid
biosynthetic gene products, we identified two proteins (Nce102
and Pil1) in a genome-wide screen (3), which are essential for
MCC pattern formation. Punctuate dynamic components of the
endocytotic machinery, never coincide with the MCC pattern. We
show that MCC protects its residents from turnover/degradation
(3). Before internalization, the MCC proteins have to leave the
area of the patch. Investigations of the plasma membrane by vari-
ous electron microscopic approaches showed that the MCC
patches coincide with short rod-shaped invaginations, originally
described by Moor and Mu¨hlethaler in 1963 (6), when freeze
fracturing was invented. These invaginations had remained
mysterious membrane differentiations until today.
References:
1. Malinska et al. Mol Biol Cell 2003; 14: 4427.
2. Malinska et al. J Cell Sci 2004; 117: 6031.
3. Grossmann et al. J Cell Biol 2008; 183: 1075.
4. Walther et al. Nature 2006; 439: 998.
5. Grossmann et al. EMBO J 2007; 26: 1.
6. Moor and Mu¨hlethaler. J Cell Biol 1963; 17: 609.
Symposium Abstracts
FEBS Journal 276 (Suppl. 1) 5–84 (2009) ª 2009 The Authors Journal compilation ª 2009 Federation of European Biochemical Societies 53
IL 5.7–5
Dynamics of Ras and Src membrane
interactions in live cells and their role in
signaling
Y. Henis1, S. Eisenberg1, M. Ehrlich1, D. Shvartsman1,
O. Gutman1, J. Donaldson2, B. Diaz2 and G. S. Martin2
1Tel Aviv University, Neurobiology, Tel Aviv, ISRAEL,
2University of California at Berkeley, Molecular and Cell Biology,
Berkeley, CA, USA
We studied the role of the dynamic interactions with the plasma
membrane in signaling by two oncogenic proteins, Ras and Src.
To investigate the role of the polybasic cluster in K-Ras4B
(K-Ras), we combined live cell microscopy and FRAP beam-size
analysis. We show that the cationic amphiphilic drug chlorprom-
azine (CPZ) modulates the membrane association of oncogenic
GFP-K-Ras(G12V) (but not H-Ras) by enhancing its exchange
with the cytoplasm. This increases K-Ras(G12V) in the cyto-
plasm and internal membranes. The cellular response to this dis-
lodgement is cell-type specific and depends on the internal
membranes to which K-Ras(G12V) is targeted; targeting to endo-
somes arrests the cell cycle, while targeting to mitochondria
induces apoptosis. Thus, by disruption of charge-based interac-
tions, CPZ alters K-Ras localization, leading to cell-specific
effects on its signaling outcome. To investigate the roles of differ-
ent elements (kinase, SH2, SH3 domains) in Src membrane inter-
actions, we employed FRAP beam-size analysis on a series of
c-Src-GFP proteins with mutations in specific domains, together
with assays that determine the ability of the mutants to generate
and bind to phosphotyrosyl-proteins. We show that wild-type Src
displays lipid-like membrane association, while constitutively
active Src-Y527F interacts transiently with membrane-associated
proteins. These interactions require Src kinase activity and SH2
binding, but not SH3 binding. Overexpression of paxillin, a
largely cytoplasmic Src substrate, competes with membrane phos-
photyrosyl-protein targets for binding activated Src. We show
that the interactions of Src with lipid and protein targets are
dynamic, and that Src kinase and SH2 domain cooperate in the
membrane targeting of Src.
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Symposium 6: Organism – The Network of Interactions
6.1. Mitochondrial Membranes, Apoptosis and Cancer
IL 6.1–1
Model membranes as valuable tools for
mechanistic studies of BCL-2 protein function
G. Basanez, O. Landeta, A. Landajuela, A. Etxebarria and
O. Terrones
CSIC-UPV/EHU, Unidad de Biofisica, Bilbao, SPAIN
BCL-2 family proteins are the main regulators of the intrinsic
pathway of apoptosis, which primarily function by modulating
the mitochondrial outer membrane permeabilization (MOMP)
process triggering release into the cytoplasm of apoptogenic fac-
tors such as cytochrome c. Core components of the BCL-2 family
are proapoptotic BAX-type proteins which directly cause
MOMP, and antiapoptotic BCL-2-type proteins which inhibit
MOMP. Numerous factors that interact with and regulate core
BCL-2 family proteins have been identified, among which mem-
bers of a third BCL-2 subgroup (BH3-only proteins), components
of the mitochondrial morphogenesis machinery, and mitochon-
drial lipids stand out. However, the inherent complexity of the
BCL-2-interacting network constitutes a major hurdle to eluci-
date the exact mode of action of individual BCL-2 regulatory
factors in studies with intact cells. Fortunately, several groups,
including ours, have shown that basic aspects of the BCL-2-regu-
lated MOMP process can be reconstituted in vitro, using purified
recombinant proteins and compositionally-defined model mem-
branes. Here, we will summarize the information gathered in our
laboratory from studies using these simplified systems, concerning
how the function of core BCL-2 family proteins is modulated by
specific regulatory factors (proteins and lipids). Additionally,
insights on the mechanism of action of promising anti-cancer
agents targeting the BCL-2 system will be discussed.
IL 6.1–2
Various modes of cell death induced by DNA
damage
B. Zhivotovsky
Karolinska Institutet, Institute of Environmental Medicine,
Stockholm, SWEDEN
In dividing cells DNA damage caused by genotoxic insults results
in the activation of cell cycle checkpoints followed by DNA
repair. p53, being a ‘guardian of genome’ is activated by stress
and, depending on the severity of damage, it triggers either G1
or G2 arrest or cell death. In addition to several known p53 tar-
gets, such as Bax and PUMA, PIDD appears to be a crucial tar-
get gene that leads to either activation of NFjB-dependent cell
survival, or apoptosis. The apoptotic pathway includes caspase-2,
which is activated within the PIDDosome complex, and causes
cytochrome c release and caspase activation. Hence,
PIDDosome-mediated caspase-2 activation might be an impor-
tant link between DNA damage and the engagement of the
mitochondria-mediated apoptotic pathway. In addition to
PIDDosome, caspase-2 is able to use the CD95 DISC as an acti-
vation platform and the recruitment of caspase-8 to this complex
is required for efficient activation of both enzymes. We prove
that caspase-2 and caspase-8 act upstream of cytochrome c
release and that they contribute to cleavage of proapoptotic
BH3-only Bcl-2 family member Bid. In the experimental system
used, the DISC is aggregated through a distinct and p53-depen-
dent upregulation of CD95. Finally, we provide evidence for a
direct interaction between these two enzymes and show that
caspase-8 is able to mediate proteolytical cleavage of caspase-2.
The observed functional link between caspase-8 and -2 within
DISC complex might be a second mechanism for caspase-2 acti-
vation in response to DNA damage. Investigation of the contri-
bution of p53 and caspase-2 to apoptotic cell death and mitotic
catastrophe (MC) induced by DNA damage in carcinoma cells
revealed that both functional p53 and caspase-2 are required for
the apoptotic response, which was preceded by translocation of
caspase-2 to the cytoplasm. In the absence of functional p53,
DNA damage resulted in caspase-2-independent MC followed by
necrosis. In these cells apoptotic functions could be restored by
transient expression of wt-p53. Hence, in this experimental model
p53 appeared to act as a switch between apoptosis and MC
followed by necrosis-like lysis.
IL 6.1–3
Mitochondrial fission-fusion and apoptosis
S. Martin
Trinity College Dublin, Dept. of Genetics, Dublin, IRELAND
Bax and Bak promote apoptosis by perturbing the permeability
of the mitochondrial outer membrane and facilitating the release
of cytochrome c by a mechanism that is still poorly defined. Dur-
ing apoptosis, Bax and Bak also promote fragmentation of the
mitochondrial network, possibly by interfering with the mito-
chondrial fusion machinery. It has been proposed that Bax/
Bak-induced mitochondrial fission may be required for release of
cytochrome c from the mitochondrial intermembrane space.
However, we have found that Bcl-xL, as well as other members
of the apoptosis-inhibitory subset of the Bcl-2 family, can antag-
onize Bax and/or Bak-induced cytochrome c release but fail to
block mitochondrial fragmentation associated with activation of
these proteins. These data argue that Bax/Bak-induced fragmen-
tation of mitochondrial networks and cytochrome c release are
distinct and separable events. Our observations suggest that the
Bcl-2 family perform an ancillary function as regulators of
mitochondrial fission and fusion events, independent of their role
in apoptosis.
IL 6.1–4
Beyond fusion: multiple roles for
mitochondria-shaping proteins
L. Scorrano
Faculty of Medicine, University of Geneva, Cell Physiology and
Metabolism, Geneva, SWITZERLAND
Mitochondria are complex organelles whose internal structure
and cytosolic organization is controlled by a growing number of
‘mitochondria-shaping’ proteins. These include mitochondrial
proteins like Mitofusin (Mfn) 1 and 2, Optic Atrophy 1 (Opa1);
as well as cytosolic ones like the dynamin-related protein 1
(Drp1) and its receptor on the outer mitochondrial membrane
Fis1. These proteins influence not only the shape of mitochon-
dria, but also the function of the organelle and integrated cellular
signalling cascades, including apoptosis. We undertook a genetic
approach to elucidate function and regulation of these proteins.
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Our data indicate that Opa1 and Parl, an inner membrane rhom-
boid protease, regulate the cristae remodelling pathway of apop-
tosis. Similarly, excess fission promoted by Fis1 results in
alteration in the shape of the cristae, mitochondrial dysfunction
and ultimately death. Surprisingly, apoptosis depends on
adequate levels of Ca2+ in the endoplasmic reticulum (ER),
strengthening the interaction between these two organelles in
controlling signalling cascades like apoptosis. The role of mito-
chondria-shaping proteins in the cross-talk between mitochondria
and ER is further substantiated by the finding that Mitofusin 2
regulates the shape of the ER and more importantly, the physical
and functional connection between ER and mitochondria.
OP 6.1–1
Signaling pathways activated by
photodynamic inducers of apoptosis in cancer
cells
J. Kralova1, I. Moserova1, T. Briza2, P. Pouckova3 and V. Kral2
1Institute of Molecular Genetics, Molecular Virology, Prague 4,
CZECH REPUBLIC, 2Department of Analytical Chemistry,
Institute of Chemical Technology, Prague 6, CZECH REPUBLIC,
3First Faculty of Medicine Charles University in Prague,
Department of Biophysics, Prague 2, CZECH REPUBLIC
Oxidative stress, such as photodynamic therapy (PDT), can act
as an apoptosis inducer. In PDT, light-absorbing molecules
(photosensitizers), which are relatively innocuous in the absence
of light, upon illumination become activated and pass on their
energy to molecular oxygen, causing localized oxidative damage
leading to cell death. In the present study we investigated apop-
totic pathways activated by various ethylene glycol porphyrin
derivatives depending on their intracellular localization. Some
derivatives, although primarily localized in lysosomes, induced
mitochondria-driven apoptosis. The induction of apoptosis was
accompanied by immediate and sustained activation of p38 mito-
gen-activated protein kinase (MAPK), connected with formation
of reactive oxygen species. Moreover, inhibition of p38 MAPK
by specific inhibitors and by the p38a dominant-negative mutant
as well as deletion of the p38a gene (MEFs-KO) protected cells
from apoptosis, thus suggesting direct involvement of the p38
kinase pathway in the initiation of this process. The other
porphyrin derivatives were found to be localized in endoplasmic
reticulum (ER) and the impact of ER stress induced by photo-
dynamic treatment of cancer cells was investigated. In vitro study
has been supplemented by in vivo results demonstrating high
potential of these compounds in anticancer treatment.
Acknowledgements: This work was supported by grants of the
Ministry of Education of the Czech Republic (LC06077), Grant
Agency of the Czech Republic (203/09/1311) and Grant Agency
of the Academy of Sciences of the Czech Republic
(KAN200200651).
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6.2. Virus–Cell Interactions
IL 6.2–1
Intracellular trafficking of retroviral proteins
E. Hunter1, L. Pereira1, L. Stansell1, N. Tsurutani1, P. Spear-
man1, J. Vlach2, J. Lipov2, R. Hrabl2, T. Ruml3, P. Grznarova3
and M. Rumlova4
1Emory University School of Medicine, Pathology and Laboratory
Medicine, Atlanta, GA, USA, 2Institute of Chemical Technology,
Laboratory of NMR Spectroscopy, Prague, CZECH REPUBLIC,
3Department of Biochemistry and Microbiology and Center of
Applied Genomics, Institute of Chemical Technology, Prague,
CZECH REPUBLIC, 4Academy of Sciences of the Czech
Republic, Institute of Organic Chemistry and Biochemistry,
Prague, CZECH REPUBLIC
The mechanism by which retroviral Gag molecules are trans-
ported through the cytoplasm to the site of budding remains a
poorly understood process in retrovirus assembly. Previous stud-
ies have shown that for Mason–Pfizer Monkey Virus (M-PMV),
a betaretrovirus, immature capsids are assembled at the pericent-
riolar region of the cell and that trafficking to the budding site at
the plasma membrane is dependent on an active vesicular trans-
port system. Targeting of assembly to the pericentriolar region is
dependent on a short N-terminal 18 amino acid sequence, the
Cytoplasmic Targeting and Retention Signal, in Gag that binds
to the TcTex-1 light chain of the microtubule dynein motor. In
this way translating polysomes are concentrated in the centriolar
region of the cell. A single amino acid substitution, R55Y, in
Gag induces a major conformational change in the protein so
that the CTRS is sequestered and TcTex-1 binding does not
occur. This mutant now assembles immature capsids at the
plasma membrane (PM). In order to further identify the role of
cellular components in the transport of capsids from the
cytoplasmic site of assembly to the plasma membrane, we have
constructed a Gag–GFP fusion and have utilized live-cell imaging
to further investigate mutations within gag known to alter intra-
cellular transport of the precursor or immature capsids. The
results of these experiments show capsids being formed at
the pericentriolar site, as well as egress of these capsids from this
site toward the plasma membrane. Preliminary analyses of parti-
cle movement are consistent with a role for microtubules in this
process, although a switch to actin filaments appears to be neces-
sary to reach the PM. Budding of M-PMV from the cell requires
wrapping of the immature capsid with the PM. This process
involves the host ESCRT machinery and phosphoinositol-
triggered exposure of an N-terminal myristate from each Gag
molecule followed its insertion into the lipid bilayer. Mutations
that inhibit myristate exposure block budding. Thus, while
retroviruses usurp key trafficking pathways within their host to
efficiently target and assemble viral components, their study has
uncovered novel processes that previously were unrecognized.
IL 6.2–2
TRIM5 and innate immunity to HIV-1
J. Luban, T. Pertel, M. Neagu, S. Hausmann, M. Zufferey and
C. S. De Castillia
University of Geneva, Microbiology and Molecular Medicine,
Geneva, SWITZERLAND
TRIM5, a member of the tripartite motif protein family, is a host
restriction factor that mediates a capsid-specific block to retrovi-
ral infection. Given that TRIM5 is located within a cluster of
interferon-stimulated genes, we sought evidence for functional
links between TRIM5-mediated restriction and innate immunity
to HIV-1. We found that TRIM5 is induced by Type I interfer-
ons and PRR agonists in THP-1 cells and monocyte-derived
dendritic cells and macrophages. The induction kinetics indicated
that TRIM5 induction by PRR agonists is dependent on type I
interferon signaling. Indeed, disruption of the interferon alpha
receptor-ISGF3 axis ablated TRIM5 induction by PRR agonists.
Furthermore, knock-down of IRF3 abolished the induction of
TRIM5 by PRR agonists but not by Type 1 interferons. As
TRIM5 mRNA was induced by type I interferons and PRR
agonists, we reasoned that reducing the level of TRIM5 expres-
sion would rescue HIV-1 from the inhibitory effect of the Type I
interferon response. Indeed, silencing of TRIM5 attenuated the
inhibitory effect of Type I interferons and PRR agonists on
HIV-1 transduction, independent of capsid-specificity. These
experiments have been extended further to show that TRIM5 has
capsid-independent effects on signaling pathways that lead to the
antiviral state.
IL 6.2–3
HIV-1 assembly and its inhibition
H. G. Kra¨usslich1, V. Bartonova1, L. A. Carlson1, B. Mu¨ller1,
I. Morales1, K. Gru¨newald2 and J. Briggs3
1University of Heidelberg, Virology, Heidelberg, GERMANY,
2Max Planck Institut, Biochemistry, Martinsried, GERMANY,
3EMBL, Structural Biology, Heidelberg, GERMANY
HIV-1 assembly is directed by the viral Gag polyprotein which
assembles into an immature shell at the plasma membrane con-
comitant with initiation of the budding process. Completion of
budding and virus release also involves the cellular ESCRT
machinery. During or after budding, proteolytic cleavage of Gag
polyproteins by the viral protease leads to separation of individ-
ual subunits MA, CA, NC and p6 and two short spacer peptides.
This triggers disassembly of the immature Gag shell and assem-
bly of the mature cone-shaped capsid required for viral infectiv-
ity. We have analyzed the structure and mechanism of HIV-1
budding as well as the structures of immature, mature and partly
matured particles providing a revised model for HIV-1 assembly
and maturation. We have also developed in vitro assembly sys-
tems faithfully mimicking the structure of the immature and
mature shell and leading to higher resolution structural models.
Using purified CA protein, we have selected peptides that block
assembly in vitro and, if modified, in tissue culture, and have
analysed their mode of binding and mechanism of action. Based
on these results, inhibition of immature and mature assembly
may be considered a promising target for antiviral therapy
against HIV-1.
IL 6.2–4
ERVWE1/Syncytin-1 – an extreme example of
interaction between retroviruses and host cells
F. Mallet
Centre Hospitalier Lyon Sud, LCR HCL-bioMe´rieux - Cancer
Biomarkers Research Group, Pierre Be´nite ce´dex, FRANCE
Sequences of retroviral origin represent about 8% of the human
genome. There are at least 31 families of human endogenous ret-
roviruses (HERVs) which derived from independent infections of
the germ line by exogenous retroviruses during the evolution of
the human lineage. The infectious retrovirus founding the con-
temporary HERV-W family entered the genome of a Catarrhine
ancestor 25–40 million years ago. The spread of the HERV-W
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family into the genome essentially results from autonomous and
non-autonomous events of intracellular retrotransposition of
transcriptionally active copies. The HERV-W family contains a
unique locus, termed ERVWE1, which encodes an envelope
glycoprotein expressed in the placenta. This envelope, also
dubbed Syncytin, exhibits fusogenic properties in vitro and is
directly involved in primary trophoblast differentiation. In addi-
tion, the functional conservation of the ERVWE1 locus among
Hominoids strongly suggest that this retroviral locus has been
recruited to play a role in placental physiology. The identification
of env ERVWE1-specific traits suggests mechanisms underlying
the process of evolution from a retroviral genome toward a bona
fide cellular gene.
IL 6.2–5
The polyoma virus middle T-antigen acts as an
active growth factor receptor analogue
S. Dilworth1, N. Ichaso-Jimenez1, K. Shah1, H. Xu1 and
W. Gullick2
1Imperial College London, Investigative Medicine, London, UK,
2Univ of Kent at Canterbury, Biosciences, Canterbury, UK
Viruses frequently encode mitogenic proteins whose role is to
provide suitable conditions for replication of the viral genome.
One of these, the middle T-antigen (MT) of polyoma virus, is a
potent oncogene that can transform established cell lines to an
oncogenic phenotype. It achieves this by mimicking a growth fac-
tor receptor by binding signaling proteins, including PP2A, the
src-family, ShcA, PI3K and PLCc1. This activates the MAP
kinase and Akt pathways resulting in uncontrolled proliferation.
MT assembles this multi-protein complex on the inner face of cell
membranes. Reaching this location is mediated by two elements
in MT, the PP2A binding site and a 22 hydrophobic residue
region near the C-terminus. We show that in the absence of
PP2A binding, MT no longer reaches the plasma membrane, but
is instead concentrated on cytoplasmic membranes near to the
nucleus. Deletion of the hydrophobic region generates a MT
species that does not associate with membranes, binds only
PP2A, and fails to transform. Although specific sequence motifs
in the hydrophobic region do not seem to be required, some
mutants associate with membranes and all the binding
proteins but fail to transform. Epitope tags demonstrate that the
C-terminus of MT is exposed on the outside of the cell in trans-
forming mutants, but not in defective ones. This suggests that
MT must reach the external membrane of the cell to transform,
and that receptor mitogenic signalling might have similar
restrictions. The requirements for oncogenic signalling will be
discussed, together with the other constituents of MT complexes.
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6.3. Molecular Immunology
IL 6.3–1
Signaling amplification at the immunological
synapse
A. Viola and R. L. Contento
Laboratory of Adaptive Immunity, Department of Translational
Medicine, University of Milan, I.R.C.C.S. Istituto Clinico Humani-
tas, Rozzano, Milan, ITALY
The immunological synapse (IS) is a dynamic structure, formed
between a T cell and one or more antigen-presenting cells
(APCs), characterized by lipid and protein segregation, signaling
compartmentalization, and bidirectional information exchange
through soluble and membrane-bound transmitters. In addition,
the IS is the site where signals delivered by the T cell receptors,
adhesion molecules, co-stimulatory receptors are decoded and
integrated. This complex process is required to tune TCR signal-
ing and T cell activation thresholds, allowing T cells to interpret
the context of antigen presentation, recognize infectious stimuli
and finally decide between activation and tolerance. We study the
molecular mechanisms underlying the costimulatory strategies at
the IS. Our group has been proposed that CD28, the main costi-
mulatory molecule for naı¨ve T lymphocytes, amplifies TCR signal
by inducing membrane rafts rearrangement and recruitment into
the IS. We have shown that after physiological stimulation CD28
interacts with and recruits into the IS filamin-A, that organizes
TCR and CD28 signaling by controlling cytoskeletal remodelling.
We have described the T cell costimulatory properties of chemo-
kines released as soluble immuno-transmitters by APCs at the IS.
The T cell chemokine receptors CCR5 and CXCR4 are recruited
into the IS and enhance T cell proliferation and cytokine produc-
tion. Interestingly, whereas CXCR4 is constitutively expressed in
T cells, CCR5 expression is induced by antigenic or inflammatory
stimuli. We have demonstrated that CXCR4-CCR5 costimulation
depends on receptor heterodimers. We are analizing how LFA-1,
besides its classical role in promoting adhesion, prepares and
facilitates TCR signaling by controlling mitochondrial localiza-
tion. It has been reported that mitochondria accumulate under
the IS in response to TCR stimulation, to allow proper
TCR-induced calcium influx. We found that LFA-1 induces
localization of mitochondria at the IS. This process is antigen-
independent and is enhanced by the presence of chemokines in
the T cell environment. However, TCR triggering stabilizes mito-
chondria at the IS and it is important to sustain their recruitment
in time.
IL 6.3–2
Activation signals for naive and class-switched
memory B cells
J. Wienands
Georg-August-University, Cellular & Molecular Immunology,
Goettingen, GERMANY
Distinct immunoglobulin (Ig) isotypes can be expressed as inte-
gral part of the B cell antigen receptor (BCR) or become secreted
as soluble immune effectors upon terminal differentiation of acti-
vated B cells into plasma cells. Newly generated B cells harbor
an IgM-BCR. Following class switch recombination antigen-
experienced B cells express a BCR of the IgG, IgE or IgA class.
These B cells constitute the main reservoir from which memory B
cells become established. A hallmark of class-switched memory B
cells is their rapid activation and differentiation into antibody-
secreting plasma cells upon antigen recall even in the absence of
costimulation by T helper cells. In marked contrast, naı¨ve B cells
require BCR signals plus BCR-extrinsic costimulation. However,
all BCR classes utilize the canonical Ig-alpha/Ig-beta subunit for
signaling via the immunoreceptor tyrosine-based activation motif
(ITAM) in their cytoplasmic domains. The lecture will focus on
the molecular mechanisms of BCR signal initiation and down-
stream signal processing in a BCR class-specific manner. I will
describe the role of ITAM and non-ITAM phosphorylation
events and how the resulting phosphotyrosine residues in differ-
ent BCR subunits couple to the generation of the intracellular
second messengers as well as nuclear responses. Here I will high-
light the critical importance of enzymatically inert adaptor pro-
teins such as SLP-65, Grb2 or Dok-3. These scaffolding proteins
can exert positive and/or negative regulatory signaling functions
by controlling the multi-molecular assembly of BCR ‘signalo-
somes’ and their precise subcellular localization in the absence or
presence of antigen stimulation. This provides the necessary
signal plasticity that allows the B cell to properly respond to
antigen encounter in a developmental stage-specific manner.
IL 6.3–3
Fooling the antigen-presenting phagocyte:
molecular tricks and signaling of Bordetella
adenylate cyclase toxin
P. Sebo1, J. Kamanova1, L. Bumba1, I. Adkins1, R. Fiser2,
J. Masin1, M. Basler1, R. Osicka1 and I. Konopasek2
1Institute of Microbiology AS CR v.v.i., Cell and Molecular
Microbiology Division, Prague 4, CZECH REPUBLIC, 2Faculty
of Science Charles University, Genetics and Microbiology, Prague
2, CZECH REPUBLIC
Bordetella pertussis adenylate cyclase toxin (CyaA) binds the alp-
haMbeta2 integrin receptor CD11b/CD18 (Mac-1 or CR3) of
myeloid phagocytic cells and delivers into the cytosol of host
phagocytes its catalytic adenylate cyclase (AC) enzyme domain.
This binds intracellular calmodulin and subverts cellular signaling
by unregulated conversion of ATP to cAMP. Independently from
translocation of the AC domain into cells, the CyaA can also
permeabilize cell membranes by forming small cation-selective
pores. We have recently characterized the third activity of CyaA,
its capacity to promote influx of calcium ions into cells concomi-
tantly with translocation of the AC domain across cell mem-
brane, forming a new type of calcium entry path that is not
regulated by cAMP and is insensitive to specific inhibitors of
known calcium channels. An intriguing manifestation of CyaA
receptor binding and AC translocation-mediated Ca2+ entry into
cells consists in relocalization of the CD11b/CD18 receptor from
the bulk of the membrane into cholesterol and sphingolipid-rich
membrane regions, known as lipid rafts or lipid microdomains.
From microdomains the CyaA translocates the AC into cell cyto-
sol and produces cAMP that causes transient inactivation of the
small GTPase RhoA, thus provoking massive actin cytoskeleton
rearrangements and ruffling of the phagocyte membrane. Loss of
oxidative burst and block of macropinocytosis and complement
mediated phagocytosis follow, disabling bactericidal capacities of
phagocytes. I will discuss in the lecture our current understanding
of structure–function relationships and molecular mechanisms
underlying these subversive activities of CyaA.
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IL 6.3–4
Role of TC21 in homeostatic antigen receptor
signaling
B. Alarcon, P. Delgado, B. Cubelos, N. Martinez-Martin and
E. Calleja
Centro biologı´a molecular severo ochoA, Cell Biology and
Immunology, Madrid, SPAIN
Peripheral T and B cell pools remain remarkably constant in size
throughout life thanks to strict homeostatic mechanisms to pre-
vent antigen-independent growth, which could provoke the devel-
opment of lymphomas. The T and B cell antigen receptors (TCR
and BCR) transmit low-grade signals necessary for the survival
and maintenance of the mature cell populations. Another impor-
tant mediator of antigen receptor survival and homeostatic sig-
nals is the phosphoinositide 3-kinase (PI3K). Genetic studies in
mice show that PI3Ks, especially class IA PI3Ks, participate in
lymphocyte homeostasis. We show here that TC21, a small
GTPase, interacts constitutively with the TCR and BCR through
their immunoreceptor tyrosine-based activation motifs (ITAMs).
Expression of a dominant negative TC21 mutant in T cells pro-
vokes a rapid decline in cell viability. More importantly, TC21–/–
mice have fewer mature T and B cells, possibly as a result of defi-
cient homeostatic proliferation and impaired survival. B cell
defect in TC21–/– mice specially affects the marginal zone B cell
population and the germinal center response to antigen. We show
that TC21 is overexpressed in several lymphoid malignancies,
suggesting that deregulation of TC21 activity participates in
lymphomagenesis. Finally, we demonstrate that TC21 is neces-
sary to recruit the p110delta catalytic subunit of PI3K to the
TCR and BCR. Consequently, we propose TC21 directly links
antigen receptors to PI3K-mediated survival pathways.
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6.4. P53 New Functions, New Targets, New Controls
IL 6.4–1
Single nucleotide polymorphisms in the p53
pathway
A. Levine
Institute for Advanced Study, Biology, Princeton, NY, USA
The p53 protein and the signal transduction pathway controlled
by that protein responds to a wide variety of stress signals which
can disrupt the fidelity of DNA replication and cell division. To
prevent these errors or mutations the p53 pathway responds by
initiating a process of cell cycle arrest, senescence or apoptosis
which either permits repair of these errors or kills the clone of
cells that contain these mutations. Central to this pathway are a
series of proteins that respond to the stress signals and regulate
the levels and activity of the p53 pathway. We have identified a
number of single nucleotide polymorphisms (SNP) in those genes
that regulate p53 activity and functions and these SNPs can play
a role in the incidence of cancers in a population, the age of
onset of cancers and the response to therapy. Some of the haplo-
types containing these SNPs appear to be under positive evolu-
tionary selection pressures in some human populations. The
reason for this appears to be the role of p53 in the implantation
of embryos into the uterus and the impact of some of these SNPs
upon the fecundity of mice and humans. This process is mediated
by the p53 regulated gene, Leukemia Inhibitory Factor or LIF, a
cytokine that is essential for the implantation of embryos. SNPs
in the p53 gene, the MDM-4 gene and the LIF gene regulate the
efficiency of implantation of embryos in humans. It could well be
that the p53 protein is also involved in the surveillance of devel-
opmental abnormalities.
IL 6.4–2
Functions of mutant p53 in promoting
invasion
K. Vousden
The Beatson Institute for Cancer Researc, Glasgow, UK
In the majority of tumours normal function of p53 is abrogated
either by loss of the pathways that allow activation of wild type
p53 or by the expression of mutant forms of p53. Although these
cancer associated mutations in p53 result in loss of wild type
transcriptional activity, studies in mice and cells have shown con-
vincingly that expression of mutant p53 is not equivalent to loss
of p53, and strongly support a gain-of-function for mutant p53
in promoting metastasis and proliferation. As half of all human
cancers express a mutant form of p53, we have sought to eluci-
date the mechanisms by which mutant p53 enhances the metasta-
sis observed in vivo. We have found that expression of mutant
p53 in human cell lines lacking wild type p53 can promote their
ability to invade in an in vitro matrigel assay. In wound healing
assays, these mutant p53 cells show a pronounced loss of direc-
tionality in comparison to vector control cells that move persis-
tent into the wounded area. Loss of directionality and increased
invasion has previously been associated with increased integrin-
dependent signalling through the RHO-ROCK pathway. Interest-
ingly, mutant p53 expressing cells show a marked activation of
this pathway. Inhibition of alpha5/beta1 integrin-dependent
signalling or ROCK activity can clearly prevent the loss of direc-
tionality and promote invasion. This signalling is also dependent
on the EGF receptor, which can interact with alpha5/beta1 inte-
grin via RCP (rab coupling protein) and facilitate invasion.
Studies designed to examine whether this effect of mutant p53
results from the acquisition of novel transcriptional activities, or
modulation of the transcriptional functions of the p53-relatives
p63 or p73, are in progress. In summary, our results demonstrate
that mutations in p53 result in increased invasiveness of cells by
enhancing integrin/EGF receptor-dependent signalling towards
cofillin. These findings open the possibility that blocking alpha5/
beta1 integrin and/or the EGF receptor will have therapeutic
benefit in mutant p53 expressing cancers.
IL 6.4–3
Identification and characterization of p53-
associated ‘gene signatures’ involved in
cellular transformation
V. Rotter
Weizmann Institute of Science, Head of the Department of
Molecular Cell Biology, Rehovot, ISRAEL
As it is well accepted that malignant transformation is a step-
wise process, it is challenging to discover which of these steps
involve the p53 protein. To that end we have established several
in-vitro transformation models in which normal cells were trans-
formed into cancer cells by well-controlled genetic alterations. In
our experiments, we have immortalized various human primary
cells of lung and prostate origin and engineered into them sev-
eral defined cancer associated genetic alterations. These included
inactivation of the p53 tumor suppressors by several methods,
over-expression of mutant p53, over-expression of the Ras onco-
gene and various combinations of these modifications. As a
result we have obtained transformed cells that are capable of
developing into tumors in mice, suggesting that the in-vitro
developed system represents authentic model of cancer develop-
ment. To characterize the gene networks that are associated with
the defined malignant steps, we have used a genome-wide
approach, which permits the identification of gene signatures
that are associated with the individual steps of malignant trans-
formation. In general it seems that the clusters that we have
identified and analyzed using this in-vitro model agree with
specific steps of transformation and thus may serve as specific
hallmark signatures of tumorigenesis.
IL 6.4–4
Regulation of p53 tumor suppression
G. Lozano
University of Texas, M. D. Anderson Cancer Center, Houston,
TX, USA
Mdm2 and Mdm4 are critical inhibitors of the p53 tumor sup-
pressor. Loss of Mdm2 or Mdm4 in mice leads to embryo lethal
phenotypes that are p53-dependent. We have tested the hypo-
thesis that Mdm2 and Mdm4 haploinsufficiency also contributes
to differences in p53 activity and in tumor outcome. While
Mdm2 and Mdm4 heterozygous mice are normal, they show an
increased p53 response with regards to ionizing radiation and a
delay in tumor onset of B-cell lymphomas. Moreover, Mdm2
Mdm4 double heterozygous mice die shortly after birth due to
lack of hematopoiesis, and this phenotype is rescued by deletion
of a single p53 allele. Lastly, we have generated mice with a
single nucleotide polymorphism (SNP) in Mdm2 that mimics the
human MDM2 SNP that was recently identified. This SNP alters
Mdm2 levels, p53 activity, and a tumor phenotype. These data
emphasize the exquisite sensitivity of the p53 pathway to changes
in Mdm2 and Mdm4 gene dosage.
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IL 6.4–5
The p53 mRNA
R. Fahreus, M. Candeias, L. Malbert-Colas and K. Bourougaa
Hopital St Louis, Cible Therapeutic, Paris, FRANCE
Control of p53 expression takes place on a post transcriptional
level. Mdm2 plays a key role by controlling p53 rate of synthesis
and degradation. The capacity of Mdm2 to carry out its dual
function requires interactions between the N-termini of Mdm2
and p53 and between the p53 mRNA and the C-terminal RING
domain of Mdm2. The same RNA sequence that binds Mdm2
encodes the amino acids that interacts with Mdm2, suggesting
that the control of p53 synthesis and degradation has evolved in
parallel from the same genomic sequence. Single silent point
mutations identified in human cancers reduce the affinity for the
p53 mRNA to Mdm2 and suppresses p53 activity. This illustrates
how single silent nucleotide polymorphism can affect the encoded
protein. The p53 mRNA is translated from two sites of initiation
giving rise to full length p53 (p53FL) and p53/47 lacking the first
40 amino acids that includes the Mdm2 binding site and transac-
tivation domain (TA I). The physiological role of this isoform, or
any p53 isoform, has been obscure. Induction of stress to the
endoplasmic reticulum (ER) and triggering of the unfolded
protein response activates cap-independent expression of p53/47
and the induction of a specific set of gene products that give rise
to a defined cell biological outcome. The ratio of p53FL:p53/47
remains high even after ER stress and the interesting question of
how relatively small amounts of p53/47 can induce a dominant
phenotype in the presence of much larger amounts of the full
length protein will be discussed.
OP 6.4–1
A study of the stability of wild type and
mutant p53 complexes with different DNA
substrates
P. Sebest, H. Pivonkova, K. Nemcova and M. Fojta
Institute of Biophysics AS CR, Biophysical Chemistry and
Molecular Oncology, Brno, CZECH REPUBLIC
The tumor suppressor protein p53 is a transcription factor that
plays a critical role in cell cycle regulation and differentiation
and its function is closely related to maintaining genetic integrity
of the cells and to defense against malignant transformation (1).
Biological functions of p53 are closely connected with its ability
to interact with DNA. The importance of DNA binding for
tumor suppressor function of p53 is emphasized by the fact that
most of the mutations in the p53 gene are located in the protein
core DNA binding domain, which mediates sequence-specific
DNA binding. We studied interactions of wild type (wtp53) and
mutant p53 (mut p53) with different DNA substrates (super-
coiled, sc; or linear, lin DNA containing or lacking specific p53
target sequence – p53CON) upon exposure to increased salt con-
centrations using an immunoprecipitation assay on magnetic
beads. Complexes of wild type or mutant p53 with scDNA, cap-
tured at the beads via DO-1 antibody mapping to its N-terminus
(amino acid aa 21–25), were remarkably stable in increasing ionic
strenght (at least up to 400 mM KCl). On the contrary, com-
plexes of wtp53 with linDNA lacking p53CON were unstable at
‡150 mM KCl and those of linDNA containing p53CON at
‡200 mM KCl. Immunoprecipitation with Bp53-10.1 antibody,
binding to the p53 C-terminal DNA binding site (aa 375–379)
(2), resulted in a formation of salt-unstable complexes of mut
p53 with sc and linear DNA containing or lacking p53CON at
‡100 mM KCl. Using the same antibody, wtp53 complexes with
lin DNA lacking p53CON were destabilized at ‡150 mM KCl
while those with lin DNA containing p53CON at ‡190 mM KCl.
Acknowlegement: This work was supported by GA ASCR
(IAA500040701), GACR (204/07/P476) and MEYS CR
(LC06035).
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SYMPOSIUM 7: TRENDS IN BIOTECHNOLOGY
7.1. Nanosensors and Nanomachines
IL 7.1–1
Physiologically active nanofibrin
L. Medved and G. Tsurupa
University of Maryland School of Medicine, Center for Vascular
and Inflammatory Diseases, Baltimore, MD, USA
Fibrinogen, a soluble plasma protein, after conversion into fibrin
forms an insoluble fibrin polymer (clot), which prevents the loss of
blood upon vascular injury and contributes to subsequent fibrino-
lysis and wound healing through the interaction with various pro-
teins and cell types. Fibrinogen is inert in the circulation while
fibrin is highly reactive due to exposure of its numerous protein-
and receptor-binding sites; among them are several tPA- and plas-
minogen-binding sites located in fibrin(ogen) alphaC-, P-, and
coiled-coil-D domains. Binding of tPA and plasminogen to these
sites results in conversion of the latter into active fibrinolytic
enzyme plasmin and degradation of fibrin clot (fibrinolysis). To
study the role of the alphaC-domain in initiation of fibrinolysis, we
expressed alphaC-fragment corresponding to this domain in bacte-
rial system and refolded it into a compact structure by standard
procedures. However, because this fragment mimics the inactive
conformation of two alphaC-domains in fibrinogen, it failed to
bind tPA and plasminogen and stimulate activation of the latter in
solution. To mimic the active conformation of the alphaC-domains
in fibrin, where they form alphaC polymers, we identified condi-
tions in which the alphaC-fragment formed short oligomers (8–12
molecules); however, the oligomers were unstable. To increase
their stability, we expressed and refolded an extended version of
the alphaC-fragment that formed similar oligomers, and covalently
cross-linked such oligomers with factor XIIIa. The resulting prod-
uct, alphaC-nanofibrin, which was highly soluble and stable in
solution, exhibited functional properties of polymeric fibrin.
Namely, in ELISA and SPR experiments, alphaC-nanofibrin, in
contrast to the monomeric alphaC-fragment, bound both tPA and
plasminogen and in the chromogenic substrate assay drastically
increased the rate of activation of the latter into plasmin. Further,
it significantly facilitated integrin-dependent endothelial cell bind-
ing, spreading, and signaling. Thus, alphaC-nanofibrin represents
a nanoparticle that preserves some structural and physiological
properties of polymeric fibrin. It can be utilized for studying the
adhesive properties of a fibrin clot using single molecule manipula-
tion techniques. It may also be used as a component for a nanosen-
sor measuring plasmin(ogen) activity.
IL 7.1–2
Nanotechnology and protein arrays: recent
developments
D. J. Cahill
University College, Belfield, Dublin, IRELAND
IL 7.1–3
Machines made from DNA
A. Turberfield
University of Oxford, Department of Physics, Oxford, UK
DNA is a wonderful material for nanoscale construction: it is a
structural material whose self-assembly can be programmed
by making use of its information-carrying capability, and its
hybridization or hydrolysis can be used as to provide energy for
molecular devices. I shall describe our work on self-assembled
molecular machinery made from DNA, including active cages
and the construction of a free-running bipedal molecular motor.
References:
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JL A DNA-fuelled molecular machine made of DNA. Nature
2000; 406: 605–608.
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IL 7.1–4
Surface plasmon resonance biosensors
J. Homola
Department of Optical Sensors, Institute of Photonics and
Electronics, Prague, CZECH REPUBLIC
Optical affinity biosensors are devices that incorporate a biologi-
cal recognition element which specifically recognizes a particular
analyte and an optical transduction system which allows observa-
tion and quantification of the interaction between the analyte
and the biomolecular recognition element. In the last decade we
have witnessed development of numerous optical transduction
methods, including both label-based methods such as fluorescence
spectroscopy and label-free methods such as optical interferome-
try, spectroscopy of guided modes of optical waveguides, and
surface plasmon resonance. Label-free optical biosensors repre-
sent a unique technology that enables the direct observation of
molecular interaction in real-time and the rapid and sensitive
detection of a wide variety of chemical and biological species.
Optical biosensors based on surface plasmon resonance (SPR)
represent the most advanced and mature optical label-free bio-
sensor technology. This paper reviews the present state of the art
and recent advances in the development of SPR sensors (1–2)
and presents selected results of SPR sensor research at the Insti-
tute of Photonics and Electronics, Prague. The developments dis-
cussed in detail cover advances in SPR sensor instrumentation
(mobile SPR sensors for field use, SPR sensor platforms for
parallelized observation of biomolecular interactions) and appli-
cations for study of molecular interactions and detection of
chemical and biological analytes related to medical diagnostics
(hormones, antibodies), environmental monitoring (endocrine
disrupting compounds) and food safety (pathogens and toxins).
References:
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IL 7.1–5
Nano devices for next-generation DNA
sequencing techniques
A. W. Ansorge
Ecole Polytechnique Federal Lausanne, Lausanne,
SWITZERLAND
The availability of ultra-deep sequencing of the genomic DNA
will in the near future transform the biological and medical fields,
in the analysis of the causes of a disease, in the development of
new drugs, as well as in diagnostics sequencing. It may become a
promising tool in analysis of mental and developmental disorders
like schizophrenia and autism. It is anticipated that DNA
sequencing of whole genomes for clinical purposes using these
new technologies will likely occur in the next couple of decades.
At present it seems more acceptable to sequence and analyse
genomes of seniors who reached high age in a very good health.
The proposed Human Microbiome Project (also called Second
Human Genome Project), analyzing the collection of microbes in
and on the human body, will contribute to understanding human
health and disease. Genomics, Proteomics and Medical research
benefit from recent advances and novel techniques for high-
throughput analysis (e.g. DNA and Protein microarrays, quanti-
tative PCR, mass spectrometry, novel DNA sequencing
techniques, others). Devices with short DNA sequence readings
(25–50 bases) have already found many applications, as described
above. But for genomic sequencing, and for analysis of the ever
more important structural genetic variations in genomes (e.g.
copy number variations CNVs selected by the journal Science as
the most important scientific discovery of the year 2007, also
chromosomal translocations, inversions, large deletions, inser-
tions and duplications), it would be a great advantage if the
sequence reading length on the original single DNA molecule
could be increased, to several thousands bases and more, per
second. Ideally, the goal would be the sequence determination of
a whole chromosome from one single original DNA molecule.
Hopes for future in this direction may give novel developments
in several physics techniques (e.g. AFM, electron microscopy,
soft X-rays, various spectroscopic techniques, nano-pores and
nano-edges, to name some of them), with many improvements
needed and under intense development.
Reference:
Ansorge WJ. Next-generation DNA sequencing techniques. New
Biotechnol 2009; doi:10.1016/j.nbt.2008.12.009.
OP 7.1-1
Quick screening methods for quantification of
oligonuclotides and antibodies bound to gold
nanoparticles
F. Franko, M. Bambouskova´, L. Potuckova´ and P. Dra´ber
Institute of Molecular Genetics, Laboratory of Signal Transduc-
tion, Prague 4, CZECH REPUBLIC
Colloidal gold nanoparticles (GNPs) armed with oligonucleo-
tides, either alone or together with antibodies, are increasingly
used for sensitive detection of DNA or proteins. An important
step in optimizing the sensitivity and/or reproducibility of GNP-
based assays is the quantification of oligonucleotides bound to
the particles. To this end, several techniques, including real-time
PCR with fluorescent beacon probes, have been described. How-
ever, these techniques are either insensitive or require expensive
probes. Here we report on a SYTO9-based real-time PCR
method for quantification of oligonucleotides bound to GNPs. In
some experiments, rabbit polyclonal antibody specific for selected
antigen was bound to 30 nm GNPs (30GNPs), followed by bind-
ing of thiol-capped oligonucleotides. To detect gold-bound oligo-
nucleotides, the particles were pelleted and resuspended directly
in 1x PCR master mix containing SYTO9 fluorescent dye. Routi-
nely, 40 cycles of PCR were monitored using real-time Mastercy-
cler Realplex. No inhibitory effect of 30GNPs on SYTO9-based
real-time PCR was detected. An inverse relationship was found
between the amount of oligonucleotides bound to 30GNPs and
the Ct values obtained. Calibration curves were constructed using
free thiol-capped oligonucleotides. Membrane dot-blot procedure
was used for selection of appropriate antibodies. Briefly, antigen
was diluted in borate buffer and 10 ll drops were spotted on a
nitrocelulose membrane, followed by blocking in 1% bovine
serum albumin. 30GNPs covered by oligonucleotides and antibo-
dies were spotted on the membrane and allowed to absorbe for
5 min. After washing, the membrane was stained by a silver
enhancer kit. Gray spots refer to antigen-antibody interactions.
Rabbit antibodies bound to 30GNPs were detected with commer-
cial 5 nm GNPs armed with goat-anti rabbit IgG (GaR_5GNPs)
by electron microscopy. When properly prepared, 30GNPs with
bound rabbit antibodies were surrounded by GaR_5GNPs form-
ing rosette-like structures. The combined data indicate that
SYTO9-based real-time PCR offers a rapid, simple and inexpen-
sive method for mapping the surface coverage of oligonucleotides
bound to GNPs. In combination with detection of antibodies
bound to the same particles it makes it possible to monitor the
properties of nanogold conjugates. Such data are important in
standardization of bio-barcode amplifications and other assays
used for detection of proteins. Supported by KAN200520701.
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7.2 Photosynthesis and Solar Energy Conversion
IL 7.2–1
How nature solved its energy problem
J. Barber
Imperial College London, Division of Molecular Biosciences,
London, UK
An enzyme emerged about 2.5 billion years ago which would dra-
matically change the chemical composition of our planet and set
in motion an unprecedented explosion in biological activity. This
enzyme used solar energy to power the thermodynamically and
chemically demanding reaction of water splitting. In so doing it
provided biology with an unlimited supply of ‘hydrogen’ needed
to convert carbon dioxide into the organic molecules of life. In a
nutshell, when biology learnt to split water using sunlight it had
solved its energy problem allowing life to prosper and diversify
on an enormous scale as witnessed by the extent of the fossil fuel
reserves and the variety of living organisms which constitute
present day biomass. Therefore the energy we derive from the
burning of fossil fuels, biomass and other organic substances
(food) originates from solar energy. The questions are now, can
we continue to exploit the photosynthetic process through
increased use of biomass as an energy source and, more impor-
tantly, can we address the energy/CO2 problem by developing
new photochemical technologies which mimic the natural system?
After all there is no shortage of water for this reaction and the
energy content of sunlight falling on our planet well exceeds our
needs.
IL 7.2–2
How conformational switching in plant
light-harvesting complexes regulates
photosynthesis
R. van Grondelle
Department of Physics and Astronomy, Vrije Universiteit,
Amsterdam, THE NETHERLANDS
Regulation of photosynthetic light harvesting, which protects
plants from the damaging effects of excess light, occurs by the
rapid and reversible transformation of the photosystem II light-
harvesting complexes (LHCII) from a state of efficient light util-
isation to one in which absorbed excitation energy is dissipated
as heat. This transformation is known as non-photochemical
quenching (NPQ). Similar to many biological regulatory mecha-
nisms, NPQ arises by a change in protein conformation, which
turns LHCII into a quencher of chlorophyll excited states. Using
femtosecond spectroscopy on strongly quenched aggregates of
LHCII we were recently able to identify the quencher as lutein
L1 in the structure of LHCII. The speed of NPQ formation
in vivo suggests the involvement of only a subtle rearrangement
of the pigments of LHCII. However, whilst the spectroscopic dif-
ferences between the unquenched and quenched states of LHCII
have been analysed in detail, little is known about the dynamics
of the conformational change. We have analysed fluorescence
emission of single, purified LHCII complexes, using single-mole-
cule spectroscopy, a powerful experimental technique for study-
ing molecular properties that are otherwise obscured by ensemble
averaging. I will show that LHCII trimers have the inbuilt capac-
ity to spontaneously, rapidly and reversibly switch into two
different states: the first is a quenched state and the second state
is characterised by a red-shifted emission peak (see figure below).
Both states reflect properties of what is observed both in LHCII
aggregates and in some states of NPQ in vivo. The relative rate
of forward and backward switching therefore establishes whether
the population of complexes is, on average, unquenched or
quenched, red-shifted or not. Moreover, subtle manipulation of
the switching rates is sufficient to reproduce the various extents
of NPQ observed in plants under different physiological condi-
tions.
IL 7.2–3
Biological and biomimetic water photolysis
A. W. Rutherford
CEA, iBiTec-S, Gif-sur-Yvette, FRANCE
The water oxidising enzyme of photosynthesis is in large part
responsible for converting solar energy into the high energy
chemicals that sustain life on the planet. The excess energy stored
has accumulated as the fossil fuels. This solar-driven enzyme also
put the oxygen into the atmosphere and thus made the biosphere
aerobic with all the associated repercussions for the planet
(O2-based respiration, multicelluar life, UV screening by ozone
etc). It is also one of very few catalysts known that is able to
oxidise water at close to its thermodynamic optimum. As such it
is the focus of much attention with a view to producing
bio-inspired catalysts that have potential uses for more efficient
(and sustainable) energy conversion processes: such as (i) H2
production by electrolysis or by photolysis and (ii) in electricity
production in fuel cells. We have applied biophysical, biochemi-
cal and molecular biological methods to investigate the photo-
chemistry and molecular enzymology of this remarkable enzyme.
The active site is made up of four high valence Mn ions and a
calcium ion. In parallel to the biochemical and biophysical
studies, we (in association with the University of Paris at Orsay)
also design, synthesize and study chemical models that are aimed
at mimicking certain features of the water oxidising enzyme.
Mn-based catalysts linked to photochemical charge separating
systems have been constructed and characterised. Some of the
properties of these photo-catalysts will be reported.
Acknowlegement: Supported by EU network Solar H2.
IL 7.2–4
Combining biology with technology for the
sustainable production and use of fuels
T. A. Moore, A. L. Moore and D. Gust
Department of Chemistry and Biochemistry, Arizona State
University, Tempe, AZ, USA
Energy transduction is fundamental to biology; biological organ-
isms have evolved elegant machinery for energy capture and utili-
zation. Parallels between technological and biological energy
transduction suggest potentially fruitful research into biological,
hybrid and artificial systems for efficient energy conversion.
These parallels also set the stage for a major challenge facing
hybrid constructs: coupling electromotive force (emf) provided by
human technology to the phenomenal catalysts for the synthesis
of energy-rich fuels found in natural systems (1). Addressing this
challenge, several bio-inspired constructs for solar energy conver-
sion have been assembled. In one, a photobiofuel cell uses artifi-
cial reaction centers, visible light and two enzymes to reform
biological substrates such as ethanol into hydrogen (2). This
system interfaces redox chemistry with emf at two junctions, and
demonstrates two methods for coupling biological redox catalysts
with emf. In a second system, solar-driven water oxidation using
an IrO2 catalyst replaces the anodic organic substrates, and an
external boost of about 0.3 V allows the electrons to combine
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with protons, producing hydrogen at the cathode (3). Another
construct uses a bio-inspired molecular heterojunction-based
polymer material to assemble a photovoltaic device (4). The
control of energy flow in biological systems is crucial to their
stability. We have developed energy and electron transfer-based
models for incorporation of these features into artificial systems
(5,6). Conducting the high oxidation potential necessary for
water oxidation from sensitizer to catalyst presents challenges in
electronic coupling and thermodynamics to control the flow of
electrons. We have recently reported a bio-inspired system which
accomplishes this by mimicking the elegant redox relay found in
water-oxidizing photosynthesis (7).
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OP 7.2–1
Electrokinetic properties of pea thylakoid
membranes
V. Doltchinkova1, N. Traytcheva2, E. Ivanova3, J. Dimitrov4,
S. Lozanova5 and C. Roumenin5
1Sofia University ‘‘St. Kliment Ohridski’’ Faculty of Biology,
Biophysics and Radiobiology, Sofia, BULGARIA, 2Veeco
Instruments, Metrology Group, Goleta CA, USA, 3Roumen Tsanev
Institute of Molecular Biology, Bulgarian Academy of Sciences,
Gene Regulation, Sofia, BULGARIA, 4Stephan Angeloff Institute
of Microbiology, Bulgarian Academy of Sciences, Immunology,
Sofia, BULGARIA, 5Control and System Resaerch, Bulgarian
Academy of Sciences, Sensor Systems and Modeling, Sofia,
BULGARIA
The crucial role of the membrane structure in clarifying the
mechanism of static magnetic field (SMF) action on biological
structures was studied. The electrophoretic mobility of the thyla-
koid membranes as a model system was determined after exposi-
tion with SMF (2T) in dependence of iron content in culture
media as follows: an iron sufficient medium (‘Fe-sufficient’
variant), an iron-deficient medium (‘Fe-starved’ variant) and an
excess of iron supply medium (‘2 · Fe’ variant). We report the
generation of light-induced increase in surface electrical charge of
‘Fe-sufficient’ thylakoids due to a strong aggregation and
increase in lipid peroxidation of pea thylakoids after SMF
pre-treatment. SMF altered the membrane potential (a significant
increase in fast phase of LS) in ‘Fe-starved’ thylakoids upon
exposure at near saturated light intensity. This light treatment
induced a decrease in the production of thiobarbituric acid –
reactive substances, marker for lipid peroxidation in ‘Fe-starved’
and ‘2 · Fe’ SMF pre-exposed thylakoids. These results suggest
the decay in charge recombination during electro-transport reac-
tions. We have used atomic force microscopy (AFM) to scan the
surface topography of the thylakoid membrane under physiologi-
cal conditions as well as after lectin treatment. The AFM images
were acquired using a Multimode, Nanoscope V (Veeco Instru-
ments, Santa Barbara, CA, USA), employing an E scanner. The
probe was DNP-S (Veeco Probes) and was mounted on a fluid
cell for imaging in physiological conditions. The imaging was
performed in tapping mode at 0.5 Hz scanning rate and resolu-
tion of 131 072 pixels. Imaging three-dimensional thylakoids
without and in the presence of phytohemagglutinin (PHA-M)
molecules revealed a height reduction of the thylakoid volume.
There was a change in the topography of the scanned surface.
The thylakoid height changed from 246.626 nm in isotonic buffer
solution before lectin exposure to 202.449 nm after 0.1 ng/ml
PHA-M treatment. Consequently, a change in the curvature of
the membrane could be expected due to cross-link molecular
reorganizations in the plane of the membrane.
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7.3. Plants for the Future
IL 7.3–1
Improving plant cell walls for bio-energy
W. Boerjan
UGent-VIB Research, Plant Systems Biology, Gent, BELGIUM
Plant biomass is an interesting alternative source for energy.
Plant cell walls are composed of polysaccharides that can be con-
verted to glucose and further fermented to bio-ethanol. However,
the aromatic cell wall polymer lignin, which makes up about
20% of the cell wall, limits the access of cellulases to the cellulose
microfibrils. Therefore, lignin needs to be degraded prior to sac-
charification, a process which consumes large amounts of energy
and chemicals. The importance of lignin in biomass quality has
been the main driver for research in this field. By genetic engi-
neering, plants can be tailored that have an altered cell wall
structure enabling a more efficient conversion to bio-ethanol.
Research over the last decade has mainly focused on understand-
ing the lignin biosynthesis pathway. These studies have shown
that the lignin polymer, which is composed of various phenyl-
propanoids, is plastic in its composition and structure, and that
it readily incorporates products from incomplete monolignol bio-
synthesis. This allows engineering lignin structures that are more
easily degraded prior to saccharification. It now also becomes
clear that genetic modification of monolignol biosynthesis in the
cell wall has wide-ranging consequences on a number of meta-
bolic processes, such as starch metabolism and photosynthesis,
and that it affects the biosynthesis of the other cell wall macro-
molecules, such as hemicellulose. Molecular insight into these
pleiotropic effects is essential if we want to design cell walls for
end use applications.
IL 7.3–2
Functional analysis of genes related to
secondary metabolism in plants
H. Rischer1, A. Goossens2, D. Inze´2 and K. Oksman Caldentey3
1VTT Technical Research Centre of Finland, Plant Biotechnology,
Espoo, FINLAND, 2Flanders Interuniversity Institute for
Biotechnology, Department of Plant Systems Biology, Gent,
BELGIUM, 3VTT Technical Research Centre of Finland, Medical
Biotechnology, Espoo, FINLAND
Plant-derived secondary metabolites constitute an extremely
diverse resource for drugs currently available on the market and
for the discovery of active principles which are effective in new
indication areas. The classical plant-based pharmaceutical pro-
duction has been notoriously hampered by low yields, lack of
reproducibility and the high complexity of plant extracts. Utiliza-
tion of cell culture systems for biotechnological production offers
many benefits but requires optimization through genetic engineer-
ing to reach economic feasibility. We have applied a comprehen-
sive profiling approach based on functional genomics, which is
independent of prior sequence knowledge i.e. applicable to
medicinal plants, to monitor elicitor-induced changes in the tran-
script and metabolite profiles of cell and organ cultures. In a sin-
gle experiment the behaviour of hundreds of known and
unknown differentially expressed genes and metabolites can be
followed simultaneously. The integration of gene expression pro-
files and the metabolite accumulation profiles through correlation
network analysis allows the visualization of gene-to-metabolite
networks and the prioritization of candidate genes for further
characterization. Functional analysis is mainly achieved by
homologous or heterologous overexpression in Agrobacterium
induced hairy root systems and utilizing again metabolic profiling
tools such as LC-MS and NMR for monitoring the effects. Inte-
gration with metabolic profiling provides direct insight on which
genes are involved in biosynthetic pathways of relevant secondary
metabolites at the structural or regulatory level while at the same
time novel compounds through combinatorial biosynthesis may
be discovered. This strategy has so far been employed to several
medicinal plant species including Catharanthus and Hyoscyamus
and the tobacco model.
IL 7.3–3
The potential of genetically modified plants for
phytoremediation
N. Marmiroli
Dept. Environmental Sciences, University of Parma, Parma,
ITALY
Phytoremediation, nowadays called phytotechnology, is a green
and promising solution to problems of environmental contamina-
tion, since it entails the use of higher plants for uptake, seques-
tration, detoxification or volatilisation of inorganic and organic
pollutants from soils, water, sediments and possibly air. Immedi-
ately after discovering that plant physiological properties can be
exploited for remediation, scientists tried to improve these char-
acteristics: they started by exploring species and ecotypes found
in the natural environment, and then considered application of
breeding techniques. Development of breeding approaches led to
the search for markers and genes to be used in selection of useful
properties, and this has produced hundreds of papers and book
chapters on identification, cloning, characterisation, mapping of
genes which can be involved at some level in specifying the plant
properties useful in phytoremediation. Based on this knowledge,
the possibility of creating transgenic plants with increased capa-
bilities was taken into consideration. Even within the never end-
ing debate surrounding environmental release of GM plants, the
scientific community thinks in general that GM plants beneficial
for the environment will be considered more favourably by the
public opinion. After nearly 20 years of research, several exam-
ples of transgenic plants for application to phytoremediation
have been described, but none have reached commercial exis-
tence. Three main approaches have been developed: (i) transfor-
mation with genes from other organisms (mammals, bacteria,
etc.); (ii) transformation with genes from other plant species; (iii)
overexpression of genes from the same plant species. Results have
rarely been encouraging, and sometimes even contrary to expec-
tations. This review will illustrate the main examples with a
critical discussion of what we have learnt from them.
IL 7.3–4
New tools for the phytoremediation of
xenobiotics
R. Edwards, M. Brazier-Hicks and D. Dixon
Durham University, Biological and Biomedical Sciences, Durham,
UK
Plants have a surprising capacity to metabolize and detoxify
man-made chemicals entering the environment as pollutants and
crop protection agents. We have termed the biosystem which
recognizes, transports and biotransforms such xenobiotics the
‘xenome’ and using a combination of chemical biology and
molecular genetic approaches we are functionally characterizing
and engineering key xenome components for applications in crop
protection, phytoremediation and metabolic/industrial chemical
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biotransformations. In this presentation, the engineering of
xenome enzymes to metabolise (i) herbicides and (ii) pollutants
to improve plant performance in crop protection and remediation
will be presented. In the first example, we will demonstrate how
forced evolution approaches can be used to enhance the detoxifi-
cation of diphenyl ether herbicides by glutathione transferases. In
the second example, the molecular basis for the activity of a type
1 glucosyltransferase N-conjugating aniline pollutants has been
determined and a surprising observation made concerning the
role of this enzyme in controlling the metabolism and toxicity of
pollutants. Finally, the potential to modify the expression of
remediating enzymes and associated pathways using herbicide
safeners will be presented. This will include new insights into
how safeners function to accelerate the detoxification of
xenobiotics and the potential for using this ability to remediate
contaminants in the environment.
IL 7.3–5
Plant biochemistry as a source of new
anticancer drugs
M. Strnad
Institute of Experimental Botany ASCR & Palacky´ University,
Laboratory of Growth Regulators, Olomouc, CZECH REPUBLIC
In malignant cells, altered expression of cyclin-dependent kinases
(CDKs) and their modulators, including overexpression of cyclins
and loss of expression of CDK inhibitors, results in deregulated
CDK activity, providing a selective growth advantage. In
contrast to CDKs governing the transitions between cell cycle
phases, transcriptional CDKs, including cyclin H-CDK7, and
cyclin T-CDK9 (pTEFb), promote initiation and elongation of
nascent RNA transcripts by phosphorylating the carboxy-
terminal domain (CTD) of RNA polymerase II. Because of their
critical role in cell cycle progression and cellular transcription, as
well as the association of their activities with apoptotic pathways,
the CDKs comprise an attractive set of targets for novel anti-
cancer drug development. Our research focused on the primary
mechanism of action of plant hormones cytokinins (N6-substi-
tuted adenine derivatives) in cell division cycle has showed that
natural plant cytokinins are also rather non-specific inhibitors of
various protein kinases. Surprisingly, among aromatic cytokinin
derivatives, we have discovered a compound, 2-(2-hydroxyethyla-
mino)-6-benzylamino-9-methylpurine, named ‘olomoucine’ (OC),
which specifically inhibits some CDKs at micromolar concentra-
tion. One of the inhibited kinases, the p34cdc2/cyclin B kinase,
assumed to be a key mitotic factor, which is highly conserved
and strongly implicated in cell cycle transitions in all eukaryotic
cells. The total lack of the inhibitory effect of olomoucine on
major kinases, such as cAMP- and cGMP-dependent kinases,
protein kinase C, and others, suggests that OC might be a useful
tool for cell cycle regulation studies. The design and inhibitory
activity of OC was further improved by modifications at posi-
tions 2, 6, and 9, i.e., the positions that control binding to
CDK1. This led to discovery of novel specific CDK inhibitors
named roscovitine, olomoucine II and purvalanol A (Fig. 1),
which display an enhanced inhibitory activity toward CDK1, a
higher selectivity toward some CDKs, an increased antimitotic
activity at the G1/S and G2/M points of the cell cycle, and
stronger and more selective antitumour effects. The compounds
are also effective in vivo and one of them is already in clinical
trials in USA and Europe (roscovitine Seliciclib; Cyclacel Phar-
maceuticals Ltd, UK). Seliciclib is currently in Phase IIb clinical
trials as a single therapy in multiple myeloma as well as two
other B-cell hematological malignancies: B-cell chronic
lymphocytic leukemia and mantle cell lymphoma. An additional
Phase IIb clinical trial is in progress investigating the effects of
Seliciclib in patients with non-small cell lung cancer in combina-
tion with gemcitabine and cisplatin. Recently, we have developed
also first CDK9 inhibitors and discovered whole range of new
structural motifs for development of CDK inhibitors which are
derived from anticytokinin structures.
OP 7.3–1
Preparation of geneticaly modified plants with
enhanced metal tolerance and accumulation
J. Najmanova´1, N. Jitka2, K. Pavel1, M. Martina1, M. Martina2,
M. Tomas2 and M. Tomas1
1Institute of Chemical Technology Prague, Department of
Biochemistry and Microbiology, Prague 6, CZECH REPUBLIC,
2Institute of Organic Chemistry and Biochemistry CAS,
Department of Natural Products, Prague 6, CZECH REPUBLIC
A large number of sites worldwide are contaminated by heavy
metals as a result of human activities, leading to elevated risk for
health and the environment. Although phytoremediation may
offer a viable solution to this problem, the presence of heavy
metals may inhibit plant growth and the concentration of metals
could be limiting for the application of phytoremediation. There-
fore, one option is to genetically engineer fast-growing species to
improve their metal tolerance and metal-accumulating capacity.
The c-glutamylcysteine synthetase (c-ECS) and the glutathione
synthetase (GS) are key enzymes in glutathione (GSH) biosynthe-
sis. GSH is not only the direct precursor of phytochelatins (PCs),
but glutathion itself is also believed to play important roles in
the detoxification of many heavy metals. The aim of the present
study is to overexpress Saccharomyces cerevisiae gsh1 gene for
c-ECS and gsh2 gene for GS in Nicotiana tabacum, as a model
plant, and a species of technological use, Linum usitatissimum,
which is an annual plant species widely cultivated in temperate
climates, to obtain plants with enhanced Cd accumulation and
tolerance. Several vectors were designed for Agrobacterium medi-
ated transformation, pNOV1 and pNOV2 contain gsh1 gene and
gsh2 gene, pNOV12 contains both gsh1 and gsh2 genes. Each
gene was flanked by Rubisco small subunit light-inducible pro-
moter RbcS from Chrysanthemum sp. and at 3¢ end by RbcS
transcriptional terminator. Special vector was constructed for
promoter expression study harboring gus gene for b-glucuroni-
dase. Transient expression with tobacco leaves was carried out
applying this vector and proving promoter activity. A method
was designed for determination of glutathion and phytochelatins
using RP-HPLC. For this purpose aseptically grown flax was
stressed in 14 days’ period by different concentrations of CdCl2.
Analysis of leaves extracts indicated the presence of GSH, PC2,
3, 4 and 5.
Acknowledgement: This work is funded by grants MSMT
1M06030, MSM 6046137305 and Z 40550506.
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7.4. Biochemistry of Phytoceuticals in Plant and Mammalia
IL 7.4–1
How plant cells survive their own toxins-
controlled gene expression and dynamic
compartmentation in secondary metabolism
W. Roos, M. Heinze and M. Vogel
Institute of Pharmacy, Pharmaceutical Biology, Halle (Saale),
GERMANY
The secondary metabolism of plants provides an unlimited diver-
sity of bioactive molecules, including established and prospective
drugs. Secondary biosynthesis poses a burden to the producing
cell as it competes for energy sources and building blocks and
may generate cytotocic products. Thus, evolution of secondary
metabolites is not only driven by their advantagous functions
(pathogen defense, signaling etc.) but also selects for mechanisms
to minimize the risk of self-intoxication. As a result, biosynthesis
is embedded in programs of cell specialization and cellular ultra-
structure: (i) genes encoding biosynthetic enzymes are often silent
until activated by specific stressors, (ii) intermediates and prod-
ucts are compartmented via metabolons and membrane flow,
(iii) cytotoxic products remain under the control of detoxifying
enzymes. These principles are exemplified with the benzophenan-
thridine alkaloids, cytotoxic phytoalexins of the Papaveraceae. In
the model plant Eschscholzia californica, biosynthetic genes are
selectively activated via a novel signal path that operates beyond
the ubiquitous, jasmonate-dependent control of defense genes
and thus avoids hypersensitive cell death. Pathogen contact acti-
vates a G-protein controlled phospholipase A2 thus giving rise to
the signal intermediate lysophosphatidylcholine. This compound
modulates vacuolar H+/Na+ antiporters, and the resulting pH
shift in the cytoplasm activates gene transcription. The signal
path is blocked by accumulated alkaloids. The overproduced
benzophenanthridines are excreted to the cell wall but do not
escape the cellular control: above a threshold, they are
re-absorbed, reduced to less toxic dihydro-alkaloids, derivatized
and re-excreted. This recycling process is driven by the novel
enzyme sanguinarine reductase. Cloning and site-directed muta-
genesis of this enzyme points to a common progenitor within a
family of ubiquitios enzymes of plant steroid metabolism, thus
highlighting the evolution of a detoxifying mechanism.
IL 7.4–2
Targeting inflammatory pathways for
prevention and therapy of cancer
B. B. Aggarwal
Deparment of Experimental Therapeutics, University of Texas
M.D. Anderson Cancer Center, Cytokine Research Laboratory
Houston, TX, USA
Chronic infections, obesity, alcohol, tobacco, radiation, environ-
mental pollutants, and high-calorie diet have been recognized as
major risk factors for the most common types of cancer. All
these risk factors are linked to cancer through inflammation.
While acute inflammation that persists for short-term mediates
host defense against infections, chronic inflammation that lasts
for long-term can predispose the host to various chronic illnesses,
including cancer. Linkage between cancer and inflammation is
indicated by numerous lines of evidence; first, transcription
factors NF-KB and STAT3, two major pathways for inflamma-
tion, are activated by most cancer risk factors; second, an inflam-
matory condition precedes most cancers; third, NF-KB and
STAT3 are constitutively active in most cancers; fourth, hypoxia
and acidic conditions found in solid tumors activate NF-KB;
fifth, chemotherapeutic agents and gamma irradiation activate
NF-KB and lead to chemoresistance and radioresistance; sixth,
most gene products linked to inflammation, survival, prolifera-
tion, invasion, angiogenesis, and metastasis are regulated by
NF-KB and STAT3; seventh, suppression of NF-KB and STAT3
inhibits the proliferation and invasion of tumors; and eighth,
most chemopreventive agents mediate their effects through inhi-
bition of NF-KB and STAT3 activation pathways. Thus suppres-
sion of these proinflammatory pathways may provide
opportunities for both prevention and treatment of cancer.
IL 7.4–3
Transcriptional regulation of flavonoid
biosynthesis
C. Dubos, J. M. Routaboul, P. Bidzinski, I. Debeaujon,
E. Harscoit, M. Caboche and L. Lepiniec
INRA, Seed Biology, Versailles, FRANCE
Flavonoids (anthocyanins, flavonols and proanthocyanidins) are
secondary metabolites presenting valuable properties as antioxi-
dants and colorants for foods, and as human health promoting
factors (e.g. nutraceuticals, pharmaceuticals). Flavonoids play
important roles in the interactions of plants with their environ-
ment; however their role in plant development appears not to be
critical. Therefore, the modulation of flavonoids accumulation in
different plant tissues/organs is theoretically feasible by breeding
or molecular engineering as well as by using various growth con-
ditions. To date, many structural and regulatory genes of the
pathway have been discovered, but the identification of some
proteins involved in specific branches that are responsible for fla-
vonoid diversity are still to be characterized. In addition, the
complex regulatory mechanisms of the pathway by biotic, abiotic
or developmental factors remain largely unknown. We will pres-
ent how the use of the model plant Arabidopsis thaliana contrib-
utes to the elucidation of some molecular and genetic aspects of
flavonoid biosynthesis. The metabolic and regulatory mechanisms
involved will be presented and few examples of the possible use
of these results for crops improvement will be shown.
IL 7.4–4
Transformation of alkaloids in plant and
mammalian cells. Green–red biology
J. Ulrichova
Faculty of Medicine and Dentistry, Department of Medical
Chemistry and Biochemistry, Palacky University, Olomouc,
CZECH REPUBLIC
Alkaloids are nitrogen-containing secondary metabolites in living
organisms having a range of structure types, biosynthetic path-
ways and pharmacological activities. Plants containing quater-
nary benzo[c]phenanthridine alkaloids have long been used in
folk medicine and one of these is sanguinarine (SG). SG is
involved in the defense mechanism of the plants that produce it.
In the plant, the cell enzyme catalyzing its formation from dihy-
drosanguinarine (DHSG) is an oxidase. The enzyme catalyzing
its reverse conversion to the quaternary cation is sanguinarine
reductase. Sanguinarine-containing extracts are employed in a
number of phytopreparations for their anti-microbial and anti-
inflammatory effects. SG is also linked to toxic effects on humans
such as the formation of leukoplakia and the syndrome termed
epidemic dropsy. In mammalian cells, SG modulates a number of
Symposium Abstracts
FEBS Journal 276 (Suppl. 1) 5–84 (2009) ª 2009 The Authors Journal compilation ª 2009 Federation of European Biochemical Societies 69
molecular targets such as: Na+/K+-ATPase, NF-kappaB,
caspase-3, bcl-2 etc. In vitro, the effects of SG depend on the
presence of the iminium bond, DHSG is biologically inactive. We
studied the mechanism of SG and DHSG transformation in
mammalian cells: human hepatocytes, HepG2 cell line, porcine
enterocytes as well as their pharmacokinetic parameters. In rat,
after oral administration, SG is reduced in the GIT and/or liver
to dihydrosanguinarine and is eliminated from the organism after
24 hours. Reduction of the quaternary cation was the only pro-
ven detoxifying mechanism in rodents. In contrast to plants,
reaction is not reverse. Whether this is a reduction of the imini-
um bond by reduced nucleotides or reduction catalyzed enzymati-
cally, we have not yet established. We are looking for a reductase
close to the plant one. A pharmacokinetic study of DHSG
showed that DHSG undergoes enterohepatic cycling with a maxi-
mum plasma concentration in the first or second hour following
application with no oxidation of DHSG to the parent cation.
Elucidating the mechanism of reduction/oxidation of the iminium
bond in mammals is a key step in clarifying whether or not SG is
toxic for mammals.
Acknowledgement: This work was supported by grants
MSM6198959216 and GA CR 525/07/0971.
OP 7.4–1
Plant as a factory for breast cancer antigen
production
I. Petrunya, O. Frolova, T. Komarova, Y. Dorokhov
Lomonosov Moscow State University, Virology, Moscow, RUSSIA
The characterization of HER2/neu antigen recognized by
immune effector cells has opened the perspective of developing
therapeutic vaccines in the field of breast cancer. Plants as a
source of vaccines and mAb are currently one of the most attrac-
tive approaches of modern biotechnology providing the low-tech
cheap manufacturing process and animal pathogen-free product.
Here we report that N. benthamiana leaves agroinjected with
virus-based vectors may be used as a source for production
HER2/neu specific antigen on surface of TMV called as a hera-
sim. N. benthamiana leaves co-agroinjected with TMV- and PVX-
based vectors provided accumulation nanoparticles assembled
from origin of assembly containing TMV RNA and PVX-
encoded TMV coat protein or its C-terminal extension variants.
Agroinjection with PVX vectors provided in leaves accumulation
of expected CP with linker and HER2/neu peptides revealed in
Western tests. Immunization of mice with herasim elicited anti-
bodies, which specifically recognized purified herasim samples
and HER2/neu on the surface tumor SKBR-3 cells. It is worth
to emphasize that 585 peptide had negligible immunogenicity and
did not occur immunoprotective effect on mouse model whereas
anti-herasim mouse antiserum gave distinctive positive signal. We
suggest that TMV nanoparticles with exposed HER2/neu epitope
may be used for developing therapeutic vaccines.
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7.5. Biochemical Prospects for Better Food
IL 7.5–1
The main trends in biochemical research
helping to improve food and feed
J. Kas
Institute of Chemical Technology, Biochemistry and Microbiology,
Prague, CZECH REPUBLIC
Biochemical research played important role in elucidation of
essential nutritional factors and in this way helped practically to
eliminate deficiency diseases through food fortification and offer-
ing suitable food and feed products. It helps to understand the
metabolic fate of nutrients and the consequences for physiologi-
cal status and health of humans and animals. Its important role
we can find in completely new technologies developed in food
and feed production, tremendous improvements in food and feed
stability and shelf-life, initiation or even introduction of new
approaches. New biochemical techniques and procedures caused
revolution in monitoring of food quality and safety, as well as in
examination of food and feed origin and adulteration. All these
scopes outlined above are still in focus of food and feed biochem-
ists, however, there are a few more targets which can be consid-
ered as present main trends of biochemical research in this field.
This new generation of issues includes metabolomics, proteomics
and genetic engineering. Metabolomics (metabolic profiling) is
concerned with identification and quantification of metabolites
including small molecules. It offers us many aspects of ‘molecular
nutrition’: analysis of food components, assaying of food quality
and authenticity, monitoring of food consumption and physiol-
ogical monitoring during various diets. These studies will allow
examinating well various technological processes, modification of
crops, improvement of breeding and feeding livestock or prepara-
tion of processed food. Potential of metabolomics is still limited
by instrumentation and lack of databases. Proteomics deals with
proteins from natural sources and recombinant technologies and
monitor changes which occur in proteome (collection of all
proteins occurring e.g. in the tissue, cell, organelles or skeletal
muscle/meat). Proteome analysis is based on combination of
powerful instrumental techniques (mainly two-dimensional poly-
acrylamide gel electrophoresis (2D-PAGE) and mass spectro-
metry) with bioinformatics. Proteomics has been already
successfully applied in solving various topics in meat and cereal
sciences and food technology. Genetic engineering found already
application in commercialization of transgenic plants and geneti-
cally modified microorganisms used for preparation of various
food additives or enzymes.
IL 7.5–2
Increasing the health benefits of wheat
P. Shewry
Rothamsted Research, Plant Science, Harpenden, UK
The consumption of whole grain wheat products is known to
have significant health benefits, including reducing the risk of car-
diovascular disease and type 2 diabetes. The UE FP6 HEALTH
GRAIN programme is focused on understanding the basis for
these effects, and increasing the contents of the bioactive compo-
nents in wheat products. In order to facilitate the latter aim we
have carried out an extensive diversity screen, analysing a collec-
tion of 150 lines grown on the same site for a range of phyto-
chemicals (alkylresorcinols, phenolic acids, sterols, tocols, folates)
and dietary fibre components (b-glucans and arabinoxylans)
which are considered to have health benefits. The total concen-
trations of these components varied significantly, from 1.4-fold
for sterols to 3.6-fold for phenolic acids and 4.8-fold for soluble
arabinoxylans. Further studies of 26 lines grown on multiple
sites/years showed that a substantial proportion of the variation
is genetically determined, with additional effects of the environ-
ment. Whole genome mapping of the 150 wheat lines is allowing
the identification of chromosomal regions associated with high
levels of specific phytochemicals and should lead to the develop-
ment of molecular markers for use in plant breeding. Additional
variation in the composition of starch (including the proportion
of amylose which is resistance to digestion) and dietary fibre is
also being generated by mutagenesis and transgenesis. The pro-
gramme is therefore expected to lead to benefits to consumers as
well as improved understanding of the mechanism of action.
IL 7.5–3
Novel enzyme applications in food and feed
improvement
J. Tams, G. Lynglev, H. Hendriksen and S. Ernst
Novozymes, Food & Specialties, Bagsvaerd, DENMARK
The use of enzymes for food application are well established in
food industry, e.g. cheese making (chymosin), fructose used in
soft drinks (amylases/glucose isomerase) and bread fresh-keeping
(maltogen amylase). The trends in the food industry with respect
to (i) health and wellness, (ii) food safety and (iii) sustainability
increase the demands for new product development tools.
Enzymes are an obvious choice to fulfill these demands. Further-
more, enzymes can also improve the nutritious value of various
animal feed and enzymes is used today in poultry and livestock
feed. During the last couple of years Novozymes have launched
several new enzymes to the food and feed industry. Two exam-
ples are highlighted here. Acrylamide is a potential carcinogenic
compound formed in baked and fried starchy foods, such as
potato chips, breads and cookies (the Swedish National Food
Administration, April 2002). Acrylamide is formed from a
maillard reaction between asparagine and a reducing sugar.
Novozymes has launced an enzyme (2007) which deamidates
asparagine which is able to significant reduce the formation of
acrylamide in various foods. Partial hydrogenation of fat is an
old process to improve melting point properties of oils. However,
trans-fat is unhealthy and is being phased out in many countries.
Enzymatic interesterification is a healthy alternative to improve
melting point properties of oils.
IL 7.5–4
Positive and negative effects of polyphenol
oxidases in food processing
G. M. Smith and J. R. Whitaker
University of California Davis, Food Science, Davis, CA, USA
PPO is an enzyme that catalyzes the oxidation of o-diphenols to
o-quinones; most also catalyze oxygenation of monophenols to
o-diphenols. The o-quinones spontaneously condense to form
colored compounds. This color formation is generally perceived
as a quality defect, e.g. in bruised or cut fruits and vegetables,
grape musts and post-mortem crustaceans. In plants, PPO is
encoded in the nucleus but targeted to the chloroplast thylakoid
membrane. Yet even tissues that are deficient in chloroplasts,
such as grape berries, exhibit PPO activity. PPO contains two
active-site copper ions coordinated by four His side chains. It is
synthesized as an inactive precursor, and its activation appears to
involve proteolytic processing, and perhaps oxidation of a novel
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adduct formed between a Cys sulfur and a His side chain. Reduc-
ing agents such as ascorbate or sulfite, acidulants and heat
treatment are commonly used to inactivate the enzyme. Micro-
wave treatment, c-irradiation and pulsed electric field processing
also inactivate to varying extents. Chemical inhibitors of PPO
include chelating agents, sulfhydryl-containing reagents, aromatic
carboxlyates lacking (or with alkoxy-substituted) phenolic OH
groups, m-diphenols (e.g. 4-hexlresorcinol), and other oxygen-
substituted planar ring structures (e.g. kojic acid). Cyclodextrins
appear to inhibit PPO action by sequestering substrate. The reac-
tion can also be limited by the use of oxygen-barrier packaging
films. Color development is sometimes beneficial: endogenous
PPO is important in fermentation in black tea leaves, and
appears to be involved in betalin synthesis. Exogenous PPO has
been used to reduce astringency and bitterness in chocolate nibs
and reduce total phenolics in canola meal.
IL 7.5–5
Protection of food lipids by natural
antioxidants
M. N. Maillard and M. E. Cuvelier
AgroParisTech, UMR Inge´nierie Proce´de´s Aliments, Massy,
FRANCE
Lipid oxidation, and particularly poly-unsaturated fatty acids’
oxidation, is an unavoidable phenomenon which can alter the
sensorial and nutritional quality of food products and make them
less acceptable to consumers. Preventive actions, like limiting
contact with oxygen, metals or light, can limit these reactions,
but they are generally not sufficient and the recourse to antioxi-
dants is often necessary. Food antioxidants can either occur as
natural constituents of foods or be intentionally added or gener-
ated during processing. Their action mechanisms are multiple,
particularly depending on the oxidation pathways (i.e. autooxida-
tion, photooxidation or enzymatic oxidation). They can act as
chain-breaking antioxidants or as preventive ones by limiting the
action of oxidation factors (e.g. metal chelators, oxygen reducing
agents, singlet oxygen quenchers). In any case, they are not able
to avoid definitely food rancidity, but to delay the onset of oxi-
dation or slow the rate at which it proceeds. If efficient synthetic
antioxidants are available for the food market, strategies of
valorization of natural molecules are developing, due to the
world-wide trend to minimize the use of synthetic additives and
to take advantage of the biological interest of natural antioxi-
dants on human health. Three main strategies will be presented
and their efficiency on lipids stabilization, food quality improve-
ment and shelf-life extension will be evaluated. (i) The first one
consists to enrich edible oils with natural antioxidants (phenolic
compounds and tocopherols) by optimizing the traditional indus-
trial process in softer ways respecting the micro-constituents’
content of oil seeds (e.g. sunflower, rapeseed) and the environ-
ment, as proposed in the Optim’oils european project (FP 6).
(ii) The second one is the addition of antioxidants coming from
natural sources (during food processing), with the benefit of pos-
sible synergies between the antioxidants. (iii) The third one aims
to better value antioxidants naturally generated during thermal
food processing, i.e. Maillard reaction products, and to take
advantage of their possible interaction with phenolic anti-
oxidants.
OP 7.5–1
Nutrigenomics analysis revealed that the
methanol extract of Tamarindus indica
changes the expression of genes associated
with lipid metabolism
S. Mat-Junit, N. Razali and A. Abdul-Aziz
Department of Molecular Medicine, University of Malaya, Kuala
Lumpur, MALAYSIA
Various parts of Tamarindus indica L. (T. indica) or locally
known as Asam Jawa, have been used for decades as components
of foods and in traditional medicine. The T. indica pulp fruit
extract had been shown to decrease serum cholesterol and trigly-
cerides levels in an experimental model of hypercholesterolaemic
hamsters. However, the mechanisms for the lipid lowering action
of this plant have not been elucidated. An earlier studies per-
formed in our laboratory showed that apart from the fruit, the
methanol extracts of seed, stem and leave of T. indica also have
high antioxidant activities. A nutrigenomics analysis on the meth-
anol extract from T. indica fruit was recently performed in our
laboratory to investigate the changes in gene expression in liver
cell line, HepG2, in response to treatment with non-toxic dose of
methanol extract of T. indica fruits. Gene expression microarray
studies were performed on Affymetrix Human Genome 1.0 S.T
arrays. Data generated were pre-analysed using the NetAffx
Analysis Centre before further analysed using The Partek Ge-
nomics Suite software. Filtering criteria were set as a fold change
‡1.5. Two-way analysis of variance (ANOVA) was applied to
determine differentially expressed sets of genes from control and
treated HepG2 cells. The microarray data were validated using
reverse transcription-PCR (RT-PCR). Our microarray data gen-
erated from three biological replicates showed that 590 genes
were up-regulated whereas 656 were down regulated. Amongst
the down-regulated genes were those that are involved in choles-
terol synthesis and lipoprotein metabolism indicating the fruit’s
potential as hypolipidaemic and hypocholesterolaemic agents.
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7.6 Biofilms: Social Life of Microbes
IL 7.6–1
Biofilms and quorum sensing regulation
O. Tresse
INRA UMR1014 Secalim, Mica, Nantes, FRANCE
Bacteria are described as the smallest autonomous organism in
the environment. Based on the data available on complete
genomes, the bacterial genome size varies from 0.27 Mb (Bacillus
anthracis strain A2012) to 9.7 Mb (Rhodococcus sp. RHA1). This
genome material allows the binary fission process which is the
main way of reproduction of bacteria. This mode of growth lim-
its genetic variations to sporadic mutations. However, the genetic
potential of a bacterium is not limited to the genetic materials
inherited from its parents. Bacteria have evolved mainly by
exchanging genetic material from other bacteria via plasmids and
DNA recombinations. This ability confers a large potential to
bacteria to adapt to the environment. Moreover, bacterial cells
are able to communicate between themselves. This type of inter-
action offers facilities to coordinate some physiological processes
in bacteria such as the quorum sensing. The cell-to-cell communi-
cation exports the gene expression at the level of the bacterial
population rendering the bacterial world more complex. This
complexity is reinforced by the ability of bacterial cells to form a
well-structured cell cluster organization, namely biofilms. This
dynamic structure ensures a higher potential for bacteria to sur-
vive to environmental conditions by combining diverse phenotype
responses. Through the biofilm formation, bacteria developed
new strategies to adapt and to survive in the environment. Do
cells in biofilm communicate between themselves? How and what
for? Advances of cell-to-cell communication in bacterial biofilm
will be presented.
IL 7.6–2
Biofilms, flocculation and quorum sensing in
yeast: from molecular to social interactions
K. J. Verstrepen
CMPG and VIB K.U. Leuven, Genetics and Genomics/Systems
Biology, Leuven, BELGIUM
The budding yeast, Saccharomyces cerevisiae, has emerged as an
archetype of eukaryotic cell biology. Here we show that S. cerevi-
siae is also a fantastic model for the evolution of cooperative,
biofilm-like behavior by revisiting flocculation, a self-adherence
phenotype lacking in most laboratory strains. Most feral and
industrial yeasts, however, show various degrees of flocculation
behavior, ranging from weak to extremely strong. The strongest
form of flocculation, where thousands of individual yeast cells
clump together in compact ‘flocs’ of almost one centimeter in
diameter, is linked to expression of FLO1. FLO1 encodes a long,
rod-shaped lectin-like protein that protrudes from the cell wall
and binds mannose residues in the cell walls of adjacent cells.
FLO1 expression is under quorum-sensing control, ensuring that
FLO1 is not expressed until enough yeast cells are present to
form flocs. Flocculating cells enter an altered physiological state,
reminiscent of bacterial biofilms (including overexpression of
drug exporters, stress genes and repression of genes involved in
proliferation). Flocculation protects the FLO1-expressing cells
from multiple stresses, including antimicrobials and ethanol.
Furthermore, FLO1+ cells avoid exploitation by non-expressing
flo1 cells by self/non-self recognition: FLO1+ cells preferentially
stick to one another, regardless of genetic relatedness across the
rest of the genome. Flocculation, therefore, is driven by one of a
few known ‘green beard genes’, which direct cooperation towards
other carriers of the same gene. Moreover, due to the presence of
internal coding tandem repeats, FLO1 is highly variable among
strains both in expression and in sequence, suggesting that floccu-
lation in S. cerevisiae is a dynamic, rapidly-evolving social trait.
IL 7.6–3
Cyclic di-GMP as a second messenger linking
cell-cell signalling to biofilm formation in the
plant pathogen Xanthomonas campestris
M. Dow, Y. McCarthy, K. O’Donovan, A. O’Connell and
R. Ryan
BIOMERIT Research Centre, Department of Microbiology,
University College Cork, Cork, IRELAND
The full virulence of Xanthomonas campestris pv. campestris
(Xcc) to plants depends upon cell-cell signalling mediated by the
signal molecule DSF (for diffusible signal factor), which has been
characterised as cis-11-methyl dodecenoic acid. DSF-mediated
signalling regulates motility, biofilm formation and the synthesis
of particular virulence determinants including the extracellular
polysaccharide xanthan. The synthesis and perception of the
DSF signal involve products of the rpf gene cluster. DSF synthe-
sis is fully dependent on RpfF, whereas a two-component system
comprising the complex sensor histidine kinase RpfC and the
HD-GYP domain regulator RpfG is implicated in DSF percep-
tion. We have previously provided evidence that the HD-GYP
domain of RpfG is a cyclic di-GMP phosphodiesterase. Conso-
nant with these observations, we have shown recently that muta-
tion of rpfG or rpfF leads to an increase in the cellular levels of
cyclic di-GMP, whereas addition of DSF reduces cyclic di-GMP
levels to wild type in the rpfF mutant but not in the rpfG mutant.
Yeast two-hybrid analysis has indicated that the HD-GYP
domain of RpfG can interact with a subset of GGDEF domain
(cyclic di-GMP synthase) proteins. FRET analysis indicates that
these interactions also occur within Xcc. We speculate that DSF
signalling influences biofilm formation and dynamics through
divergent signal transduction pathways that involve RpfG. This
regulator may exert specific regulatory effects through protein–
protein interactions with particular GGDEF domain proteins as
well as having a broader regulatory influence by the impact on a
global pool of cyclic di-GMP.
IL 7.6–4
Biofilm formation of members of the genus
Burkholderia is dependent on cell-to-cell
communication
L. Eberl, K. Riedel, C. Aguilar and N. Schmid
Department of Microbiology, Unversity of Zurich, Zurich,
SWITZERLAND
Taxonomic studies of the past few years have shown that Burk-
holderia cepacia-like organisms comprise a very heterogenous
group of strains, collectively referred to as the B. cepacia complex
(Bcc). Strains of the Bcc are ubiquitously distributed in nature
and have been frequently isolated from water, the plant
rhizosphere, the hospital environment, and industrial settings.
B. cepacia complex strains have an enormous biotechnological
potential and have been used for bioremediation of recalcitrant
xenobiotics and biocontrol purposes. At the same time, however,
Bcc strains have emerged as opportunistic pathogens of humans,
particularly those with cystic fibrosis. An important factor that
contributes to the great versatility of these bacteria is their ability
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to form surface associated consortia, so-called biofilms, on vari-
ous surfaces. To investigate the factors required for surface colo-
nization random mini-Tn5 insertion mutants were generated and
analyzed both on the genetic and phenotypic level. The identified
genes fell into several classes: (i) genes encoding for surface pro-
teins, (ii) genes involved in the biogenesis and maintenance of an
integral outer membrane, (iii) genes encoding regulatory factors,
and (iv) genes involved in cell-to-cell communication (quorum
sensing, QS). To investigate the role of QS in biofilm formation
we mapped the QS regulon employing both transcriptomics and
proteomics. QS-regulated genes that link cell signaling with the
formation of surface-associated consortia, including genes encod-
ing a type I pilus, lectins and a large surface protein, are
currently analyzed in better detail.
OP 7.6–1
Galactomannan-based edible film: water
vapour barrier
R. A. Moreira1, E. C. M. Santos2, M. J. Sousa-Gallagher3
and A. C. Monteiro-Moreira1
1Universidade de Fortaleza – UNIFOR, Pharmacy, Fortaleza,
BRAZIL, 2Universidade Federal do Ceara´ – UFC, Bioquı´mica e
Biologia Molecular, Fortaleza, BRAZIL, 3University College
Cork, of Process and Chemical Engineering, Cork, IRELAND
Edible films and coating are of the highest interest since that
have the potential to improve food shelf live and quality at the
same time that protect them from deterioration by micro-organ-
ism and physical damages. The deterioration of packaged food-
stuffs largely depends on the transfers that may occur between
the packaged food internal environment and reduce water vapour
permeability, oxygen, lipid, and flavour migration between
components of the food products, and between food and the
surroundings. These films are usually prepared with mixed high
molecular weight compounds as proteins, lipids, and polysaccha-
rides. The polysaccharide – protein blends show excellent selec-
tive permeability to O2 and CO2. Galactomannan (GAL) edible
films plasticized by glycerol (GLY) water vapour permeability
(WVP) were investigated in several conditions. The WVP
increased significantly as the Gal and Gly concentration
increased, with a positive effect on WVP values of the film.
Combining the two variables the lowest level of WVP (83 g mm/
dm2 kPa) was found when the Gal and Gly concentrations were
0.4% and 1.0%, The model described the process adequately
(R2 = 0.92), showing good agreement between experimental and
predicted WVP, apparently due to the fact that plasticizing with
glycerol reduces polymeric packaging density. On the other hand,
the increased interactions between Gal molecules (hydrogen
bonding type) increased with Gal concentration, therefore
increasing the water vapour transmission rate. The effects of tem-
perature and humidity on WVP were quantified with a Pareto
analysis at 95% significant level, showing that in the range of
conditions studied, both temperature and humidity were the
influential variables. The effect of temperature (T) on WVP was
more pronounced than that of relative humidity (RH). The
interactive effects between T and RH were also significant, with
WVP, increasing with increasing T and RH.
Acknowledgement: Supported by: Capes, CNPq, FUNCAP,
a-VALNATURA, RENORBIO.
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SYMPOSIUM 8: FROM BIOCHEMISTRY TO MEDICINE
8.1. Molecular Mechanisms of Kidney Diseases
IL 8.1–1
Transcriptional networks in human glomerular
disease: markers of podocyte function and
failure
M. Kretzler
Nephrology/Internal Medicine Center for Computational Medicine
and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
Current glomerular disease classification is based on descriptive
classification of structural alterations. However, prognostic infor-
mation has been limited. An international multicenter study was
established and protocols developed to identify and validate
molecular diagnostic markers and outcome predictors. Human
renal biopsies have been obtained from 24 medical centers span-
ning four continents. More than 2500 biopsies have undergone
manual microdissection of nephron segments and are available
for gene expression analysis. Affymetrix HG-U133 based gene
expression profiles from nine different renal diseases [focal and
segmental glomerulosclerosis (FSGS), minimal change disease,
membranous nephropathy (MGN), diabetic nephropathy, lupus
nephritis (LN), IgA nephropathy, thin basement membrane dis-
ease, and controls] has allowed a network analysis approach to
define relatedness of major human diseases on a molecular level.
Transcriptional network analysis using automated promoter
modeling tools combined with natural language processing was
performed. Network analysis identified a shared transcriptome of
progressive renal disease. From this shared transcriptome ridge
regression analysis enabled glomerular filtration rate (GFR)
prediction with a marker panel of 40 mRNAs independent of
histopathology (r = 0.78, p < 0.001). This panel performed
equally well in a second series with three independent disease
cohorts (r = 0.69, p < 0.001) and allowed the classification of
chronic kidney disease (CKD) stage III–V versus stage I–II with
a sensitivity of 0.73 and specificity of 0.82. In an independent
cohort this mRNA marker panel was able to correctly predict
the CKD stage 36 months after renal biopsy (sensitivity 0.77,
specificity 0.75). Transcriptional network analysis of the shared
transcriptome observed in microdissected glomeruli of patients
with FSGS, MCD and membranous nephropathy identified
co-regulated gene sets and define shared promoter modules. This
strategies allow to define distinct and share regulatory cascades
in glomerular disease and can form the basis of a systems level
understanding of human glomerular disease processes.
IL 8.1–2
Hereditary proteinuria syndromes and
mechanisms of proteinuria
K. Tryggvason
Karolinska Institute, Department of Medical Biochemistry and
Biophysics, Stockholm, SWEDEN
Glomerular insults leading to end-stage renal disease (ESRD) are
an enormous clinical challenge and socio-economic burden. Over
two-thirds of kidney disease cases leading to ESRD initiate as
glomerular injuries. Recent identification of gene mutations in
some rare glomerular diseases have shown that defects in both
GBM proteins, as well as proteins associated with the slit dia-
phragm can lead to progressive glomerular diseases characterized
by malfunction of the glomerular filter. Thus, mutations in the
genes for a the GBM specific type IV collagen trimer, a3:a4:a5,
cause distorted GBM structure and hematuria (Alport syn-
drome)1, while mutations in the laminin beta-2 chain gene cause
proteinuria and nephrosis (Pierson syndrome)2. The discovery of
nephrin as the protein affected in congenital nephrotic syndrome
of the Finnish type, demonstrated a major role for the slit dia-
phragm in the glomerular filter3. The important role of the slit
diaphragm structure for podocyte foot process function and con-
tribution to the filter functions was substantiated by the discov-
ery of podocin that is mutated in steroid resistant nephrotic
syndrome4, as well as by the discovery of Neph15. Subsequent
reports describing mutations in the genes for a-actinin-46 and
TRPC6 cation channel7 emphasized the role of the foot processes
in maintaining a functional slit diaphragm. Despite the significant
progress made in glomerular research during the last decade, the
etiology of the bulk of the glomerulopathies, such as diabetic
nephropathy, minimal change disease, membranous nephropathy,
IgA nephropathy, lupus nephropathy remain to be clarified. This
lack of knowledge hampers the development of novel diagnostic
methods and identification of novel drug targets.
In order to get more insight into glomerular biology and
mechanisms of diseases, we have undertaken a global approach
to the vertebrate glomerulus to identify novel proteins important
for glomerular development and the filtration function. Analyses
of the glomerular transcriptome have yielded the existence of
over 300 previously uncharacterized proteins, as well as several
known ones that, in the kidney, are highly specific for glomerular
cells8,9. This systems biology approach has facilitated the
establishment of a protein interaction database10. Knockouts of
several of those genes in mice, as well as knockdowns in zebrafish
embryos have yielded genes that, when affected, cause abnormal
glomerular development and/or proteinuria (unpublished data).
Expression profiles of isolated glomeruli in various diseases lead-
ing to nephrosis have been elucidated and they show that despite
a similar primary manifestation as proteinuria, they can have dif-
ferent pathways11 (unpublished observations). It is likely that
many of the novel glomerular proteins are involved in the
mechanisms of human proteinuria and nephrotic syndromes.
References:
1. Barker DF, et al. Identification of mutations in the COL4A5
collagen gene in Alport syndrome. Science 1990; 248: 1224–1 227.
2. Zenker M, Pierson M, Jonveaux P, Reis A. Demonstration
of two novel LAMB2 mutations in the original Pierson syn-
drome family reported 42 years ago. Am J Med Genet 2005;
138: 73–74.
3. Kestila M, et al. Positionally cloned gene for a novel glomer-
ular protein–nephrin–Is mutated in congenital nephrotic
syndrome. Mol Cell 1998; 1: 575–582.
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NEPHRIN. Mol Cell Biol 2001; 21: 4829–4836.
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10. He L, et al. The glomerular transcriptome and a predicted
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IL 8.1–3
The slit diaphragm: a signaling platform to
regulate podocyte function. Symposion on the
role of podocytes in the glomerular injury
T. Benzing
Uniklinik Ko¨ln, Klinik IV fu¨r Innere Medizin, Ko¨ln, GERMANY
Diseases of the glomerular filter of the kidney are a leading cause
of end-stage renal failure. Recent studies have emphasized the
critical role of the slit diaphragm of podocytes for the size-selec-
tive filtration barrier of the kidney and revealed novel aspects of
the mechanisms leading to proteinuria, both in inherited and
acquired diseases. Several critical structural protein components
of the slit diaphragm have been identified. Recently, it has been
shown that slit diaphragm proteins are signaling proteins. This
talk will focus on what is known about the importance of the
podocyte for the function of the glomerular filter of the kidney.
It will provide a snapshot of our current understanding of the
signaling properties of slit diaphragm proteins and project a
framework for further studies necessary to delineate the function
and dynamics of the slit diaphragm protein complex and the
pathogenesis of nephrotic syndrome.
IL 8.1–4
Oxidative stress in glomerular injury
V. Tesar
Department of Nephrology, 1st Faculty of Medicine - Charles
University, Prague, CZECH REPUBLIC
Reactive oxygen species (ROS) play an important role in the
amplification of immune response, regulation of cell adhesion,
programmed cell death and different signaling cascades, including
MAPK, protein kinase C isoforms and transcription factors AP-1
and NFkappaB. In the kidney, ROS formation in glomerular
podocytes may result in the podocyte loss followed by the loss of
glomerular filtration rate. Renoprotective effect of angiotensin
and aldosterone blockers, statins, and possibly also thiaziolidined-
iones may be at least partly mediated by the decreased ROS
formation. In experimental nephrotic syndrome, puromycine
aminonucleoside-induced ROS formation cause podocyte DNA
damage resulting in the upregulation of cell cycle inhibitors lead-
ing to cell cycle arrest. In adriamycine nephropathy ROS-induced
podocyte loss may be attenuated by the specific expresson of the
antioxidant protein metallothionein in podocytes. In diabetic
nephropathy both hyperglycemia and advanced glycation
endproducts (AGEs) through its receptor (RAGE) induce podo-
cyte apoptosis via the activation of MAP kinases (p38) and
FOXO1 transcription factor and inhibit antiapoptotic pathways,
e.g. PI3K, Akt mediated activation of Bcl-2. Except from that
AGE-stimulated podocyte apoptosis is also mediated by the
increased production of ROS with subsequent activation of
TGFbeta regulated proteins as SMADs and Notch 1. AGE-
induced podocyte apoptosis may be attenuated by soluble RAGE.
AGEs may also induce cell cycle regulatory protein p27Kip1 with
resultant cell cycle arrest and podocyte hypertrophy and AGEs
also inhibit podocyte migration by downregulation of neuropilin-
1. Decreased migration of podocytes can facilitate the formation
of glomerular tuft adhesions to the Bowman’s capsule contribut-
ing to the focal segmental glomerulosclerosis.
IL 8.1–5
Podocytes and mesangial cells in diabetic
nephropathy
G. Wolf
Department of Internal Medicine III, University of Jena, Jena,
GERMANY
On a molecular level, metabolic pathways activated by hypergly-
cemia as well as glycated proteins (AGEs) and oxidative stress
are key players in the genesis of diabetic kidney disease. A vari-
ety of growth factors and cytokines are then induced through
complex signal transduction pathways. Transforming growth fac-
tor-beta 1 (TGF-b1) has emerged as an important downstream
mediator for the development of renal hypertrophy and the accu-
mulation of mesangial extracellular matrix components. Podo-
cyte-derived vascular endothelial growth factor (VEGF), a
permeability and angiogenic factor, has been recently implicated
in the development of diabetic proteinuria. Current research has
focused on the podocyte as a victim of pathophysiological events
associated with diabetic nephropathy and a target for the effects
of high glucose, glycated proteins, mechanical stretch, and pro-
teinuria itself. Decreased podocyte number and/or density, GBM
thickening with altered composition, and foot process effacement
are the principal features of diabetic podocytopathy. A reduction
in nephrin protein at the slit diaphragm leads to podocyte foot
process effacement with further proteinuria. Many of these events
are mediated by angiotensin II whose local concentration could
be stimulated by high glucose, mechanical stretch, and protein-
uria. Angiotensin II in turn stimulates podocyte-derived VEGF,
suppresses nephrin expression as well as induces TGF-b1 leading
ultimately to an increase in podocyte apoptosis and fostering the
development of glomerulosclerosis. Angiotensin II also enhances
synthesis of a3(IV) collagen contributing to the increased thick-
ness of the basement membrane in diabetic nephropathy. AGEs
are actively taken up by podocytes and induce cell cycle arrest
associated by hypertrophy. This effects is mediated by the cell
cycle inhibitor p27Kip1. Furthermore, AGEs suppress migration
of podocytes through down-regulation of neuropilin-1. AGE-
induced inhibition of podocyte migration via down-regulation of
neuropilin-1 likely contributes to the development of glomerulo-
sclerosis because a reduced migration of podocytes fosters adher-
ence of uncovered areas of the glomerular basement membrane
to Bowman’s capsule. Angiotensin II further enhance these
effects by inducing upregulation of RAGE, a receptor for AGEs
on podocytes. Interestingly, this effect is mediated by the AT2-
subtype of the angiotensin II and is not antagonized by sartanes.
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8.2. Proteases as Therapeutic Targets
IL 8.2–1
Dipeptidyl peptidase IV (DPP-IV) inhibition as a
treatment for type 2 diabetes
N. Thornberry
Department of Metabol Disorders, Merck Research Laboratories,
Rahway, NJ, USA
Defective insulin secretion is a hallmark of type 2 diabetes
(T2DM), and agents that increase the concentration of circulat-
ing insulin have proven beneficial in the treatment of diabetes.
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a new oral
approach to T2DM that lower glucose via stabilization of the
incretin hormone glucagon-like peptide-1 (GLP-1), which has
clearly established roles in insulin secretion and inhibition of
glucagon production. These agents have been shown to produce
clinically meaningful glucose control in a range of patients with
T2DM without the many of the liabilities that are associated
with other oral therapies, including weight gain, edema, GI intol-
erability, and hypoglycemia. Accordingly, DPP-4 inhibitors have
excellent potential for use in both monotherapy and combination
with established agents. Extensive structure-activity-relationship
(SAR) studies in many different laboratories have resulted in the
identification of a number of clinical candidates. The most
advanced of these have recently been approved for the treatment
of T2DM, representing the first new oral therapy for treatment
of this disease since the introduction of troglitazone in 1998.
IL 8.2–2
Comparative studies on retroviral proteases
J. Tozser
University of Debrecen, Medical and Health Science Center,
Biochemistry and Molecular Biology, Debrecen, HUNGARY
Exogenous retroviruses comprise a large family of enveloped
RNA viruses subclassified into seven genera and include at least
two retroviruses (HIV and HTLV) that cause diseases in humans.
In the last stage of their replication, the Gag and Gag-Pro-Pol
polyproteins of the virions are processed by the retroviral prote-
ase (PR) at a limited number sites, causing ‘maturation’. The PR
is a target of chemotherapy, and HIV-1 PR inhibitors are widely
used in the treatment of AIDS. The first PR structures were
determined 20 years ago, and currently this enzyme is the most
represented one in the protein structural databanks. The PR is a
homodimeric aspartic protease that recognizes at least seven
substrate residues. Even though the retroviral proteases are fairly
specific, they do not have consensus substrate sequences. Based
on detailed specificity studies and crystallographic determina-
tions, there appear to be a very strong sequence context depen-
dence of their specificity. Currently there are nine protease
inhibitors used in AIDS therapy, but due to the development of
resistance, new compounds are continuously tested. Important
features of the enzyme that may change as a consequence of
resistance mutations are the activity and folding capability, sub-
strate specificity, sensitivity to inhibitors and strength of dimeri-
sation. Comparative studies of retroviral proteases suggested a
relatively conserved specificity in spite of the great sequence
diversity, while HIV-1 PR clinical inhibitors typically only weakly
inhibited, if at all, the other enzymes. This apparent contradic-
tion might be due to the fact that the clinical inhibitors are typi-
cally rigid molecules, while substrates are more flexible, and
capable of adapting to altered substrate binding sites in different
proteases. The same phenomenon is observed in drug resistant
HIV-1 PR variants. Many of the mutations occurring in drug
resistance introduce amino acids that can be found at the equiva-
lent position in other retroviral PRs. Therefore, characterization
of the similarities and differences of the specificities of retroviral
proteases may help to design broad-spectrum inhibitors against
HIV-1 PR.
IL 8.2–3
Protease inhibitors for the treatment of
malaria
P. Rosenthal1, J. Legac1, P. S. Sijwali1, S. Subramanian1,
I. Kerr2, L. Brinen2, J. M. Coteron3, S. Ferrer3 and
P. J. Rosenthal1
1University of California San Francisco, Medicine, San Francisco,
CA, USA, 2University of California San Francisco, Cellular &
Molecular Pharmacology, San Francisco CA, USA,
3GlaxoSmithKline, Tres Cantos, SPAIN
Malaria remains one of the most important infectious diseases,
and new antimalarial drugs are needed. Among new targets for
chemotherapy are proteases. Proteases of all main catalytic clas-
ses play key roles in the biology of malaria parasites, including
mediation of exit from and entry into host cells and the hydroly-
sis of hemoglobin. Intraerythrocytic parasites degrade hemoglo-
bin in an acidic food vacuole to acquire amino acids and
maintain homeostasis. Among proteases involved in this process
are the cysteine proteases falcipain-2, falcipain-3, and dipeptidyl
aminopeptidase-1, four plasmepsin aspartic proteases, and the
metalloprotease falcilysin. Evidence supporting critical roles for
falcipains include inhibitor studies in which specific inhibitors
block hemoglobin hydrolysis and gene disruption studies in
which parasites with knockout of falcipain-2 had altered hemo-
globin hydrolysis and those with knockout of falcipain-3 were
not viable. We have determined the roles of unique domains of
falcipain-2, potentially identifying novel targets for chemo-
therapy. In addition, studies of active site-directed inhibitors have
identified small molecules with good drug properties and potent
inhibition of falcipain-2 and falcipain-3. Optimal compounds also
block development of cultured malaria parasites at low nanomo-
lar concentrations and, using a new animal model, cure mice
infected with P. falciparum. To facilitate drug discovery, struc-
tures of falcipain-2 complexed with protein (cystatin, chagasin)
and small molecule (E-64) inhibitors, and falcipain-3 complexed
with leupeptin have been solved. Improved understanding of the
inhibition and structural features of falcipains should facilitate
drug discovery directed toward the identification of specific
falcipain inhibitors as new antimalarial drugs.
IL 8.2–4
Glutaminyl cyclase, a degenerated
aminopeptidase – a new causative target in
Alzheimer’s disease therapy
H. U. Demuth, H. Cynis, H. Ulrich and S. Stephan
Probiodrug AG, Enzymology, Halle (Saale), GERMANY
Post mortem analysis of brain samples from demented and non-
demented persons with pathological aging revealed that the
plaque load is almost equal in both groups. Moreover, neither
BACE-1, Neprylisin, oxidative state nor Ab(1–42) seem to corre-
late with the neuropsychiatric symptoms of the Alzheimer’s
patient group. Correspondingly, mice expressing human wildtype
APP do not show deposits or plaque-like histopathology, but
develop memory impairment and synaptic loss similar to mutant
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APP-expressing mice, which primarily deposit Ab(1–40/42). Simi-
lar, newly designed animal models display N-terminal Ab hetero-
geneity as found in human sporadic AD and memory deficits
long before extracellular deposits are detectable. These results
support the notion that intraneuronal toxicity of Ab-peptides ini-
tiates neurodegeneration. In search of Ab-peptides most prone to
form toxic oligomers, we found that Ab-peptides possessing a
N-terminal pyroglutamic acid (pGlu) aggregate two orders of
magnitude faster as compared to Ab(1–42). In addition, pGlu-
peptides are potent seeds of Ab(1–42) oligomerization. Our
in vitro and in vivo studies provide strong evidence for a slow
Glutaminyl cyclase (QC, EC 2.3.2.5) catalyzed cyclization of
N-terminal glutamic acid, substantiating a crucial role for genera-
tion of pGlu-Ab peptides. Characterization of QC catalysis
cyclizing both glutaminyl and glutamyl residues revealed similar
catalytic proficiency of QCs for the different substrates. Conse-
quently, the formation of pGlu-Ab can be suppressed by QC
inhibitors in vitro and in vivo. This supports a catalyzed forma-
tion of pGlu-modified amyloid peptides in neurodegeneration.
Our efforts have led to new, Alzheimer mouse models and initi-
ated the discovery of potent and selective compounds as new
drugs (Schilling et al., Nat Med 2008; 14: 1106–1111).
IL 8.2–5
The structural basis of serpin function and
dysfunction
J. A. Huntington
University of Cambridge, Cambridge Institute for Medical
Research, Cambridge, UK
Serpins must undergo rapid conformational change in order to
inhibit proteases. The energy stored in the metastable native state
of the serpin is used to trap the protease in an inactive state. The
complexity inherent in this mechanism provides opportunity for
regulatory control, but also renders serpins susceptible to dys-
function. Intracellular polymerization of serpins underlies a
diverse set of loss-of-function and gain-of-function disorders,
including neurodegeneration, thrombosis, emphysema, cirrhosis
and angioedema. Previous work has established that polymeriza-
tion proceeds via a folding intermediate (denoted M*) and
involves the expansion of the main b-sheet A from five to six
strands. We recently solved the crystal structure of a self-termi-
nating antithrombin dimer that revealed an unexpected 51-resi-
due domain swap, including the intermolecular incorporation of
both strands 4 and 5 into b-sheet A. This mechanism provides
satisfying explanations to several important features of serpin
polymers, including: why partial unfolding is required for poly-
merization in vitro; how polymers propagate; why polymers are
hyperstable and yet highly susceptible to proteolysis; and how
polymers form larger aggregates. We conducted several biochemi-
cal studies that support the general nature of this mechanism,
and demonstrate that the previous model of partial strand 4A
incorporation is incorrect. It is now possible to envision rational
drug design strategies that target the propagation of serpin poly-
mers, their lateral association, or the M* state itself.
OP 8.2–1
Design, structure and activity of potent HIV
protease inhibitors based on inorganic
polyhedral metallacarboranes
J. Pokorna1, J. Brynda1, M. Kozisek1, P. Cigler1, M. Lepsik1,
J. Plesek2, B. Gru¨ner2, H. Oberwinkler3, H. G. Kra¨usslich3,
V. Kral4, J. Konvalinka1 and P. Rezacova1
1Institute of Organic Chemistry and Biochemistry AS CR v.v.i.,
Biochemistry, Prague, CZECH REPUBLIC, 2Institute of
Inorganic Chemistry AS CR, Synthesis of boron compounds, Rez,
CZECH REPUBLIC, 3Department of Virology, University of
Heidelberg Germany, Heidelberg, GERMANY, 4Department of
Analytical Chemistry, Institute of Chemical Technology CR,
Prague, CZECH REPUBLIC
We recently discovered and characterized a new class of potent
HIV protease (HIV PR) inhibitors, substituted metallacarboranes
(Cigler et al., 2005). The crystal structure revealed a unique bind-
ing mode: two inhibitor molecules occupied hydrophobic pockets
in the flap-proximal region of the S3 and S3’ subsites of the
enzyme active site. In a structure-guided drug design effort, we
connected the two parent clusters with a linker and obtained set
of compounds based on hydrogen imino bis-8,8-[5-(3-oxa-
pentoxyl)-3-cobalt bis(1,2-dicarbollide)]di-ate. We explored inhi-
bition properties of these compounds with various substitutions,
determined the HIV PR-inhibitor crystal structure and computa-
tionally explored the conformational space of the linker. Our
results prove the capacity of linker-substituted dual-cage cobalt
bis(dicarbollides) as lead compounds for design of more potent
inhibitors of HIV PR.
Reference:
1. Cigler et al., Proc Natl Acad Sci U S A 2005; 102: 15394–
15399.
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8.3 Biochemistry of Diabetic Complications
IL 8.3–1
Hyperglycemia, oxidative stress and diabetic
complications: an overview
A. Ceriello
Warwick University, Coventry, UK
Oxidative stress appears when an imbalance between free radical
production and antioxidant defences is generated. This condition
is largely present in diabetes, and hyperglycemia plays a major
role. Assessment of oxidative stress in diabetic patients, both type
1 and type 2, evidenced the correlation between the pathology
and oxidative stress markers. Different studies evidenced an
increased production of reactive oxygen species, especially in
those with poor glycaemic control. Both levels of oxidative stress
markers and antioxidant status is compromised with a concomi-
tant high glucose inhibited expression of antioxidant enzymes.
Recent study led to asses oxidative stress in children and adoles-
cents with type 1 diabetes show that diabetic patients had greater
oxidative damage to lipids, proteins and DNA. All the oxidative
stress markers were significantly raised at onset, decreased during
the first 1.5 years of evolution, due to the started insulin therapy,
and rose progressively thereafter. In type 2 diabetic patients,
endothelial dysfunction, assessed by asymmetric dimethylarginine
(ADMA) plasma levels, and oxidative stress levels, assessed by
urinary 8-iso-prostaglandin (PG)F(2alpha) levels, were enhanced,
while a soluble form of AGE receptor (sRAGE), whose interac-
tion with AGE is able to moderate AGE contribution to vascular
complications, is diminished. In recent years attention is growing
around effects of acute glucose fluctuations with the high post-
prandial related glucose levels showing a more specific triggering
effect on oxidative stress than chronic sustained hyperglycaemia.
Postprandial hyperglycaemia seems to have a direct toxic effect
on the vascular endothelium with a central role in cardiovascular
disease development in diabetic patients.
IL 8.3–2
Drug-induced changes in biochemical
indicators of diabetic vascular disease
J. Skrha
3rd Department of Internal Medicine, Charles University 1st
Faculty of Medicine, Praha 2, CZECH REPUBLIC
Oxidative stress plays major role in pathogenesis of diabetic
vascular disease. Reactive oxygen species participate on the endo-
thelial dysfunction development, the first step preceeding
morphological impairment of vessel wall. Activated endothelial
cell overexpresses the cell-adhesion molecule receptors and other
compounds. It is therefore important whether drugs may protect
endothelium against undemanded reactions. Specific effects on
oxidative stress have been reported by several drugs. Metformin
brings controversies with either increased or decreased oxidative
stress. We found oxidative stress induction together with activa-
tion of antioxidant system following 3 months of metformin
administration. Higher plasma malondialdehyde (MDA) concen-
tration (p < 0.001) and erythrocyte superoxide dismutase (SOD)
activity (p < 0.01) were associated with decreased cell adhesion
molecules (p < 0.001) and fibrinolysis. Simvastatin activates vas-
cular wall as measured by vonWillebrand factor (p < 0.05) and
cell adhesion molecules (p < 0.01) but also it activates antioxi-
dant system. On contrary, fenofibrate decreases plasma MDA
concentration (p < 0.001) without significant changes in anti-
oxidant system. Protective effects of hypolipidemic drugs on
vascular endothelium were therefore reported. Thiazolidinedions
(TZD) reduce oxidative and nitrative stress and increase nitric
oxide bioavailability together with PKC pathway correction.
Improved vascular function has been observed following TZD
administration. Finally, angiotensin converting enzyme inhibitors
(ACEI) or receptor blockers (AT1) reduce oxidative stress and
improve NO bioavailability as well as they decreased intima-
media thickness. In conclusion, several drugs have pleiotropic
effects and they may reduce oxidative or nitrative stress in dia-
betes and thus improve vascular function. Such drugs have anti-
atherogenic properties and their administration may protect
vascular wall against chronic impairment.
IL 8.3–3
Transient high glucose causes persistent
epigenetic changes and altered gene
expression during subsequent normoglycemia
M. Brownlee
Albert Einstein College of Medicine, New York, NY, USA
The current goal of diabetes therapy is to reduce time-averaged
mean levels of glycemia, measured as HbA1c, to prevent diabetic
complications. However, HbA1c only explains < 25% of the
variation in risk of developing complications. Because HbA1c
does not correlate with glycemic variability when adjusted for
mean blood glucose, we hypothesized that transient spikes of
hyperglycemia may be an HbA1c – independent risk factor for
diabetic complications. We show that transient hyperglycemia
induces long-lasting activating epigenetic changes in the promoter
of the nuclear factor jB (NF-jB) subunit p65 in aortic endothe-
lial cells both in vitro and in nondiabetic mice, which cause
increased p65 gene expression. Both the epigenetic changes and
the gene expression changes persist for at least 6 d of subsequent
normal glycemia, as do NF-jB – induced increases in proinflam-
matory gene expression, including monocyte chemoattractant
protein 1 and vascular cell adhesion molecule 1. Hyperglycemia-
induced epigenetic changes and increased p65 expression are pre-
vented by reducing mitochondrial superoxide production or
superoxide-induced a-oxoaldehydes. These results highlight the
dramatic and long-lasting effects that short-term hyperglycemic
spikes can have on vascular cells and suggest that transient spikes
of hyperglycemia may be an HbA1c – independent risk factor for
diabetic complications.
IL 8.3–4
Involvement of transcription factor nrf2 and
antioxidant response element linked gene
expression in countering oxidative stress in
diabetes
P. Thornalley, M. Xue and N. Rabbani
University of Warwick, Warwick Medical School, Coventry, UK
Transcription factor NF-E2-related factor-2 (nrf2) regulates gene
expression through the antioxidant response element (ARE)
promoter signaling system. Nrf2 regulates the transcription of a
battery of protective and metabolic enzymes. Activation of the
nrf2 system may enhance protection against damage to proteins
by oxidation and glycation, enhance proteasomal removal of
damaged proteins, down regulate lipogenic enzyme expression to
correct dyslipidaemia and counter metabolic dysfunction by
increasing pentosephosphate pathway activity. This may poten-
tially reverse activation of multiple pathways of biochemical dys-
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function during hyperglycaemia and associated diabetes linked to
the development of vascular complications. In initial investiga-
tions, we assessed if activation of nrf2 by the dietary bioactive
compound, sulforaphane (SFN) prevented metabolic dysfunction
induced by hyperglycaemia in human microvascular endothelial
cells in vitro. Activation of nrf2 by SFN induced nuclear translo-
cation of nrf2 and increased ARE-linked gene expression. For
example, 3–5-fold increased expression of transketolase and
glutathione reductase. Hyperglycaemia increased the formation
of reactive oxygen species (ROS) – an effect linked to mitochon-
drial dysfunction and prevented by SFN. ROS formation was
increased further by knockdown of nrf2 and transketolase expres-
sion. This also abolished the counteracting effect of SFN, sug-
gesting mediation by nrf2 and related increase of transketolase
expression. SFN also prevented hyperglycemia-induced activation
of the hexosamine and protein kinase C pathways, and prevented
increased cellular accumulation and excretion of the glycating
agent, methylglyoxal. Activation of nrf2 may prevent biochemical
dysfunction and related functional responses of endothelial cells
induced by hyperglycaemia in which increased expression of
transketolase has a pivotal role. Activation of the nrf2 system
may emerge as a potent new target of therapeutic intervention.
Reference:
1. Xue et al., Diabetes 2008; 57: 2809–2817.
IL 8.3–5
Beyond oxidative stress - is there a cure for
vasoregression in the diabetic retina?
H. -P. Hammes, Y. Feng, F. Pfister and Q. Wang
University Medicine Mannheim, 5th Medical Department, Mann-
heim, GERMANY
Diabetic retinopathy is characterized by progressive occlusions
and increased permeability of retinal microvessels. The latter
leads to impaired vision in patients with long-standing diabetes
by affecting the macula, particularly in type 2 diabetes, the for-
mer causes neovascularizations in response to increasing tissue
hypoxia typically in the eyes of type 1 diabetic patients. Vaso-
regression in diabetic animal models is preceded by pericyte loss
which involves apoptotis, but also migration of subtypes of the
pericyte population. Pericytes exert a protective role for endo-
thelial cells in retinal capillaries, and pericyte loss may involve
the activation of the Angiopoietin-Tie system which regulates
vessel maturation during developmental angiogenesis. Angio-
poietin-2 (Ang-2) is the natural antagonist of Angiopoietin-1
(Ang-1). Ang-2 is expressed in three cell types of the retina, i.e.
the endothelial cell, the Mu¨ller cells, and the horizontal cells.
Ang-2 is highly upregulated in diabetic animals before the onset
of pericyte dropout, and the intravitreal injection and the intra-
retinal overexpression of Ang-2, both, trigger pericyte ejection
from capillaries. Superposition of diabetes to Ang-2 overexpress-
ing mice aggravate pericyte dropout and subsequent vasoregres-
sion. Ang-2 transcription is induced by hypoxia, and by
hyperglycemia. Chronic hyperglycemia causes the overproduction
of reactive oxygen species of mitochondrial sources which leads
to inhibition of the glycolytic substrate flux in cells exposed to
high glucose, and to the activation of biochemical pathways such
as the hexosamine pathway, and to overproduction of alpha-
oxoaldehyde-type AGEs. Methylglyoxal is the most abundant
intracellular AGE. Methylglyoxal modifies the corepressor
mSin3A in microvascular endothelial cells, resulting in recruit-
ment of the enzyme O-GlcNAc transferase to an mSin3A-Sp3
complex. Subsequently, Sp3 modification by O-linked N-acetyl-
glucosamine decreases its binding to a glucose-responsive GC
box in the Ang-2 promoter and increased binding of Sp-1 by
which Ang-2 transcription is activated. The same mechanism
operates in retinal Mu¨ller cells consistent with in vivo data from
retinae of diabetic rats and mice. The inhibition of metabolic
pathways involved in AGE production, and the shift from toxic
to non-toxic pathways have been successfull in the prevention of
experimental retinopathy. Novel approaches include the combi-
nation of antioxidant with prosurvival effects on the retinal
vasculature.
OP 8.3–1
Cogenic expression of FAT/CD36 in
spontaneously hypertensive rats ameliorates
insulin resistance and upregulates protein
kinase C
M. Klevstigova1, I. Markova2, O. Novakova3, L. Kazdova2,
M. Pravenec4 and F. Novak1
1Charles University Faculty of Science, Biochemistry, Prague 2,
CZECH REPUBLIC, 2Institute for Clinical and Experimantal
Medicine, Prague, CZECH REPUBLIC, 3Charles University
Faculty of Science, Cell Biology, Prague 2, CZECH REPUBLIC,
4Czech Acadamy of Science Institute of Physiology, Genetics of
Model – Diseases, Prague, CZECH REPUBLIC
Insulin resistance and lipid accumulation has been implicated in
the pathogenesis of cardiac disease in the metabolic syndrome.
To search for mechanism, we examined a role of fatty acid trans-
porter FAT/CD36 on protein kinase (PKC) delta, epsilon expres-
sion and triacylglycerols (TAG) content in spontaneously
hypertensive rats (SHR). SHR that lack FAT/CD36 and exhibit
disorders in lipid metabolism, impaired insulin action and glucose
intolerance was compared with the genetically modified SHR-
chr4 strain harbouring a segment of chromosome 4 from the
strain Brown Norway which possesses FAT/CD36. Two weeks
before sacrifice half of the animals were fed high-sucrose diet.
PKC delta expression was determined by western blotting in par-
ticulate and cytosolic fractions from left ventricles. SHR-chr4
had lower insulin level, free fatty acid concentration in serum
and higher relative amount of PKC epsilon in heart compared
with SHR fed standard chow. The high-sucrose diet increased the
serum insulin level in SHR-chr4 and the free fatty acid concen-
tration in both strains. In heart of SHR-chr4, the high sucrose
diet increased the relative amount of PKC delta in the particulate
fraction by 51% while had no effect on SHR. In SHR the high-
sucrose diet impaired the glucose tolerance during oral glucose
tolerance test. Results indicate that expression of FAT/CD36 in
the genetically modified SHR-chr4 improved tolerance to high
sucrose diet induced insulin resistance and that PKC delta may
play a role in this signalling pathway.
Acknowledgement: Supported by grant: MSM 0021620858.
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8.4. Cancer Stem Cells
IL 8.4–1
Cancer stem cells: genetics, epigenetics and
therapy
S. Sell
Wadsworth Center and Ordway Research Institute, Molecular
Medicine, Albany NY, USA
The origin of cancer from tissue stem cells for each of the major
causes of cancer will be presented and therapy directed to stem
cells discussed. (i) Teratocarcinoma serves as the prototype for
the development of cancer from germinal stem cells due to a field
or niche effect, and for induction of differentiation of cancer
stem cells (differentiation therapy). (ii) Exposure to chemicals
was thought to induce cancer by de-differentiation. However,
study of the cellular reactions of the liver exposed to chemical
carcinogens shows that liver cancers arise from maturation arrest
of liver stem and progenitor cells. (iii) Virus infections of adult
tissues were also thought to induce de-differentiation, but viruses
that cause cancer infect tissue stem cells (for example basal
epithelial cells) with resultant continued proliferation of imma-
ture cells. (iv) Leukemias provide examples of specific gene rear-
rangements (mutations) that produce constitutive signaling
lesions at various stages of differentiation (maturation arrest).
Specific reversal of the molecular lesions is effective in restoring
maturation. (v) Finally in gastric cancers associated with
H. Pylori infection, hypermethylation of the gastric epithelial
cells leads to field cancerization which is maintained by long-liver
gastric stem cells. The stem cell theory of cancer implies that
cancers are made up of the same cell populations as normal
tissues: stem cells, transit amplifying cells and mature terminally-
differentiated cells. Better ways to identify and characterize
cancer stem cells are needed to be able to direct therapy to these
cells. Conventional therapies are directed toward the proliferating
transit amplifying cells. When these therapies are discontinued,
the cancer will often re-grow from the cancer stem cells, which
are not proliferating at the time therapy is administered. In order
to prevent re-growth new therapies must be developed that are
directed to the cancer stem cells.
IL 8.4–2
Epithelial-mesenchymal interaction: a
definition of the colon cancer stem cell niche
J. P. Medema1, L. Vermeulen1, K. Kemper1, F. de Sousa e
Melo1, M. Todaro2 and G. Stassi2
1LEXOR – Lab for Exp. Oncology and Radiotherapy, Academic
Medical Center (AMC), Amsterdam, THE NETHERLANDS,
2Department of Surgical and Oncological Sciences, Cellular and
Molecular Pathophysiology Laboratory – University of Palermo,
Palermo, ITALY
It is well described that colorectal cancer initiation and progres-
sion strongly depends on genetic alteration and thereby activa-
tion of the canonical Wnt signalling pathway. In tumors carrying
for instance a mutated APC, a high Wnt signalling is predicted
in all cancer cells. Nevertheless, by using a Wnt reporter GFP
construct, we found that xenografts of human colorectal cancers
display heterogeneous Wnt signalling, which correlates with the
heterogeneous nuclear beta-catenin localization. We further show
that the CSC marker CD133 and the clonogenic potential corre-
lates with the Wnt activity suggesting that regulation of the Wnt
signalling cascade in colorectal carcinomas harbouring APC
mutations occurs and is involved in maintaining a functional
colon-CSC compartment. This Wnt regulatory mechanism
implicates an extrinsic mechanism of regulation, potentially via a
niche-like organization. Whether a niche also applies for the
organization of the CSCs remains unexplored. However, using a
co-culture system, we showed that colonic myofibroblasts prevent
differentiation of colon CSCs and regulate their clonogenic
potential. We are currently defining the secreted paracrine factors
and exploring their potential regulation on Wnt signalling. More-
over we found that CSCs can activate and recruit myofibroblasts
in xenografts. Taken together these observations suggest the exis-
tence of an epithelial mesenchymal crosstalk that contributes to
the extrinsic control of tumor maintenance.
IL 8.4–3
Tumor associated fibroblasts – important
players in cancer
K. Smetana Jr
Charles University 1st Faculty of Medicine, Institute of Anatomy,
Prague, CZECH REPUBLIC
Malignant tumors are widely spread in humans and they form a
serious medical, economical and social problem. Despite of the
progress in cancer therapy, the prognosis of many patients is not
optimistic. Remarkable achievements in stem cell research delin-
eated new horizons of the improvement of cancer therapy
because the existence of cancer stem cell has been established.
Normal tissue stem cells require highly specialized microenviron-
ment necessary for the maintenance of their stemness. The
positive role of tumor stroma in course of vascularisation of
tumor bed has already been described. The sum of evidence that
cancer stromal fibroblasts exert an important role in cancer
progression is enlarged minimally in tumors of breast, pancreas,
colon, prostatic gland, skin and oral cavity. When coculture
normal keratinocytes with basal/squamous cell carcinoma associ-
ated fibroblasts, the phenotype of keratinocytes is heavily altered
to resemble cancer cells. Upregulation of genes for regulatory
factors/cytokines in tumor stromal fibroblasts seems to be
responsible for their biological activity. Nature of these fibro-
blasts is not well known yet, but principally they can originate in
local mesenchyme under the control of cancer cells or from
tumor cells undergoing epithelial-mesenchymal transition. The
participation of mesenchymal stem cells can be also possible.
Summarizing these data, similarly to embryonic development,
mesenchymal-epithelial interaction can play an important role in
tumor progression and its management may be a promising
future anticancer therapeutic tool.
Acknowledgement: Supported by Ministry of Education Youth
and Sports of the Czech Republic, projects No. 1M0538, NPVII
2B06106 and 0021620806.
IL 8.4–4
Cancer stem cells in radioresistance
M. Baumann and M. Krause
Department of Radiation Oncology, University Hospital of
Dresden, Dresden, GERMANY
Recent experiments support that cancer stem cells are a specific
subpopulation of all cancer cells, while the vast majority of
cancer cells are non-tumourigenic. The question whether cancer
stem cells may respond differently to radiotherapy or combined
modality treatment compared to the bulk of non-stem tumour
cells is of high importance for the field. Recurrent tumours after
radiotherapy originate by definition from at least one surviving
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cancer stem cell while permanent local tumour control requires
inactivation of all cancer stem cells. Local tumour control assays
therefore functionally measure survival of the subpopulation of
cancer stem cells, and can be considered as a gold standard in
this respect. In contrast changes in tumour volume after therapy,
i.e. tumour response, are governed by the changes in the mass of
tumour cells, i.e. primarily by the non-stem cells. Today the vast
majority of preclinical studies in cancer research use volume
dependent parameters such as tumour regression or tumour
growth delay as experimental endpoints. This carries the risk that
new treatments may be optimized for their effect on the bulk of
non-stem cancer cells, with no improvement in the curative
potential. Experimental and clinical data provide evidence for the
importance of cancer stem cell number and density for local
tumour control after radiotherapy. Experiments suggest that the
response of cancer stem cells and non-tumourigenic cells to radia-
tion and combined treatment may dissociate. It is currently not
clear whether this is caused by differences in the intrinsic radia-
tion sensitivity between cancer stem cells and non-tumourigenic
cells or whether other factors cause this effect.
IL 8.4–5
Regulation of normal and leukemic human
stem cells in immune deficient mice
T. Lapidot
Weizmann Institute of Science, Immunology, Rehovot, ISRAEL
The hallmark of hematopoietic stem cells is their motility, self-
renewal and developmental potential. Blood forming stem cells
are defined in transplantation assays based on their functional
ability to migrate to the recipient bone marrow and to durably
repopulate it with immature and maturing leukocytes that contin-
uously replenish the blood circulation. Functional, preclinical
models for normal and leukemic human stem cells were devel-
oped using immune deficient NOD/SCID mice as recipients.
These models identified normal human SCID repopulating cells
as well as SCID leukemia initiating cells, obtained from some
myeloid (AML) and lymphoid (Pre B ALL) leukemias. Engraft-
ment kinetics and repopulation potential of human AML and
Pre B ALL stem and progenitor cells in transplanted immune
deficient mice can predict clinical outcome. The chemokine SDF-
1 is the only powerful chemotactic factor for both human and
murine stem cells, which functionally express its major receptor
CXCR4. Engraftment and repopulation of immune deficient mice
by normal and leukemic human stem cells are dependent on
SDF-1/CXCR4 interactions. Homing, retention, release and stem
cell mobilization are tightly regulated processes, which involve
bone turnover and an interplay between cytokines, chemokines,
adhesion molecules and proteolytic enzymes. The roles of osteo-
clasts, CD44, MT1-MMP and RECK in stem cell regulation will
be discussed. Both normal and leukemic human stem and
progenitor cells functionally express neurotransmitter receptors,
which are involved in regulation of their motility and prolifera-
tion. In summary, stem cells are directly and indirectly regulated
by dynamic interactions of the nervous and immune systems with
the microenvironment.
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8.5. Proteomics in Health and Diseases
IL 8.5–1
Clinical chemistry and proteomics
D.F. Hochstrasser
Geneva University Hospital, Department of Genetics & Laboratory
Medicine, Geneva, SWITZERLAND
Diseases are either due to genes and/or the environment; the
environment is divided in two: microbes & toxics. Many diseases
including toxics and drugs can damage progressively multiple
organs without any patient warning or symptoms. Patients can
loose roughly up to 40 percent of several organ functions without
any degradation of their well being in normal resting condition.
Therefore, clinical biomarkers are needed to evaluate the pre-
sence and the development of organ damage. Historically,
laboratory medicine has moved from metabolomics to proteo-
mics, to transcriptomics and to genomics. The first few measured
biomarkers were metabolites such as glucose or urea. The follow-
ing biomarkers were proteins, especially enzymes. More recently
gene transcripts and genes were used as biomarkers. The omic
progression has brought new powerful tools especially in proteo-
mics and mass spectrometry. Proteomic and proteomic derived
methods offer today to laboratory medicine tools to discover bio-
markers in cancer, to unravel blood peptide modifications due to
toxics or to screen for drugs and metabolites. Several recent
developments will highlight the impact of proteomics and small
molecule screening in clinical chemistry and biochemistry.
IL 8.5–2
The coordination of phosphorylation and PTM
in heart failure and with cardiac
resynchronization therapy
J. Van Eyk, G. Agnetti, B. Stanley, C. Murray, L. Kane and
D. Kass
Johns Hopkins University, Medicine, Baltimore, MD, USA
Cardiac resynchronization therapy (CRT) has become an effec-
tive clinical treatment for heart failure (HF) patients leading to
improvement in heart function, clinical symptoms and survival.
Yet, the molecular mechanisms behind the therapeutic benefit of
CRT are not known. Our latest data shows that dyssynchrony-
induced heart failure (DHF) and CRT affect the mitochondrial
subproteome by altering specific key proteins in cellular redox
control and oxidative phosphorylation (OxPhos) pathways, mani-
fested as changes in both protein quantity and PTMs within the
mitochondria. As well phosphorylation and other PTM regulate
the myofilament proteome which are responsible for the contrac-
tion of the heart, itself. The interplay between the mitochondria
and myofilament maybe through a coordination of phosphoryla-
tion pathways. Cardiac mitochondria and myofilament proteins
isolated from the left ventricle of a large mammalian model of
produced by 3 weeks of rapid pacing and compared to control
unpaced hearts and hearts that underwent three additional weeks
of either synchronized or desynchronized pacing. CRT resulted
in increase efficient ATP production, reduced ROS production
from complex I and increased enzymatic activity of ATP syn-
thase, complex V. These functional improvements have been cor-
related to a number of novel phosphorylated amino acid
residues. In fact, specific phosphorylations have now been corre-
lated or causatively linked to different Oxidative phosphorylation
functional aspects including enzymatic activity, supercomplex for-
mation and ROS production. Phosphorylation changes also
occur to the myofilament proteins including the identification of
two novel sites that change with CRT. The overall, the phos-
phorylation changes results in improved myofilament ATPase
activity and force production. We proposed that the role of phos-
phorylation is involved in the functional reversal seen with CRT.
IL 8.5–3
Ras nanoclustering and inter cellular transfer:
biology, proteomics and exploitation for
cancer therapy
Y. Kloog
Tel-Aviv University, Neurobiology, Tel Aviv, ISRAEL
The recent recognition of new types of cell–cell communication
pathways challenges classic theories of cell autonomy. Evidence
of functional ‘proteome mixing’ among interacting cells, particu-
larly immune cells, supports the notion that no cell is an island,
and that even these ‘unsplittable’ units are actually non-autono-
mous. We present our results on the cell-contact-dependent inter-
cellular transfer of proteins including oncogenic Ras and of
microRNA. We show by that human lymphocytes acquire from
the cells they scan the inner-membrane protein H-Ras, a G-pro-
tein vital for common lymphocyte functions and a prominent
participant in human cancer. The acquisition of oncogenic H-
RasG12V by natural killer (NK) and T lymphocytes had impor-
tant biological functions in the adopting lymphocytes: the trans-
ferred H-RasG12V induced ERK phosphorylation, increased
interferon-c and tumor necrosis factor-a secretion, enhanced
lymphocyte proliferation, and augmented NK-mediated target
cell killing. Our findings reveal a novel mode of cell-to-cell
communication allowing lymphocytes to extend the confines of
their own proteome, which may moreover play an important role
in natural tumor immunity. These phenomena suggest exciting
new possibilities for proteome research, focusing on system-level
proteomics that characterize cell contents and functions in the
context of intercellular protein transfer.
IL 8.5–4
Profiling CD antigens on leukaemias with an
antibody microarray
R. Christopherson1, N. Barber1, S. Gez1, L. Belov1, S. Mulligan2
and A. Woolfson3
1University of Sydney, Molecular and Microbial Biosciences,
Sydney, AUSTRALIA, 2Royal North Shore Hospital,
Haematology, St. Leonards, AUSTRALIA, 3Addenbrooke’s
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Cambridge, UK
Cluster of differentiation (CD) antigens are defined when two or
more independently developed monoclonal antibodies exhibit
similar patterns of reactivity with a standard panel of human
cells. Monoclonal antibodies to surface CD antigens on leuko-
cytes have been used for flow cytometry, and more recently to
construct microarrays that capture live cells. These DotScan
microarrays enable the rapid and highly parallel characterization
of repertoires of CD antigens whose expression patterns may be
correlated with discrete leukaemia subtypes, or used to define
biomarker ‘signatures’ for non-haematological diseases. DotScan
with fluorescence multiplexing enables profiling of CD antigens
for minor subsets of cells, such as colorectal cancer cells and
tumour-infiltrating lymphocytes from a surgical sample.
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IL 8.5–5
Proteomics of anti-cancer drugs
H. Kovarova1, J. Martinkova1, R. Hrabakova1, H. Skalnikova1,
P. Novak2, M. Hajduch3 and S.J. Gadher4
1Institute of Animal Physiology and Genetics AS CR v.v.i.,
Developmental and Reproductive Biology, Libechov, CZECH
REPUBLIC, 2Institute of Microbiology AS CR v.v.i., Laboratory
of Molecular Structure Characterisation, Prague, CZECH
REPUBLIC, 3Palacky University, Laboratory of Experimental
Medicine, Olomouc, CZECH REPUBLIC, 4Millipore Bioscience,
St.Charles, MO, USA
Clinical importance of biomarkers as a ‘handle’ for monitoring
therapeutic response is of growing importance. Our study is
focused on monitoring molecular mechanisms of response to
anti-cancer drugs at earlier time intervals to detect relevant
proteins that are responsible for primary changes in signalling
networks that subsequently lead to irreversible anti-cancer
processes. The effects of typical representatives of conventional
chemotherapy at half-time to apoptosis were evaluated using
classification of 2-D protein maps by multivariate analyses. Only
about 2% of total variances represented differences that enabled
grouping of relevant anti-cancer drugs. The proteins specific for
the response to individual drugs as well as those overlapping
among different types of drugs were identified. This aspect of the
study was enhanced using additional proteomic approaches
including quantitative mass spectrometry to monitor proteins
typical for response to the group of platinum – based anti-cancer
drugs.
Acknowledgement: We acknowledge support of grants from
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Study of urinary proteomes in anderson-fabry
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L. Vojtova1, T. Zima1, V. Tesar2, J. Michalova3, P. Prikryl3,
G. Dostalova4 and A. Linhart4
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Charles University in Prague First Faculty of Medicine and
General Teaching Hospital in Prague, Prague, CZECH
REPUBLIC, 2Department of Nephrology, Charles University in
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in Prague, Prague, CZECH REPUBLIC, 3Charles University in
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in Prague, Institute of Pathological Physiology and Center of
Experimental Hematology, Prague, CZECH REPUBLIC, 42nd
Department of Internal Cardiovascular Medicine, Charles
University in Prague First Faculty of Medicine and General
Teaching Hospital in Prague, Prague, CZECH REPUBLIC
Background: Anderson–Fabry disease (AFD), an X-linked
genetic disorder with deficient a-galactosidase A activity, is char-
acterized by kidney disease and kidney failure, particularly in
affected hemizygous men. The main aim of this work was to
analyze differences between healthy controls and AFD patients
and to identify abnormal proteins using MALDI-TOF mass
spectrometry (MS) as possible biomarkers of disease.
Material and methods: We studied 2D electrophoreograms of
samples from AFD patients and healthy individuals. The proteins
were separated by the isoelectric focusing method (IEF). The
second dimensional separation was performed using SDS-PAGE.
The proteins were then visualized by the Silver Method.
Separated proteins were characterized by MALDI-TOF MS.
Results: We found that the urinary spectra of all samples with
Fabry disease included identical proteins with molecular weight
around 20–40 kDa. There was no significant difference in number
of spots on the electrophoreograms from patients with Fabry
disease compared with healthy donors. However some proteins in
AFD patients¢ samples were increased more than three times.
Abundant proteins were characterized by MALDI-TOF MS
included alpha-1-antitrypsin, alpha-1-microglobulin, prosta-
glandin H2 D-isomerase, complement – c1q tumor necrosis
factor-related protein, and Ig kappa chain V-III. Possible glyco-
sylation of Asn51 and Asn78 could occur in prostaglandin H2
D-isomerase.
Conclusions: AFD urinary proteomics revealed an increased
secretion of several proteins. The difference in the amount and
position of H2 D-isomerase could be due to different glycosyla-
tion in AFD and should be studied as a potential biomarker of
the disease.
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